Last update :
19/09/2020
Filters  
Authors : Type :
Title :
Publication : Année :  
Research teams :
Pharmacological Class :
References   References  
1510 Book
AHFS Formulary service 2000 Bethesda - 3546 p

2000
3291 Journal
Acta Pol Pharm 2012 ; 69, 1: 95-105.
Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
Kodym A, Bilski P, Domanska A, Lukasz Helminiak, Jablonska M, Jachymska A.
2012
3316 Journal
Chem Pharm Bull 2012 ; 60, 1: 86-93.
A 5% Glucose Infusion Fluid Provokes Significant Precipitation of Phenytoin Sodium Injection via Interruption of the Cosolvent Effect of Propylene Glycol.
Onuki Y, Ikegami-Kawai M, Ishitsuka K, Hayashi Y, Takayama K.
2012
3958 Journal
J Infect Dis 1988 ; 157, 3: 600-601.
A Dilute Solution of Vancomycin and Heparin Retains Antibacterial and Anticoagulant Activities .
Henrickson K.J; . Powell K.R; . Schwartz C.L.
1988
2242 Journal
Int J Pharm 1998 ; 167, 1-2: 223-228.
A note on the solution chemistry of carboplatin in aqueous solutions.
Lederer M, Leipzig-Pagani E.
1998
1232 Journal
Br J Pharm Pract 1987 ; 9: 223-226, 236.
A physical compatibility study of furosemide & flucloxacillin injections.
Beatson C, Taylor A.
1987
3847 Journal
J Pain Palliat Care Pharm 2016 ; 29, 4: 370-373.
A Pilot Chemical and Physical Stability Study of Extemporaneously Compounded Levetiracetam Intravenous Solution.
Raphael C.D, Zhao F, Hughes S.E, Juba K.M.
2016
401 Journal
Aust J Hosp Pharm 1991 ; 21: 115-118.
A preliminary study of the stability of midazolam in polypropylene syringes.
Peterson GM, Khoo BHC, Galloway JG, Paterson J.
1991
2203 Journal
J Oncol Pharm Practice 2007 ; 13: 119-126.
A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'.
Kaestner S, Sewell G.
2007
2560 Journal
Aust J Hosp Pharm 1994 ; 24: 312-316.
A short-term stability study of an oral solution of dexamethasone.
Accordino A, Chambers R, Thomson B.
1994
3279 Journal
J Clin Pharm Ther 2012 ; 37, 1: 71-73.
A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care.
Al-Tannak N.F, Cable C.G, McArthur D.A, Watson D.G
2012
3817 Poster
Gerpac Congress, Giens, France 2015
A stability study of 25 mg/mL phenylephrine hydrochloride and 5 mg/mL tropicamide eye drops.
Stordeur F, Chanat C, Brandely M.L, Chast F.
2015
3685 Journal
EJHP 2017 ; 24:4 : 235-241
A stability study of amphotericin B, colistin and tobramycin in a hydrophilic suspension commonly used for selective decontamination of the digestive tract by HPLC and in vitro potency measurements.
Pfeifer C, Noll S, Gerecke H, Fassauer G, Jira T, Remane Y , Vogel J, Frontini R, Reinhardt R.
2017
3438 Journal
J Pharm Biomed Anal 2013 ; 83 : 164-170.
A stability-indicating, ion-pairing, reversed-phase liquid chromatography method for studies of daunorubicin degradation in i.v. infusion fluids.
Respaud R, Quenum L, Plichon C, Tournamille J.F, Gyan E, Antier D, Viaud-Massuard M.C.
2013
554 Journal
J Parenter Sci Technol 1991 ; 45: 212-217.
A study of the interaction of selected drugs and plastic syringes.
Speaker TJ, Turco SJ, Nardone DA, Miripol JE.
1991
525 Journal
Int J Pharm 1990 ; 65: 49-56.
A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters.
De Vroe C, De Muynck C, Remon JP, Samsom M.
1990
2894 Journal
J Dermatolog Treat 2004 ; 15: 295-302.
A topical azythromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC, Sangha ND, Mc Carty MA et al.
2004
4045 Journal
J Pharm Biomed Anal 2016 ;124:365-373
A UHPLC-UV-QTOF study on the stability of carfilzomib, a novel proteasome inhibitor.
Sestak V, Roh J, Klepalova L, Kovarikova P.
2016
1332 Journal
J Clin Hosp Pharm 1981 ; 6: 209-211.
Absorption of isosorbide dinitrate by PVC infusion bags and administration sets.
Lee MG, Fenton-May V.
1981
3595 Manufacturer
Hospira 2009
Aciclovir - Summary of Product Characteristics
2009
3933 Manufacturer
Teva Laboratoire 2015
Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit
2015
576 Journal
Drug Intell Clin Pharm 1980 ; 14: 353-357.
Activity of antibiotic admixtures subjected to different freeze-thaw treatments.
Holmes CJ, Ausman RK, Walter CW, Kundsin RB.
1980
1624 Journal
Am J Health-Syst Pharm 2000 ; 57: 760-762.
Activity of dalteparin sodium in propylene syringes.
Louie S, Chin A, Gill MA.
2000
811 Journal
Am J Health-Syst Pharm 1998 ; 55: 1296-1298.
Activity of enoxaparin sodium in tuberculin syringes for 10 days.
Charland SL, Davis DD, Tillman DJ.
1998
375 Journal
Am J Hosp Pharm 1991 ; 48: 1511-1514.
Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes.
Patel JP, Tran LT, Sinai WJ, Carr LJ.
1991
1242 Journal
Pharm Weekbl [Sci] 1988 ; 10: 213-216.
Adsorption of human and porcin insulins to intravenous administration sets.
Tol A, Quik RFP, Thyssen JHH.
1988
2119 Journal
Eur J Anaesthesiol 2003 ; 20: 124-126.
Adsorption of sufentanil to epidural filters and catheters.
Westphal M, Hohage H, Buerckle H, Van Aken H, Ermert T, Brodner G.
2003
167 Journal
Int J Pharm 1994 ; 103: 87-92.
Adsorption of vincristine, vinblastine, doxorubicin and mitoxantrone to in-line intravenous filters.
Francomb MM, Ford JL, Lee MG.
1994
3508 Manufacturer
Sanofi Aventis Group 2013
Aflibercept (Zaltrap®) - Summary of Product characteristics
2013
3635 Manufacturer
Novartis Pharmaceuticals UK Ltd 2015
Aldesleukine (Proleukin®) - Summary of Product Characteristics
2015
3417 Poster
ADKA Congress, Dresden, Germany 2013
Aliquotierte Levosimendanlösungen - stabil ?
Trittler R, Hecklinger J.
2013
3616 Manufacturer
Boehringer Ingelheim 2012
Altéplase (Actilyse®) - Résumé des caractéristiques du produit
2012
4471 Manufacturer
Kyowa Kirin Pharma 2019
Amétycine 10 mg poudre pour solution injectable -*Résumé des caractéristiques du produit - Oct 10, 2019
2019
3598 Manufacturer
Clinigen Healthcare Ltd 2016
Amifostine (Ethyol®) - Résumé des caractéristiques du produit
2016
3549 Manufacturer
B Braun 2012
Amikacine B Braun - Résumé des caractéristiques du produit.
2012
3524 Manufacturer
Sanofi 2013
Amiodarone hydrochloride (Cordarone®) - Summary of Product Characteristics.
2013
3527 Manufacturer
Glaxo Smith Kline 2018
Amoxicillin (Amoxil®) – Summary of Product Characteristics
2018
1702 Journal
Krankenhauspharmazie 1994 ; 15: 592-595.
Amoxicillin, clavulansaür und metronidazol in kombination.
Strehl E, Heni J.
1994
3545 Manufacturer
Mylan SAS 2009
Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit
2009
265 Journal
Am J Health-Syst Pharm 1995 ; 52: 1463-1464.
Amphotericin B does not mix with fat emulsion.
Trissel LA.
1995
1498 Journal
Ann Pharmacotherapy 1996 ; 30: 409-412.
Amphotericin B formulated in a lipid emulsion.
Cleary JD.
1996
2043 Journal
Antimicrob Agents Chemother 1998 ; 42: 762-766.
Amphotericin B in lipid emulsion : stability, compatibility, and in vitro antifungal activity.
Walker S, Tailor SAA, Lee M, Louie L, Louie M, Simor AE.
1998
793 Journal
J Antimicrob Chemother 1996 ; 37: 1165-1169.
Amphotericin B intralipid formulation: stability and particule size.
Ranch?re JY, Latour JF, Fuhrmann C, Lagallarde C, Loreuil F.
1996
984 Journal
Ann Pharmacotherapy 1996 ; 30: 298.
Amphotericin B is incompatible with lipid emulsions.
Ericsson O, Hallmen AC, Wikstrom I.
1996
3398 Manufacturer
Gilead Science (France) 2013
Amphotéricine B (Ambisome®) - Résumé des caractéristiques du produit)
2013
3591 Manufacturer
Bristol Myers Squibb 2011
Amphotericine B (Fungizone®) - Résumé des caractéristiques du produit
2011
1392 Journal
Can J Hosp Pharm 1999 ; 52: 90.
Ampicillin and ciprofloxacin incompatibility.
Lewis GM, Donnelly RF.
1999
3528 Manufacturer
Essential generics 2012
Ampicillin sodium – Summary of Product Characteristics
2012
3576 Manufacturer
Prostrakan 2012
Amsacrine (Amsalyo®) - Résumé des caractéristiques du produit
2012
805 Journal
Hosp Pharm 1997 ; 32: 1013-1020.
An automated process for determining the physical compatibility of drugs.
Oskroba DM, Leissing NC, Trissel LA.
1997
3760 Journal
J Oncol Pharm Practice 1996 ; 2: 107-112.
An evaluation of the stability of granulocyte colony stimulating factor on the short-term storage and delivery from an elastomeric infusion system.
Tivnann H, Gaines-Gas R, Thorpe R et al.
1996
124 Journal
Int Pharm J 1993 ; 7: 14-19.
An in vitro interaction between promethazine hydrochloride and chloroquine phosphate.
Abubakar AA, Mustapha A, Wambebe OC.
1993
3725 Journal
Dysphagia 2014
An investigation into the stability and sterility of citric acid solutions used for cough reflex testing.
Falconer J.R, Wu Z, Lau H, Sue J, Wang L, Pottinger S, Lee E, Alazawi N, Kalllesen M, Gargiulo D.A, Swift S, Svirskis D.
2014
3190 Journal
Advance in Haematology 2009 Article ID 704928, 5 page
An NMR Study of the Bortezomib Degradation under Clinical Use Conditions.
Bolognese A, Esposito A, Manfra M, Catalano L, Petruzziello F, Martorelli MC, Pagliuca R, Mazzarelli V, Ottiero M, Scalfaro M,
2009
1895 Journal
J Pharm Biomed Anal 2004 ; 35: 57-64.
Analysis by liquid chromatography and infrared spectrometry of di(2-ethylhexyl)phtalate released by multilayer infusion tubing.
Bourdeaux D, Sautou-Miranda V, Bagel-Boithias S, Boyer A, Chopineau J.
2004
1917 Journal
J Pharm Biomed Anal 1997 ; 15: 537- 543.
Analysis of gentamicin sulfate and a study of its degradation in dextrose solution.
Graham AE, Speicher E, Williamson B.
1997
2148 Journal
Anal Biochem 2002 ; 309: 117-126.
Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum.
Lanvers C, Pinheiro JPV, Hempel G, Wuerthwein G, Boos J.
2002
3567 Manufacturer
Pfizer 2020
Anidulafungin (Ecalta®) - Summary of Product Characteristics.
2020
3006 Journal
J Am Acad Dermatol 1987 ; 16: 984-988.
Anthralin stability in various vehicles.
Green PG, Kennedy CT, Forbes DR.
1987
1230 Journal
Br J Pharm Pract 1986 ; 8: 218-220.
Anti-emetic / diamorphine mixture compatibility in infusion pumps.
Regnard C, Pashley S, Westrope F.
1986
1893 Journal
Ann Pharmacotherapy 2004 ; 38: 569-573.
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC.
2004
1386 Journal
Pharm J 1983 ; 231- 233.
Antibiotic interactions.
Gove L.
1983
3952 Journal
Hemodial Int 2010 ; 14, 3 : 322-326.
Antibiotic lock: In vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37°C.
Battistella M,. Vercaigne L.M, Cote D,. Lok C.E.
2010
3951 Journal
Hemodial Int 2009 ; 13, 3: 322-328.
Antibiotic lock: In vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37°C
Battistella M, Walker S, law S, Lok C.
2009
1103 Journal
J Pediatr 1988 ; 112: 813-817.
Antibiotic stability in a pediatric parenteral alimentation solution.
Fox AS, Boyer KM, Sweeney HM.
1988
2268 Journal
Ann Pharmacotherapy 2008 ; 42, 4: 511-515.
AntiXa stability of diluted dalteparin for pediatric use.
Goldenberg NA, Jacobson L, Hthaway H, Tripputi M, Primeaux J, Child J.
2008
3615 Manufacturer
Archimeded Pharma 2012
Apomorphine (Apomorphine Archimedes®) - Résumé des caractéristiques du produit
2012
3227 Journal
Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives
Simon B, Hancu G, Gy?resi A.
2014
3295 Manufacturer
LFB Biom?dicaments 2018
Argatroban - Résumé Caractéristiques du Produit
2018
2277 Manufacturer
GlaxoSmithKline 2008
Argatroban - Summary of Product Characteristics
2008
1916 Manufacturer
Teva Pharma BV 2000
Arsenic trioxyde (Trisenox®) - Summary of Product Characteristic
2000
3445 Journal
Krankenhauspharmazie 2013 ; 34, 8: 410-411.
Aseptische Herstellung applikationsfertiger Adrenalin-Dauerinjektionen 20 µg/ml.
Heeb R.M, Thiesen J, Krämer I.
2013
1160 Journal
Int J Pharm 1986 ; 32: 123-131.
Aspects of the degradation kinetics of doxorubicin in aqueous solution.
Beijnen JH, van der Houwen OAGJ, Underberg WJM.
1986
4292 Journal
Drugs R D 2019
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion.
Vimpolsek M, Gottar-Guillier M, Rossy E.
2019
2139 Journal
EJHP Science 2006 ; 12,5: 96-99.
Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities.
Serrurier C, Chenot ED, Vigneron J, May I, Demor? B.
2006
2815 Journal
EJHP 2009 ; 15, 4: 30-32.
Assessment of stability in extemporaneously prepared venlafaxine solutions.
Kervale JG, Castagnet S, Chiadmi F, Schlatter J, Benabadji Z, Cisternino S, Fontan JE.
2009
4434 Journal
Clin Ther 2019 ; 41, 10: 2162-2170.
Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L.
2019
1873 Journal
Clin Ther 2003 ; 25: 1219-1224.
Assessment of the stability of dalteparin sodium in prepared syringes for up to thirty days/ In vitro study.
Laposata M, Johnson SM.
2003
1608 Journal
Int J Pharm Compound 2001 ; 5: 397-400.
Assessment of the stability of teicoplanin in intravenous infusions.
Galanti LM, Hecq JD, Jeuniau P, Vanbeck D, Jamart J.
2001
4269 Manufacturer
Roche 2019
Atezolizumab (Tecentriq®) - Summary of Product Characteristics
2019
3629 Manufacturer
Actavis UK 2014
Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics
2014
3676 Manufacturer
Hospira 2014
Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit
2014
711 Journal
Am J Hosp Pharm 1980 ; 37: 492-496.
Avaibility of diazepam from plastic containers.
Cloyd JC, Vezeau C, Miller KW.
1980
177 Journal
Am J Health-Syst Pharm 1995 ; 52: 2213-2216.
Avaibility of lorazepam after simulated administration from glass and polyvinyl chloride containers.
Mancano MA, Boullata JI, Gelone SP, Zitterman RE, Borenstein MR.
1995
1102 Journal
Eur J Clin Pharmacol 1981 ; 19: 181-185.
Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems.
Cossum PA, Roberts MS.
1981
3236 Manufacturer
Celgene 2011
Azacitidine (Vidaza®) - Résumé des caractéristiques du produit
2011
3547 Manufacturer
Sanofi-Aventis France 2011
Aztréonam (Azactam®) - Résumé des caractéristiques du produit
2011
94 Journal
Am J Hosp Pharm 1990 ; 47: 1970.
Aztreonam-vancomycin incompatibility.
Chandler SW, Folstad J, Trissel LA.
1990
3683 Manufacturer
Aguettant 2014
Baclofen - Résumé des caractéristiques du produit
2014
2729 Journal
J Pharm Clin 1995 ; 14, 2: 106-111.
Bains de bouche antifongiques: études de stabilité.
Vincent I, Schmit B, Houze S, benhaiem N, Jacques L, Taburet AM.
1995
3261 Manufacturer
Bristol Myers Squibb 2011
Belatacept (Nulojix®) – Résumé des caractéristiques du produits
2011
3936 Manufacturer
GlaxoSmithKline Laboratoire 2016
Bélimumab (Benlysta®) – Résumé des caractéristiques du produits
2016
3721 Manufacturer
Spectrum Pharmaceuticals 2014
Belinostat (Beleodaq®) - Summary of Product Characteristics
2014
3158 Manufacturer
Astellas Pharma GmbH 2014
Bendamustine (Levact®) - Summary of Product Characteristics
2014
2288 Manufacturer
Cephalon 2008
Bendamustine hydrochloride (Treanda®) – Summary of Product Characteristics
2008
3585 Manufacturer
Genus Pharmaceuticals 2008
Benzylpenicillin sodium - Summary of Product Characteristics
2008
3978 Journal
Am J Health-Syst Pharm 2017 ; 74,9: 202-210
Beyond-use dating of lidocaine alone and in two “magic mouthwash” preparations.
Kirk L.M, Brown S.D, Luu Y, Ogle A, Huffman J, O. Lewis P.O.
2017
1269 Journal
J Clin Pharm Ther 1988 ; 13: 335-340.
Binding of drugs to end-line filters: a study of four commonly administered drugs in intensive care units.
DeMuynck C, De Vroe C, Remon JP, Colardyn F.
1988
857 Journal
Am J Hosp Pharm 1983 ; 40: 1323-1328.
Binding of selected drugs to a “treated” inline filter.
Kanke M, Eubanks JL, DeLuca PP.
1983
3696 Journal
Braz J Pharm Sci 2012 ; 48, 4: 691-698.
Biological and physicochemical stability of ceftazidime and aminophylline on glucose parenteral solution.
Santos C.A.D, Oliveira-Nascimento L, Knirsch M.C, Stephano M.A, Pessoa J?nior A, Penna T.C.V.
2012
3539 Manufacturer
The Medecines Company 2013
Bivalirudin (Angiox®) - Summary of Product Characteristics.
2013
4154 Manufacturer
Accord Health Care 2018
Bleomycin sulfate- Summary of Product Characteristics
2018
3646 Manufacturer
Sanofi Aventis France 2013
Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit
2013
3774 Manufacturer
Amgen 2016
Blinatumomab - (Blincyto®) - Summary of Product Characteristics
2016
1911 Manufacturer
Janssen-Cilag Ltd 2016
Bortezomib (Velcade®) - Summary of Product Characteristics
2016
3537 Journal
Krankenhauspharmazie 2013 ; 34,11: 500-505.
Bortezomib zur subkutanen Applikation.
Lipp HP, Gfr?rer W, Riedm?ller S.
2013
3495 Manufacturer
Takeda 2013
Brentuximab (Adcetris®) - Summary of Product Characteristics
2013
705 Journal
Am J Hosp Pharm 1981 ; 38: 183-187.
Bretylium tosylate admixture compatibility. II : Dopamine, lidocaine, procainamide, and nitroglycerin.
Lee YC, Malick W, Amann AH, Baaske DM, Shah JJ, Wagenknecht DM, Carter JE.
1981
743 Journal
Am J Hosp Pharm 1980 ; 37: 803-808.
Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
Lee YC, Baaske DM, Amann AH, Carter JE, Mooers MA, Wagenknecht DM, Lai CM.
1980
2878 Journal
Can J Hosp Pharm 2009 ; 62, 5: 375-380.
Buffered Lidocaine Hydrochloride Solution With and Without Epinephrine: Stability in Polypropylene Syringes.
Pascuet E, Donnelly RF, Garceau D, Vaillancourt R.
2009
3653 Manufacturer
Laboratoire L?o 2013
Bumétanide (Burinex®) - Résumé des caractéristiques du produit
2013
3684 Manufacturer
Laboratoire L?o 2012
Bumétanide (Burinex®) - Résumé des caractéristiques du produit
2012
3237 Manufacturer
Sanofi Aventis France 2011
Cabazitaxel (Jevtana®) - Résumé des caractéristiques du produit.
2011
3644 Manufacturer
Hameln Pharmaceuticals 2010
Calcium gluconate® - Summary of Product Characteristics
2010
4345 Journal
Pharmaceutical Technology in Hospital Pharmacy 2019
Carbidopa Capsules for Insulinoma Diagnostic: Compounding and Stability Study.
Curti C, Mathias F, Savelli M, Garrigue P, Lamy E, Guillet B, Vanelle P.
2019
2253 Journal
J Synchrotron Rad 2001 ; 8: 716-718.
Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS.
Curis E, Provost K, Bouvet D, Nicolis I, Crauste-manciet S, Brossard D, B?nazeth S.
2001
2254 Journal
New J Chem 2000 ; 24: 1003-1008.
Carboplatin decomposition in aqueous solution with chloride ions monitored by X-ray absorption spectroscopy.
Curis E, Provost K, Nicolis I, Bouvet D, B?nazeth S, Crauste-Manciet S, Brion F, Brossard D.
2000
3348 Manufacturer
Amgen 2016
Carfilzomib (Kyprolis®) - Résumé des caractéristiques du produit
2016
3314 Manufacturer
Bristol Myers Squibb 2011
Carmustine (Bicnu®) – Résumé des caractéristiques du produits
2011
3167 Journal
Farm Hosp 2010 ;34:293-7.
Carvedilol stability in paediatric oral liquid formulations.
Buontempo F, Bernabeu E, Glisoni RJ, Quiroga E, Bregni C, Chiappetta DA.
2010
4067 Journal
Pharmazie 2017 ;72:197-199
Caspofungin infusion solutions (50 mg/mL): chemical stability and antifungal activity against Candida spp.
Pinder N, Pelzl L.H; Walther G, Backhaus J, Kurzai O, Hoppe-Ticky T.
2017
1519 Manufacturer
Merck Sharp Dohme 2015
Caspofungine (Cancidas®) - Summary of Product Characteristics
2015
2343 Manufacturer
Fresenius Biotech 2009
Catumaxomab (Removab®)
2009
3546 Manufacturer
Panpharma SA 2007
Cefamandole Flavelab - Résumé des caractéristiques du produit
2007
1479 Journal
Krankenhauspharmazie 1995 ; 1: 9-12.
Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion.
Digel S.
1995
3548 Manufacturer
Bristol Myers Squibb 2007
Cefepime (Maxipime®) - Summary of Product caracteristics.
2007
3544 Manufacturer
Pfizer 2006
Cefoperazone (Cefobid®) - Summary of Product Characteristics
2006
1206 Journal
Am J Hosp Pharm 1983 ; 40: 564.
Cefoperazone-aminoglycoside incompatibility.
Frear RS.
1983
588 Journal
Am J Hosp Pharm 1979 ; 36: 33-38.
Cefoxitin sodium compatibility with intravenous infusions and additives.
O?Brien MJ, Portnoff JB, Cohen EM.
1979
3677 Manufacturer
Sanofi Aventis France 2008
Cefpirome (Cefrom®) - Résumé des caractéristiques du produit
2008
2902 Manufacturer
Forrest Pharmaceuticals 2015
Ceftazidime - avibactam (Avycaz®) - Summary of Product Characteristics
2015
3883 Manufacturer
Arrow 2016
Ceftazidime - Résumé des caractéristiques du produit
2016
273 Journal
Am J Health-Syst Pharm 1996 ; 53: 1302-1305.
Ceftazidime degradation rates for predicting stability in a portable infusion-pump reservoir.
Van Doorne V, Bernaards J, DeJonge P.
1996
697 Journal
Can J Hosp Pharm 1988 ; 41: 65-71.
Ceftazidime stability in normal saline and dextrose in water.
Walker SE, Dratnitsaris G.
1988
3543 Manufacturer
Wockhardt 2013
Ceftazidime – Summary of Product Characteristics
2013
3803 Manufacturer
Laboratoires Merck Sharp & Dohme Chibret 2020
Ceftolozane / tazobactam (Zerbaxa®) - Summary of Product Characteristics
2020
3828 Poster
ASHP Midyear 2015 2015
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
Thabit A.K, Hamada Y, Nicolau D.P.
2015
3523 Manufacturer
Roche 2018
Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
2018
2302 Manufacturer
Lettre AFFSAPS 30 November 2008 2008 ; 61, 5: 356-357.
Ceftriaxone et incompatibilités physico-chimiques, particulièrement avec les solutions contenant des sels de calcium.
2008
3687 Manufacturer
Stravencon 2013
Cefuroxime sodium - Summary of Product Characteristics
2013
275 Journal
Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
Cephalosporin-pentamidine isethionate incompatibilities.
Lewis JD, El-Gendy A.
1996
674 Journal
Can J Hosp Pharm 1992 ; 45: 237-242.
Cephalotin stability in normal saline, five percent dextrose in water, and Dianeal* solutions.
Walker SE, Paton TW, Oreopoulos DG.
1992
2220 Manufacturer
Merck Serono 2015
Cétuximab (Erbitux®) - Dossier scientifique
2015
2389 Journal
Am J Health-Syst Pharm 2003 ; 60: 69-74.
Characterization of an extemporaneous liquid formulation of lisinopril
Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL.
2003
410 Journal
Am J Hosp Pharm 1991 ; 48: 1500-1506.
Characterization of cisplatin degradation as affected by pH and light.
Zieske PA, Koberda M, Hines JL, Knight CC, Sriram R, Raghavan NV, Rabinow BE.
1991
2723 Journal
J Ped Hematol Oncol 2004 ; 26: 179-184.
Chemical and functional analysis of hydroxyurea oral solutions.
Heeney MM, Whorton MR, Howard TA.
2004
3898 Journal
EJHP 2016 ;23:288-293
Chemical and microbiological stability studies of an aqueous solution of pravastatin sodium salt for drug therapy of the dysphagic patients
Bonacucina G, Logrippo S, Cespi M, Ganzetti R, Casettari L, Sestili M, Perinelli D.R, Ricciutelli M, Marziali A, Polidori C, Pa
2016
3622 Journal
Int J Pharm Compound 2014 ; 18, 2 : 152-158.
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride.
Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L.
2014
2803 Journal
Respiratory Care 2008 ; 683, 12: 1716-1722.
Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium.
Bonasia PJ, McVicar WK, Williams B, Ong S.
2008
2201 Journal
EJHP Science 2007 ; 13, 3: 55-59.
Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers.
Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B.
2007
2188 Journal
EJHP Science 2007 ; 13, 2: 40-47
Chemical and physical stability of diluted busulfan infusion solutions.
Karstens A, Krämer I.
2007
482 Journal
J Parenter Sci Technol 1991 ; 45: 108-112.
Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids.
Beijnen JH, Beijnen-Bandhoe U, Dubbelman AC, Van Gijn R, Underberg WJM.
1991
436 Journal
Am J Hosp Pharm 1991 ; 48: 2635-2637.
Chemical and visual stability of amphotericin B in 5% dextrose injection stored at 4°C for 35 days.
Mitrano FP, Outman WR, Baptista RJ, Palombo JD.
1991
903 Journal
J Parenter Sci Technol 1993 ; 47: 35-39.
Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
Inagaki K, Gill MA, Okamoto MP, Takagi J.
1993
380 Journal
Crit Care Med 1995 ; 23: 1061-1066.
Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system.
Grillo JA, Gonzalez ER, Ramaiya A, Karnes HT, Wells B.
1995
1730 Journal
Act Pharm Nord 1991 ; 3: 251.
Chemical compatibility of mitoxantrone and etoposide (VP-16).
Bj?rkman S, Roth B.
1991
1461 Journal
J Pharm Pharmacol 1994 ; 46: 951-955.
Chemical incompatibility between procainamide hydrochloride and glucose following intravenous admixture.
Sianipar A, Parkin JE, Sunderland VB.
1994
585 Journal
J Clin Pharm Ther 1988 ; 13: 199-205.
Chemical stabilities of cefaperazone sodium and ceftazidime in 5% dextrose and 0.9% sodium chloride injections.
Das Gupta V, Bethea C, Dela Torre M.
1988
961 Journal
J Clin Pharm Ther 1990 ; 15: 187-196.
Chemical stabilities of cefuroxime sodium and metronidazole in an admixture for intravenous infusion.
Barnes AR.
1990
693 Journal
J Clin Pharm Ther 1988 ; 13: 329-334.
Chemical stabilities of famotidine and ranitidine hydrochloride in intravenous admixtures.
Das Gupta V, Parasrampuria J, Bethea C.
1988
631 Journal
J Parenter Sci Technol 1985 ; 39: 145-148.
Chemical stabilities of hydrocortisone sodium succinate and several antibiotics when mixed with metronidazole injection for intravenous infusion.
Das Gupta V, Stewart KR.
1985
2986 Journal
J Clin Pharm Ther 1988 ; 13: 165-169.
Chemical stabilities of isoetharine hydrochloride, metaproterenol sulphate and terbutaline sulphate after mixing with normal saline for respiratory therapy.
Gupta VD, Parasrampurian J, Gardner SN.
1988
1331 Journal
J Clin Hosp Pharm 1986 ; 11 : 449-452.
Chemical stabilities of lignocaine hydrochloride and phenylephrine hydrochloride in aqueous solution.
Das Gupta V, Steward KR.
1986
657 Journal
J Clin Pharm Ther 1996 ; 21: 173-175.
Chemical stability and adsorption of atracurium besylate injections in disposable plastic syringes.
Pramar YV, Loucas VA, Word D.
1996
667 Journal
J Clin Pharm Ther 1994 ; 19: 195-198.
Chemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringes.
Pramar YV, Moniz D, Hobbs D.
1994
2173 Journal
EJHP Science 2006 ; 12, 6: 135-139.
Chemical stability and microbiological potency of intravenous vancomycin hydrochloride syringes for use in the neonatal intensive care.
Grioffiths W, Favet J, Ing H, Sadeghipour F, Bonnabry P.
2006
1813 Journal
Int J Pharm Compound 2003 ; 7, 4: 310-312.
Chemical stability of cefuroxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Gupta VD.
2003
2875 Journal
Can J Hosp Pharm 2004 ; 57, 5: 283.287.
Chemical Stability of 4-Aminopyridine Capsules.
Donnelly RF.
2004
2319 Journal
EJHP Science 2009 ; 15, 1: 11-14.
Chemical stability of a solution of bupivacaine hydrochloride 0.125% and sufentanil citrate 0.5 µg/ml for filling syringes using a repeater pump.
Janssen K, Wisselo R, Geerlings C, Schouten J.P.
2009
2586 Journal
Br Assoc Dermatol 1998 ; 139 (suppl 52): 8-1.
Chemical stability of adepalene and tretinoin when combined with benzoyl peroxyde in presence and in absence of visible light and ultraviolet radiation.
Martin B, Meunier C, Montels D.
1998
2252 Journal
Neuromodulation 2007 ; 10, 1: 1-5.
Chemical stability of admixture combining ziconotide and bupivacaine during simulated intrathecal administration.
Shields D, Montenegro R, Aclan J.
2007
2249 Journal
Neuromodulation 2007 ; 10, 1: 12-17.
Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration.
Shields D, Montenegro R, Aclan J.
2007
2280 Journal
Int J Pharm Compound 2008 ; 12, 5: 463-466.
Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration.
Shields DE, Aclan J, Szatkowski A.
2008
2251 Journal
Neuromodulation 2005 ; 8, 4: 257-263.
Chemical stability of admixtures combining ziconotide with morphine or hydromorphone during simulated intrathecal administration.
Shields D, Montenegro R, Ragusa M.
2005
2298 Journal
Int J Pharm Compound 2008 ; 12, 6: 553-557.
Chemical stability of admixtures containing ziconotide 25 mcg/ml and morphine sulfate 10 mg/ml or 20 mg/ml during simulated intrathecal administration.
Shields D.E, Aclan J, Szatkowski A.
2008
647 Journal
Int J Pharm Compound 1997 ; 1: 347-348.
Chemical stability of amiodarone hydrochloride in intravenous fluids.
Pramar YV.
1997
2877 Journal
Int J Pharm Compound 2009 ; 13, 5: 445-446.
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms.
Das Gupta V.
2009
2737 Journal
J Pharm Pharmacol 1996 ; 48, 1: 22-26.
Chemical stability of artesunate injection and proposal for its administration by intravenous infusion.
Batty KT, Ilett KF, Timothy Davis ME.
1996
3534 Journal
Am J Health-Syst Pharm 2013 ; 70:2137-2142
Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage
Legeron R, Xuereb F, Djabarouti S, Saux M.C, Breilh D.
2013
3418 Journal
Int J Pharm Bio Sci 2013 ; 3, 1: 449-458.
Chemical stability of bortezomib solutions in original manufacturer vial at room temperature and in syringe at 4°C.
Berruezo garcia J, Espinosa Bosch M, Sanchez Rojas F, Bosch Ojeda C
2013
3349 Journal
Int J Pharm Bio Sci 2012 ; 2, 3: 344-350.
Chemical stability of bortezomib solutions in original manufacturer vials.
Bosch-Ojeda C, Sanchez-Rojas M.F, Espinosa-Bosch M.
2012
3180 Journal
Int J Pharm Compound 2011 ; 15, 1: 78-80.
Chemical stability of brompheniramine maleate in an oral liquid dosage form.
Gupta VD, Gupta VS.
2011
3086 Journal
Anaesthesia 2000 ; 55, 9: 853-858.
Chemical stability of bupivacaine, lidocaine and epinephrine in pH-adjusted solutions.
Robinson, J, Fernando, R, Sun Wai, W.Y., Reynolds, F.
2000
1814 Journal
Int J Pharm Compound 2003 ; 7, 2: 152-154.
Chemical stability of cefazolin sodium after reconstituting in 0.9% sodium chloride injection and storage in polypropylene suyringes for padiatric use.
Gupta VD.
2003
4244 Poster
2019
Chemical Stability of Cloxacillin in Sterile Water for Injection (SWFI) Stored in Polypropylene (PP) Syringes (50 and 100 mg/mL) and Glass Vials (250 mg/mL) at 4°C and 25°C.
Perks W, Marchensano R, Law S, Iazetta J, Walker SE.
2019
1229 Journal
Br J Pharm Pract 1990 ; 12: 53-54, 60.
Chemical stability of cytarabine and vinblastine injections.
Weir PJ, Ireland DS.
1990
1372 Journal
Int J Pharm Compound 2007 ; 11, 1: 79-81.
Chemical Stability of Desonide in Ear Drops.
Gupta,VD.
2007
1701 Journal
Int J Pharm Compound 2002 ; 6: 395-397.
Chemical stability of dexamethasone sodium phosphate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes.
Gupta VD.
2002
1806 Journal
Can J Hosp Pharm 2002 ; 55, 5: 307-312.
Chemical stability of dimenhydrinate in minibags and polypropylene syringes.
Donnely RF.
2002
1277 Journal
Can J Hosp Pharm 1999 ; 52: 150-155.
Chemical stability of diphenhydramine hydrochloride in minibags and polypropylene syringes.
Donnelly RF.
1999
4393 Poster
Sunnybrook Health Sciences Centre 2020
Chemical Stability of Epinephrine Diluted in 0.9% Sodium Chloride and Stored in Polypropylene (PP) Syringes at 4°C and 25°C.
Hook R, Riss V, Neault A, Ma N, Law S, Walker S.E.
2020
2886 Journal
Int J Pharm Compound 2009 ; 13, 3: 250-253.
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding.
Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S.
2009
4418 Journal
J Pediatr Pharmacol Ther 2004 ; 9, 4: 254-258.
Chemical Stability of Extemporaneously Prepared Lorazepam Suspension at Two Temperatures.
Ellaria Lee W-M, Lugo R.A, Rusho W.J, MacKay M, Sweeley J.
2004
2031 Journal
Int J Pharm Compound 2005 ; 9: 482-483.
Chemical stability of fentanyl in polypropylene syringes and polyvinylchloride bags.
Donnelly RF.
2005
1680 Journal
Int J Pharm Compound 2002 ; 6: 468-470.
Chemical stability of furosemide in minibags and polypropylene syringes.
Donnelly RF.
2002
2367 Journal
Int J Pharm Compound 2005 ; 9, 5: 399-401.
Chemical stability of hydralazine hydrochloride after reconstitution in 0.9% sodium chloride injection or 5% dextrose injection for infusion.
Gupta V.D.
2005
2835 Journal
Int J Pharm Compound 2007 ; 11, 3: 259-261.
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Das Gupta V.
2007
2659 Journal
Int J Pharm Compound 2010 ; 14, 2: 160-164.
Chemical stability of hydromorphone hydrochloride in patient-controlled analgesia injector.
Khondkar D, Chopra P, McArter JP, Rosen JA, Li SK.
2010
2837 Journal
Int J Pharm Compound 2005 ; 9, 2: 165-166.
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form
Das Gupta V, Sood A.
2005
1750 Journal
Int J Pharm Compound 1998 ; 2: 463-465.
Chemical stability of meperidine hydrochloride in polypropylene syringes.
Donelly RF, Bushfield TL.
1998
2843 Journal
Int J Pharm Compound 2004 ; 8, 6: 489-491.
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink
Donnelly R.
2004
1627 Journal
Int J Pharm Compound 2001 ; 5: 148-150.
Chemical stability of methylprednisolone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes.
Das Gupta V.
2001
1957 Journal
Int J Pharm Compound 2005 ; 9, 1: 72-74.
Chemical stability of metoclopramide hydrochloride injection diluted with 0.9% sodium chloride injection in polypropylene syringes at room temperature.
Gupta VD.
2005
2376 Journal
J Sep Sci 2007 ; 30, 12: 1233-1238.
Chemical stability of midazolam injection by high performance liquid chromatography.
de Diego M, Godoy G, Mennikent S.
2007
3998 Journal
Int J Pharm Compound 2017 ; 21:4 :347-351
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia.
Robert J, Sorrieul J, Rossignol E, Beaussart H, Kieffer H, Folliard C, Dupoiron D, Devys C.
2017
154 Journal
Pharm Res 1990 ; 7: 452-460.
Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.
Al-Razzak LA, Benedetti AE, Waugh WN, Stella VJ.
1990
3278 Journal
Int J Pharm Compound 2012 ; 16, 1: 80-81.
Chemical Stability of Pentoxifylline in a Topical Cream.
Gupta Vishnu D
2012
2849 Journal
Int J Pharm Compound 2005 ; 9, 6: 484-486.
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Das Gupta V.
2005
1631 Journal
Int J Pharm Compound 2008 ; 12, 4: 372-374.
Chemical stability of perphenazine in two commercially available vehicles for oral liquid dosage forms
Gupta VD.
2008
1891 Journal
Int J Pharm Compound 2004 ; 8, 2: 153-155.
Chemical stability of phenylephrine hydrochloride after reconstitution in 0.9% sodium chloride injection for infusion.
Gupta VD.
2004
2112 Journal
Int J Pharm Compound 2006 ; 10, 4: 318-319.
Chemical stability of pyridoxine hydrochloride 100 mg/ml injection, preservative free.
Gupta VD.
2006
2876 Journal
Int J Pharm Compound 2009 ; 13, 5: 438-439.
Chemical Stability of Scopolamine Hydrobromide Nasal Solution.
Das Gupta V.
2009
684 Journal
Ann Pharmacotherapy 1990 ; 24: 1056-1058.
Chemical stability of suramin in commonly used infusion fluids.
Beijnen JH, Van Gijn R, Horenblas S, Underberg WJM.
1990
3835 Journal
Current Ther Res 2015 ; 77: 99-104.
Chemical Stability of Telavancin in Elastomeric Pumps.
Sand P, Aladeen T, Kirkegaard P, LaChance D, Slover C.
2015
1933 Journal
Int J Pharm Compound 2004 ; 8, 5: 404-406.
Chemical stability of terbutaline sulfate injection after diluting with 0.9% sodium chloride injection when stored at room temperature in polyvinyl chloride bags.
Gupta VD.
2004
1827 Journal
J Parenter Sci Technol 1990 ; 44: 332-335.
Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation.
Beijnen JH, Van Gijn R, Underberg WJM.
1990
381 Journal
J Parenter Sci Technol 1993 ; 47: 166-171.
Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids.
Beijnen JH, Van Gijn R.
1993
527 Journal
J Clin Pharm Ther 1987 ; 12: 339-342.
Chemical stability of thiopental sodium injection in disposable plastic syringes.
Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR.
1987
172 Journal
J Parenter Sci Technol 1992 ; 46: 111-116.
Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
Beijnen JH, van Gijn R, Challa EE, Kaijser GP, Underberg WJM.
1992
2248 Journal
Neuromodulation 2007 ; 10, 1: 6-11.
Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration.
Shields D, Montenegro R.
2007
4412 Journal
J Pediatr Pharmacol Ther 2014 ;19,1:25–29.
Chiral Stability of an Extemporaneously Prepared Clopidogrel Bisulfate Oral Suspension.
Tynes C.R, Livingston B, Patel H, Arnold J.J.
2014
3326 Journal
J Pharm Pract and Res 2012 ; 42, 2: 106-110.
Chiral stability study of oral liquid clopidrogel formulations for infants.
Mihaila B, Ellis D, Rozek T, Milne R.
2012
3507 Manufacturer
AbbVie 2013
Chirocaine - Summary of Product Characteristics
2013
2199 Manufacturer
Mundipharma 2007
Chlorhydrate d'oxycodone (Oxynorm®)– Résumé des caractéristiques du produits
2007
3596 Manufacturer
Sanofi 2014
Chlorpromazine (Largactil®) - Summary of Product Characteristics
2014
3520 Manufacturer
Sanofi 2011
Cidomycin - Summary of product Chracteristics.
2011
3592 Manufacturer
Sandoz 2008
Cimetidine - Résumé des caractéristiques du produit
2008
1201 Journal
Am J Hosp Pharm 1981 ; 38: 1919-1922.
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.
1981
1203 Journal
Am J Hosp Pharm 1981 ; 38: 1173-1174.
Cimetidine hydrochloride compatibility with preoperative medications.
Yuhas EM, Lofton FT, Baldinus JG, Mayron D.
1981
747 Journal
Am J Hosp Pharm 1980 ; 37: 390-392.
Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids.
Rosenberg HA, Dougherty JT, Mayron D, Baldinus JG.
1980
1393 Journal
Pharm J 1987 ; 238: 290.
Ciprofloxacin lactate infusion.
Lyall D, Blythe J.
1987
3529 Manufacturer
Hospira 2013
Ciprofloxacin – Summary of Product Characteristics
2013
1500 Journal
Ann Pharmacotherapy 1996 ; 30: 87.
Ciprofloxacin-ampicillin sulbactam incompatibility.
Melonakos TK.
1996
3601 Manufacturer
Actavis 2012
Cisatracurium Actavis - Résumé des Caractéristiques du Produit
2012
3578 Manufacturer
Accord Healthcare 2011
Cisplatin - Summary of Product Characteristics
2011
4084 Manufacturer
Accord Health Care 2017
Cisplatine - Résumé des caractéristiques du produits
2017
3579 Manufacturer
Janssen Cilag 2005
Cladribine Janssen Cilag - Résumé des caractéristiques du produit
2005
3526 Manufacturer
Pharmacia 2010
Clindamycin (Dalacin®) - Summary of Product Characteristics
2010
2238 Manufacturer
Baxter 2018
Clinomel - Résumé des caractéristiques du produit
2018
2272 Manufacturer
Genzyme 2006
Clofarabine (Evoltra®) – Résumé des caractéristiques du produits
2006
4178 Journal
EJHP 2017 ; 25, e2
Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration.
Post T.E, Kamerling I van Rossen R, Burggraaf J, Stevens J, Dijkmans A, Heijerman H, Touw D, van Velzen A, Wilms E.
2017
1974 Journal
J Pain Symptom Manage 1996 ; 12, 3: 168-171.
Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility.
Chandler SW, Trissel LA, Weinstein SM
1996
1978 Journal
Clin Ther 1992 ; 14, 2: 192-195.
Comparative sorption of clomipramine, viloxazine and maprotiline hydrochlorides in polyvinylchloride bags and glass vials.
Airaudo C, Bianchi C, Verdier M, Gayte-Sorbier A.
1992
4317 Journal
J Pharm Technol 2019 ;35,3:105-109
Comparative Stability of Oral Vitamin K Liquids Stored in Refrigerated Amber Plastic Syringes.
Lawson S, Lewis P, Peacock G, Brown S.
2019
4140 Journal
Int J Pharm Compound 2018 ;22,4:340-344
Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes.
Huffman J, Brown S, Lewis P, Lawson S, Ogle A, Peacock G.
2018
2042 Journal
Antimicrob Agents Chemother 2002 ; 46: 2327-2332.
Comparative stability studies of antipseudomonal ß-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).
Viaene E, Chanteux H, Servais H, Mingeot-Leclerq MP, Tulkens PM.
2002
4279 Journal
Bio Drugs 2019
Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).
Hermosilla J, S?nchez-Mart?n R, P?rez-Robles R, Salmer?n-Garc?a A, Casares S, Cabeza J, Cuadros-Rodr?guez L, Navas N.
2019
1651 Journal
J Clin Pharm Ther 2002 ; 27: 205-209.
Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions.
Ars?ne M, Favetta P, Favier B, Bureau J.
2002
1246 Journal
Pharm Weekbl [Sci] 1990 ; 12: 188-189.
Comparison of clonazepam sorption to polyvinyl chloride-coated and polyethylene-coated tubings.
Hooymans PM, Janknegt R, Lohman JJHM.
1990
3464 Journal
Enferm Clin 2011 21:25-29.
Compatibilidad física de la amiodarona en perfusión continua
M?nica Maqueda-Palau, Eva P?rez-Juan, Maria Josep Ar?valo-Rubert, Sylvia M?nica Amor?s-Cerd?, B?rbara Ribas-Nicolau.
2011
3466 Journal
Enferm Intensiva 2011 ;22:78-82.
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos
B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau.
2011
3212 Journal
Enferm Intensiva 2011 ;22:78-82.
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos.
Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M.
2011
3134 Journal
Enferm Intensiva 2010 ; 21: 96-103.
Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua.
P?rez Jua En, Maqueda Palau M, Ar?valo Rubert Mt, Ribas Nicolau B, Amor?s Cerd? SM.
2010
3465 Journal
Enferm Intensiva 2010 ;21:96-103.
Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua.
E. P?rez Juan, M. Maqueda Palau, M. Ar?valo Rubert, B. Ribas Nicolau, S.M. Amor?s Cerd?.
2010
4332 Poster
JFSPH 2019 2019
Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI).
Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI)
2019
2109 Journal
Pharmactuel 2006 ; 39: 71-75.
Compatibilité de la kétamine injectable lors de l’administration en dérivé avec d’autres médicaments usuels.
Pelletier E, Forest JM, Hildgen P.
2006
3766 Journal
Pharmactuel 2014 ; 47, 3 : 161-165.
Compatibilité de l’acétylcystéine injectable lors de son administration en Y avec d’autres médicaments usuels
Forrest J.M, Hildgen P.
2014
3964 Journal
Pharmactuel 2017 ; 50,1 : 27-33.
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.
2017
3176 Poster
16èmes JFSPH, Sion, 18-19 novembre 2010
Compatibilité du Remifentanil avec d'autres médicaments injectables : influence du soluté.
Humbert Delaloye V, Berger M, Voirol P, Pannatier A.
2010
2879 Poster
GSASA Congress - Lucerne - Switzerland 2008
Compatibilité entre amiodarone, catecholamines et/ou nitroprussiate de sodium, administré en continu par voie veineuse aux soins intensifs adultes.
Imesch G., Humbert-Delaloye V., Berger M., Pannatier A.
2008
1909 Journal
J Pharm Clin 2000 ; 19: 248-251.
Compatibilité et stabilité du mélange bupivacaïne-sufentanil en poche.
Farhang-Asnefi S, Barre J, Callaert S, Boutros A, Causse R, Thebault A.
2000
3767 Journal
Pharmactuel 2014 ; 47, 3 : 167-172.
Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels.
Legris M.E, Lavoie A, Forrest J.M, Hildgen P.
2014
3823 Journal
Pharmactuel 2015 ; 48, 3 : 146-152.
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.
2015
4389 Journal
Pharmactuel 2019 ;52,4:206-213
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
2019
3985 Poster
Hopipharm Congress 2017 - Nancy 2017
Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro.
Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M.
2017
3216 Journal
Pharmactuel 2011 ; 44, 1 : 14-18
Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y.
Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G.
2011
4354 Poster
GERPAC Congress 2019 2019
Compatibilité visuelle du Vyxeos lors d'administration en Y avec une sélection de médicaments injectables.
Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.
2019
3177 Poster
16èmes JFSPH, Sion, 18-19 novembre 2010 2010
Compatibilités physico-chimique entre catécholamines, amiodarone, et/ou nitroprussiate de sodium intraveineux.
Humbert-Delaloye V, Berger M, Pannatier A.
2010
36 Journal
Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods.
Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC.
1995
311 Journal
Am J Health-Syst Pharm 1996 ; 53: 167-169.
Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours.
Newborn AL, Kessler JM, Joyner KA.
1996
3498 Journal
Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.
Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M
2008
2787 Journal
Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.
Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium.
Lee TY, Chen CM, Lee CN, Chaing YC.
2005
310 Journal
Am J Hosp Pharm 1991 ; 48: 510-514.
Compatibility and pH variability of four injectable phenytoin sodium products.
Markowsky SJ, Kohls PR, Ehresman D, Leppik I.
1991
1932 Journal
Int J Pharm Compound 2004 ; 8,5: 398-403.
Compatibility and stability of Aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate.
Trissel LA, Zhang Y.
2004
284 Journal
Am J Health-Syst Pharm 1995 ; 52: 2560-2564.
Compatibility and stability of aztreonam and vancomycin hydrochloride.
Trissel LA, Xu QA, Martinez JF.
1995
3159 Journal
Acta Anaesthesiol Taiwan 2010 ; 48, 3 : 117-121.
Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution.
Lin, T.-F., Lin, F.-S., Chou, W.-H., Yeh, Y.-C., Lin, C.-P., Fan, S.-Z., Sun, W.-Z.
2010
695 Journal
Drug Intell Clin Pharm 1988 ; 22: 873-875.
Compatibility and stability of cefazolin sodium, clindamycin phosphate, and gentamicin sulfate in two intravenous solutions.
Zbrozek AS, Marble DA, Bosso JA.
1988
3125 Journal
Int J Pharm Compound 2010 ; 14, 4: 346-349.
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin.
Baker D S, Waldrop Bruce, Arnold John.
2010
1943 Journal
Am J Health-Syst Pharm 2004 ; 61: 1924-1927.
Compatibility and stability of ceftazidime sodium and tenoxicam in 5% dextrose injection.
Wang DP, Chiou AHJ, Lee DKT.
2004
639 Journal
Drug Intell Clin Pharm 1987 ; 21: 806-810.
Compatibility and stability of clindamycin phosphate - aminoglycoside combinations within polypropylene syringes.
Zbrozek AS, Marble DA, Bosso JA, Bair JN, Townsend RJ.
1987
566 Journal
Am J Hosp Pharm 1983 ; 40: 91-94.
Compatibility and stability of clindamycin phosphate with intravenous fluids.
Porter WR, Johnson CA, Cohon MS, Gillespie W.
1983
2022 Journal
J Pain Symptom Manage 2005 ; 30: 80-86.
Compatibility and stability of dexamethasone sodium phosphate and ketamine hydrochloride subcutaneous infusions in polypropylene syringes.
Watson DG, Lin M, Morton A, Cable CG, McArthur DA.
2005
4431 Journal
Medicine 2018 ; 97:50(e13698)
Compatibility and stability of dezocine and tropisetron in 0.9% sodium chloride injection for patient-controlled analgesia administration.
Chen P, Chen F, Zhou B-H.
2018
731 Journal
Am J Hosp Pharm 1978 ; 35: 669-672.
Compatibility and stability of diazepam injection following dilution with intravenous fluids.
Morris ME.
1978
1058 Journal
Am J Hosp Pharm 1983 ; 40: 1690-1691.
Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives.
Kirschenbaum HL, Aronoff W, Piltz GW, Perentesis GP, Cutie AJ.
1983
1405 Journal
J Clin Pharm Ther 1998 ; 23: 67-72.
Compatibility and stability of fentanyl admixtures in polypropylene syringes.
Peterson GM, Miller KA, Galloway JG, Dunne PF.
1998
2205 Journal
Arzneimittel Forschung 2006 ; 56, 10: 714-720.
Compatibility and stability of furosemide and dexamethasone combined in infusion solutions.
Negro S, Rendon AL, Azuara ML, S?nchez Y, Fern?ndez-Carballido A, Barcia E.
2006
29 Journal
J Pharm Sci 1995 ; 84: 267-268.
Compatibility and stability of granisetron, dexamethasone, and methylprednisolone in injectable solutions.
Pinguet F, Rouanet P, Martel P, Fabbro M, Salabert D, Astre C.
1995
9 Journal
Can J Hosp Pharm 1992 ; 45: 187-192.
Compatibility and stability of hyaluronidase and hydromorphone.
Walker SE, Lau DWC.
1992
1194 Journal
Am J Hosp Pharm 1983 ; 40: 1007-1009.
Compatibility and stability of labetolol hydrochloride in commonly used intravenous solutions.
Yuen PHC, Taddei CR, Wyka BE, Chaudry IA.
1983
1658 Journal
J Am Pharm Assoc 2000 ; 40: 520-524.
Compatibility and stability of linezolid injection admixed with aztreonam or piperacillin sodium.
Zhang Y, Xu QA, Trissel LA, Willimas KY.
2000
1659 Journal
J Am Pharm Assoc 2000 ; 40: 509-514.
Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
Xu QA, Trissel LA, Williams KY.
2000
1668 Journal
Ann Pharmacotherapy 2000 ; 34: 996-1001.
Compatibility and stability of linezolid injection admixed with three quinolone antibiotics.
Zhang Y, Xu QA, Trissel LA, Williams KY.
2000
2353 Journal
Int J Pharm Compound 2000 ; 4, 6: 476-479.
Compatibility and stability of linezolid injection admixted with gentamicin sulfate and tobramycin sulfate.
Xu Q.A, Trissel L.A, Zhang Y, Williams K.Y.
2000
4034 Journal
Afr J Pharm Pharmacol 2012 ;27,6:2055-2060
Compatibility and stability of lornoxicam with morphine, tramadol or fentanyl in infusion solutions.
Chen F-C, Fang B-X, Li P, Zheng F, Shi X-Y.
2012
1866 Journal
Int J Pharm 1998 ; 174: 157-177.
Compatibility and stability of morphine in binary admixtures with haloperidol, midazolam, dexamethasone or methylprednisolone.
Vermeire A, Remon JP.
1998
3434 Journal
Can J Hosp Pharm 2013 ; 66, 3 : 167-170.
Compatibility and Stability of Morphine Sulphate and Naloxone Hydrochloride in 0.9% Sodium Chloride for Injection.
Kistner C, Ensom M.H.H, Decarie D, Lauder G, Carr R.R.
2013
6 Journal
Am J Hosp Pharm 1994 ; 51: 2138-2142.
Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22 and 32°C.
Trissel LA, Xu QA, Martinez JF, Fox JL.
1994
25 Journal
Am J Hosp Pharm 1993 ; 50: 1410-1414.
Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
McGuire TR, Narducci WA, Fox JL.
1993
872 Journal
Ann Pharmacotherapy 1997 ; 31: 1465-1470.
Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions.
Zhang YP, Xu QA, Trissel LA, Gilbert DL, Martinez F.
1997
1286 Journal
Ann Pharmacotherapy 1998 ; 32: 1013-1016.
Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions.
Trissel LA, Xu QA, Gilbert DL.
1998
2312 Journal
Int J Pharm Compound 2009 ; 13, 1: 78-80.
Compatibility and stability of palonosetron hydrochloride and propofol during simulated Y-site administration.
Trissel L.A, Trusley C, Kupiec T.C, Ben M.
2009
2227 Journal
Int J Pharm Compound 2008 ; 12, 2: 156-160.
Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration.
Trusley C, Ben M, Kupiec TC, Trissel LA.
2008
2228 Journal
Int J Pharm Compound 2008 ; 12,2: 170-173.
Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated Y-sirte administration.
Kupiec T, Ben M, Trusley C, Trissel LA.
2008
2281 Journal
Int J Pharm Compound 2008 ; 12, 5: 460-462.
Compatibility and stability of palonosetron hydrochloride with lactated Ringer's, Hetastarch in lactated electrolyte, an mannitol injections during simulated Y-site administration.
Ben M, Kupiec T, Trusley C, Trisel LA.
2008
3075 Journal
EJHP Science 2009 ; 15, 4: 78-82.
Compatibility and stability of parenteral analgesic admixtures for multimodal analgesia
Balayssac D, Badaroux L, Rodier C, Sautou-Miranda V, Bazin JE, Chopineau J.
2009
3366 Journal
J Pharm Sci 2012 ; DOI 10.1002 / jps.23403
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A.
2012
934 Journal
Int J Pharm Compound 1998 ; 2: 318-321.
Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated Y-site administration.
Inagaki K, Kambara M, Mizuno M, Okuda J, Gill MA, Nishida M.
1998
3927 Journal
Int J Pharm Compound 2017 ; 21, 1 : 66-75.
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate.
Wu G,Yeung S,Chen F.
2017
3928 Journal
Int J Pharm Compound 2017 ; 21, 1: 76-82.
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
Wu G, Yeung S, Chen F.
2017
3327 Journal
Am J Health-Syst Pharm 2012 ; 69:1405-1409
Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
LaPlante K.L, Woodmansee S, Mermel L.A.
2012
3132 Journal
J Palliat Med 2010 ; 13, 3: 273-277.
Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine.
Negro S, Martin A, Azuara L, Sanchez Y, Barcia E.
2010
2211 Journal
J Clin Pharm Ther 2007 ; 32: 441-444.
Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients.
Negro S, Salama A, S?nchez Y, AzuaraM.L, Barcia B.
2007
1671 Journal
Int J Pharm 1996 ; 139: 243-247.
Compatibility and stability of vancomycin hydrochloride with PVC infusion material in various conditions using stability-indicating high-performance liquid chromatographic assay.
Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Cazin M, Cazin JC.
1996
4061 Journal
Int J Pharm Compound 2018 ; 22,1 :86-94
Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous granisetron hydrochloride.
Wu George, Powers Dan, Yeung S, Chen F, Neelon K.
2018
4062 Journal
Int J Pharm Compound 2018 ;22,1:76-85
Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous palonosetron hydrochloride injection and dexamethasone sodium phosphate injection.
Wu George, Powers Dan, Yeung S, Chen F, Neelon K.
2018
1033 Journal
Am J Health-Syst Pharm 1999 ; 56: 985-989.
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
Wolfe JL, Thoma LA, Du C, Goldspiel BR, Gallelli JF, Grimes GJ, Potti GK.
1999
1606 Journal
Am J Health-Syst Pharm 2001 ; 58: 594-598.
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Yuan P, Grimes GJ, Shankman SE, Daniels CE, Goldspiel BR, Potti GK.
2001
307 Journal
Am J Hosp Pharm 1994 ; 51: 1792-1799.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1994
3 Journal
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1995
364 Journal
Am J Hosp Pharm 1989 ; 46: 97-100.
Compatibility of aminophylline and verapamil in intravenous admixtures.
Johnson CE, Lloyd CW, Mesaros JL, Rubley GJ.
1989
1172 Journal
Am J Hosp Pharm 1981 ; 38: 377-378.
Compatibility of amphotericin B with certain large-volume parenterals.
Jurgens RW, DeLuca PP, Papadimitriou D.
1981
1982 Journal
Am J Health-Syst Pharm 2005 ; 62: 834-837.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Trissel LA, Ogundele AB.
2005
431 Journal
Am J Hosp Pharm 1975 ; 33: 1010-1013.
Compatibility of antineoplastic, antibiotic and corticosteroid drugs in intravenous admixtures.
McRae MP, King JC.
1975
3019 Journal
Curr Med Res Opin 2007 ; 23: 2477-2483.
Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs.
Bonasia P, Cook C, Cheng Y et al.
2007
2004 Journal
Am J Health-Syst Pharm 2005 ; 62: 1381-1384.
Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration.
Patel K, Hursting MJ.
2005
1963 Journal
Am J Health-Syst Pharm 2004 ; 61: 2415-2418.
Compatibility of argatroban with selected cardiovascular agents.
Honisko ME, Fink JM, Militello MA, Mauro VF, Alexander KS.
2004
1260 Journal
Am J Hosp Pharm 1981 ; 38: 871-875.
Compatibility of azathioprime sodium with intravenous fluids.
Johnson CA, Porter WA.
1981
99 Journal
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1995
4177 Journal
Int J Pharm Compound 2018 ;22,6:516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
2018
2774 Journal
Ann Pharmacotherapy 2004 ; 38: 967-972.
Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions.
McKenzie J.E, Mario Cruz-Rivera M.
2004
220 Journal
Am J Health-Syst Pharm 1997 ; 54: 61-64.
Compatibility of bupivacaine hydrochloride and morphine sulfate.
Johnson CE, Christen C, Perez MM, Ma M.
1997
3378 Journal
Am J Health-Syst Pharm 2013 ; 70:515-519.
Compatibility of butorphanol and droperidol in 0.9% sodium chloride injection
Chen F-C, Fang B-X, Li P, Yang J-G, Zhou B-H.
2013
3910 Journal
EJHP 2016 ; 23: 352-358.
Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.
Polonini H.C, Silva S .L, de Almeida T.R, Brand?o M.A, Ferreira A.O.
2016
2247 Journal
Int J Pharm Compound 2008 ; 12, 3: 276-278.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
2008
93 Journal
Am J Health-Syst Pharm 1996 ; 53: 2185-2188.
Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery.
Hutchings SR, Rusho WJ, Tyler LS.
1996
79 Journal
Am J Hosp Pharm 1991 ; 48: 111-113.
Compatibility of cefoperazone sodium and cimetidine hydrochloride in 5% dextrose injection.
Lee DKT, Wang DP, Lee A.
1991
87 Journal
Am J Hosp Pharm 1991 ; 48: 108-110.
Compatibility of cefoperazone sodium and furosemide in 5% dextrose injection.
Lee DKT, Lee A, Wang DP.
1991
1670 Journal
Pharmazie 1998 ; 53: 112-116.
Compatibility of cefpirome and cephalotin with PVC bags during simulated infusion and storage.
Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Kablan J, Cazin M, Cazin JC.
1998
3249 Journal
Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB.
2011
900 Journal
Ann Pharmacotherapy 1992 ; 26: 1221-1226.
Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion.
Pleasants RA, Vaughan LM, Williams DM, Fox JL.
1992
3984 Journal
Hosp Pharm 2017 ,52;3 : 221-228
Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
Meyer K, Santarossa M, Danziger L.H, Wenzler E.
2017
2269 Journal
Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H.
2008
3846 Journal
Pharmazie 2016 71: 185?191.
Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend® SF PH4 oral suspensions.
Polonini HC, Silva SL, Cunha CN, Brand?o MAF, Ferreira AO.
2016
434 Journal
Am J Hosp Pharm 1991 ; 48: 2166-2171.
Compatibility of ciprofloxacin injection with selected drugs and solutions.
Goodwin SD, Nix DE, Heyd A, Wilton JH.
1991
14 Journal
Am J Health-Syst Pharm 1997 ; 54: 1193-1195.
Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration.
Gilbert DL, Trissel LA, Martinez JF.
1997
299 Journal
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF, Gilbert DL.
1997
413 Journal
Am J Hosp Pharm 1990 ; 47: 1373-1377.
Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injection.
Stewart CF, Fleming RA.
1990
565 Journal
Drug Intell Clin Pharm 1986 ; 20: 960-963.
Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditions.
Marble DA, Bosso JA, Townsend RJ.
1986
644 Journal
Drug Intell Clin Pharm 1988 ; 22: 54-57.
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
Marble DA, Bosso JA, Townsend RJ.
1988
421 Journal
Am J Hosp Pharm 1985 ; 42: 839-843.
Compatibility of clindamycin phosphate with cefotaxim sodium or netilmicin sulfate in small-volume admixtures.
Foley PT, Bosso JA, Bair JN, Townsend RJ.
1985
3012 Journal
Hosp Pharm 2015 ; 50, 3: 214-220.
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration
Sullivan T, Forrest J.M, Leclair G.
2015
549 Journal
Int J Pharm Compound 1997 ; 1: 121-122.
Compatibility of common respiratory therapy drug combinations.
Owsley HD, Rusho WJ.
1997
3715 Journal
Am J Health-Syst Pharm 2014 ; 71:1534-1535
Compatibility of conivaptan injection with select cardiovascular medications.
Mauro V.F, Howard M.S, Boddu S.H.S, Churchwell M.D.
2014
227 Journal
Am J Hosp Pharm 1994 ; 51: 2292.
Compatibility of cyclizine lactate and haloperidol lactate.
Fawcett JP, Woods DJ, Munasiri B, Becket G.
1994
3981 Journal
EJHP 2017 ;24:162?166
Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions: a comprehensive study
He G, Zeng F, Lei K, Xia S, Deng L, Zhang C, Liu D.
2017
389 Journal
Am J Hosp Pharm 1991 ; 48: 2161-2166.
Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride.
Walker SE, DeAngelis C, Iazzetta J, Eppel JG.
1991
712 Journal
Am J Hosp Pharm 1980 ; 37: 496-500.
Compatibility of diazepam with intravenous fluid containers and administration sets.
Parker WA, MacCara ME.
1980
2087 Journal
Pharmactuel 2004 ; 37: 17-20.
Compatibility of dimenhydrinate injectable by Y administration.
Ferreira E, Forest JM, Hildgen P.
2004
250 Journal
Am J Health-Syst Pharm 1997 ; 54: 566-569.
Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials.
Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P.
1997
1754 Journal
Int J Pharm Compound 1999 ; 3: 241-244.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Wolkin AC.
1999
2262 Journal
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
2008
251 Journal
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF.
1997
1897 Journal
EJHP 2001 ; 7, 3: 108-115.
Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage.
Sautou-Miranda V, Brigas F, Thibault M, Chopineau J.
2001
789 Journal
Am J Hosp Pharm 1990 ; 47: 604-606.
Compatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion system.
Garner SS, Wiest DB.
1990
963 Journal
J Clin Pharm Ther 1990 ; 15: 371-376.
Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside.
Schaaf LJ, Tremel LC, Wulf BG, Vernon KK.
1990
3708 Poster
ECOP 2 Krakow 2014
Compatibility of epirubicin-loaded DC Beads with different contrast media.
Sarakbi I, Thiesen J, Krämer I.
2014
3918 Journal
J Oncol Pharm Practice 2016 ; 22: 749-756.
Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.
Sarakbi I, Krämer I.
2016
8 Journal
Am J Hosp Pharm 1988 ; 45: 368-371.
Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
Karnatz NN, Wong J, Kesler H, Baaske DM, Speicher ER.
1988
319 Journal
Am J Health-Syst Pharm 1995 ; 52: 997-999.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Hadzija BW, Lubarsky DA.
1995
1410 Journal
J Am Pharm Assoc 1999 ; 39: 141-145.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF, Simmons M.
1999
1722 Journal
EJHP 2002 ; 2: 33-40.
Compatibility of etoposide solution with polyvinyl chloride and low density polyethylene containers and its stability in different storage conditions.
Gras C, Sautou-Miranda V, Bagel-Boithias S, Brigas F, Chopineau J.
2002
1803 Journal
Am J Health-Syst Pharm 2003 ; 60: 80-85.
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.
2003
1993 Journal
Am J Health-Syst Pharm 2005 ; 62: 1190-1192.
Compatibility of fentanyl citrate, ketamine hydrochloride, and droperidol in 0.9% sodium chloride injection stored in polyvinyl chloride bags.
Lee DKT, Wang DP, Harsono R, Wong CY.
2005
104 Journal
Am J Health-Syst Pharm 1997 ; 54: 185-189.
Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration.
Hall PD, Yui D, Lyons S, Bosso JA.
1997
244 Journal
Am J Hosp Pharm 1994 ; 51: 1907-1913.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1994
367 Journal
Am J Hosp Pharm 1985 ; 42: 116-119.
Compatibility of furosemide with aminoglycoside admixtures.
Thompson DF, Allen LV, Desai SR, Rao PS.
1985
1423 Journal
J Am Pharm Assoc 1999 ; 39: 514-518.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF, Gilbert DL.
1999
182 Journal
Am J Health-Syst Pharm 1997 ; 54: 56-60.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF.
1997
1676 Journal
Int J Pharm 1997 ; 154: 95-102.
Compatibility of granisetron towards glass and plastics and its stability under various storage conditions.
Hourcade F, Sautou-Miranda V, Normand B, Laugier M, Picq F, Chopineau J.
1997
982 Journal
Ann Pharmacotherapy 1995 ; 29: 1168.
Compatibility of haloperidol and diphenhydramine in a hypodermic syringes.
Ukhun IA.
1995
1970 Journal
Support Care Cancer 2003 ; 11, 2: 107-113.
Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care.
Barcia E, Reyes R, Azuara M.L, S?nchez Y, Negro S.
2003
617 Journal
Am J Hosp Pharm 1982 ; 39: 843-844.
Compatibility of haloperidol lactate and heparin sodium.
Solomon DA, Nasinnyk KK.
1982
229 Journal
Am J Hosp Pharm 1994 ; 51: 2962-2963.
Compatibility of haloperidol lactate with benztropine mesylate.
Jackson CW, Cunningham K.
1994
216 Journal
Am J Hosp Pharm 1994 ; 51: 2963.
Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine.
Huang E, Anderson RP.
1994
1910 Manufacturer
Baxter 2002
Compatibility of imiglucerase
2002
21 Journal
Am J Hosp Pharm 1986 ; 43: 2803-2809.
Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
Bigley FP, Forsyth RJ, Henley MW.
1986
2090 Journal
Pharmactuel 2004 ; 37: 193-196.
Compatibility of injectable pantoprazole in Y-site administration.
Pere H, Chasse V, Forest JM, Hildgen P.
2004
2164 Journal
Perit Dial Int 2006 ; 26, 4: 498-502.
Compatibility of insulin over 24 hours in standard and bicarbonate-based peritoneal dialysis solutions contained in bags made of different materials.
Voges M, Divinop-Filho JC, Faict D, Somers F, Vermeulen P.
2006
4398 Journal
J Pharm Pract and Res 2020
Compatibility of intravenous busulfan with BBraun giving sets, fludarabine and Posiflush.
Smith E. K., Shergold J.A., McWhinney B.C.
2020
3459 Journal
Cancer Chemother Pharmacol 2013 ; 72: 509-513.
Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids.
Sun S, Schaller J, Placek J, Duersch B.
2013
3948 Journal
JPEN 2012 ;30. 416?424.
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P .
2012
312 Journal
Am J Health-Syst Pharm 1997 ; 54: 570-571.
Compatibility of iron dextran with neonatal parenteral nutrient solutions.
Mayhew SL, Quick MW.
1997
3829 Poster
ASHP Midyear 2015 2015
Compatibility of isavunazonium sulfate during simulated Y-site administration.
So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
2015
1864 Journal
Pain 1998 ; 75: 389-390.
Compatibility of ketamine and morphin injections.
Lau MH, Hackman C, Morgan DJ.
1998
469 Journal
Am J Hosp Pharm 1990 ; 47: 1097-1100.
Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.
Floy BJ, Royko CJ, Fleitman JS.
1990
1072 Journal
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
1999
4176 Journal
Am J Health-Syst Pharm 2018 ;75:1467-1477
Compatibility of linezolid with commercial peritoneal dialysis solutions
Poeppl W, Rainer-Harbach E, Kussmann M, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Reznicek G.
2018
2466 Journal
Am J Hosp Pharm 1981 ; 38: 1750-1753.
Compatibility of lithium citrate syrup with 10 neuroleptic solutions
Theesen KA, Wilson JE, Newton DW, Ueda CT.
1981
1415 Journal
JPEN 1999 ; 23: 67-74.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
1999
4376 Journal
Int J Pharm Compound 2020 ;24,1:83-85
Compatibility of Melphalan in Iodinated Contrast Media.
Shi Z, Abruzzo T, Wanasathop A, Li S K.
2020
266 Journal
Am J Health-Syst Pharm 1996 ; 53: 2853-2855.
Compatibility of meropenem with commonly used injectable drugs.
Patel PR.
1996
3922 Journal
Perit Dial Int 2016 doi:10.3747/pdi.2016.0001
Compatibility of meropenem with different commercial dialysis solutions.
Wiesholzer, Winter A, Kussmann M, Zeitlinger M, Pichler P, Burgmann H, Reznicek G,Poepp l W.
2016
2108 Journal
Int J Pharm Compound 2006 ; 10: 230-232.
Compatibility of micafungin injection with other drugs during simulated Y-site co-administration.
Trusley C, Kupiec TC, Trissel LA.
2006
186 Journal
Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
Swart EL, Mooren RAG, Van Loenen AC.
1995
1842 Journal
Arzneimittel Forschung 1995 ; 45: 93-98.
Compatibility of morphin, baclofen, floxuridine and fluorouracil in an implantable infusion pump.
Sadjack A, Wintersteiger R.
1995
1492 Journal
Can J Hosp Pharm 1995 ; 48: 155-160.
Compatibility of morphine and midazolam or haloperidol in parenteral admixtures.
LeBelle MJ, Savard C, Gagnon A.
1995
519 Journal
Aust J Hosp Pharm 1991 ; 21: 316.
Compatibility of morphine tartrate admixtures in polypropylene syringes.
Poggi GL.
1991
616 Journal
Am J Hosp Pharm 1982 ; 39: 841-843.
Compatibility of nalbuphine hydrochloride with other preoperative medications.
Jump WG, Plaza VM, Poremba A.
1982
405 Journal
Am J Hosp Pharm 1985 ; 42: 1108-1109.
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Nieves-Cordero AL, Luciw HM, Souney PF.
1985
2550 Journal
Aust J Hosp Pharm 1993 ; 23: 35-37.
Compatibility of nebulizer solutions
Roberts GW, Rossi S.O.P.
1993
316 Journal
Am J Health-Syst Pharm 1996 ; 53: 2611-2613.
Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs.
Veltri M, Lee CKK.
1996
1200 Journal
Am J Hosp Pharm 1981 ; 38: 1737-1742.
Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives.
Chaudry IA, Bruey KP, Hurlburt LE, Oden EM.
1981
1960 Journal
J Pharm Biomed Anal 2005 ; 37: 259-264.
Compatibility of nitroglycerin, diazepam and chlorpromazine with a new multilayer material for infusion containers.
Kambia NK, Dine T, Dupin-Spriet T, Gressier B, Luycks M, Goudaliez F, Brunet C.
2005
3865 Journal
Int J Pharm Compound 2016 ; 20, 3 : 236-238.
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration.
Vicky M, Samit S, Jaymin P, Michael C T.
2016
2012 Journal
Am J Health-Syst Pharm 2005 ; 62: 2001-2005.
Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
Bougouin C, Thelcide C, Crespin-Maillard F, Maillard C, Kinowski JM, Favier M.
2005
16 Journal
Am J Health-Syst Pharm 1995 ; 52: 1554-1556.
Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
Chung KC, Moon YSK, Chin A, Ulrich WU, Gill MA.
1995
332 Journal
Ann Pharmacotherapy 1995 ; 29: 1106-1109.
Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration.
Xu QA, Trissel LA, Fox JL.
1995
1865 Journal
Int J Pharm 1999 ; 178: 77-82.
Compatibility of paclitaxel in 5% glucose solution with ECOFLAC® low-density polyethylene containers - Stability under different storage conditions.
Sautou-Miranda V, Brigas F, Vanheerswinghels S, Chopineau J.
1999
158 Journal
Am J Hosp Pharm 1994 ; 51: 2804-2810.
Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets.
Trissel LA, Xu QA, Kwan J, Martinez JF.
1994
2016 Journal
Am J Health-Syst Pharm 2005 ; 62: 1998-2000.
Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
Xu QA, Trissel LA.
2005
3210 Journal
Int J Pharm Compound 2011 ; 15, 3: 259-261.
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations.
Jasti Bhaskara R, Saraf Poonam.
2011
301 Journal
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
1997
81 Journal
Am J Hosp Pharm 1994 ; 51: 672-678.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF.
1994
1501 Journal
Int J Pharm 1999 ; 185: 113-121.
Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials.
Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M.
1999
391 Journal
Am J Hosp Pharm 1987 ; 44: 1620-1624.
Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Michelini TJ, McMahon RE.
1987
372 Journal
Am J Hosp Pharm 1988 ; 45: 609-612.
Compatibility of premixed theophylline and verapamil intravenous admixtures.
Johnson CE, Lloyd CW, Aviles AI, Rybarz KL.
1988
1860 Journal
Int J Pharm 1996 ; 130: 251-255.
Compatibility of propofol diluted in 5% glucose with glass and plastics (polypropylene, molyvinylchloride) containers.
Sautou-Miranda V, Levadoux E, Groueix MT, Chopineau J.
1996
300 Journal
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF.
1997
1863 Journal
Journal of clinical anesthesia 1996 ; 8: 329-336.
Compatibility of propofol, fentanyl,and vecuronium mixtures designed for potential use in anesthesia and patient transport.
Isert PR, Lee D, Naidoo D, Carasso ML, Kennedy RA.
1996
1198 Journal
Am J Hosp Pharm 1982 ; 39: 1685-1687.
Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers.
Cummings DS, Park MK, Howard B.
1982
3913 Journal
EJHP 2018 ;25,3:150-156.
Compatibility of proton pump inhibitors in a preservative-free suspending vehicle.
Polonini H.C, Silva S.L, Loures S, Almy R, Balland A, Brandao M.A.F, Ferreira A.O.
2018
59 Journal
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF, Kim MC.
1997
1665 Journal
J Clin Pharm Ther 2002 ; 21: 39-45.
Compatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidine.
?ster Svedberg K, McKenzie J, Larrivee-Elkins C.
2002
295 Journal
Am J Health-Syst Pharm 1996 ; 53: 1048-1051.
Compatibility of selected critical care drugs during Y-site administration.
Yamashita SK, Walker SE, Choudhury T, Iazzetta J.
1996
207 Journal
Am J Health-Syst Pharm 1995 ; 52: 2024-2025.
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection.
Ku YM, Min DI, Kumar V, Noormohamed SE.
1995
3827 Poster
ASHP Midyear 2015 2015
Compatibility of tedilozid phosphate with selected intravenous drugs via simulated Y-site conditions.
Ghazi I.M, Hamada Y, Nicolau D.P.
2015
1165 Journal
Int J Pharm 1980 ; 4: 263-265.
Compatibility of the cephalosporin, cefamandole nafate with injections.
Bowtle WJ, Heasman MJ, Prince AP, Easthope DA.
1980
249 Journal
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1996
1420 Journal
J Clin Pharm Ther 1999 ; 24: 125-132.
Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.
Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M.
1999
924 Journal
J Pharm Pharmacol 1998 ; 50: 407-411.
Compatibility of tropisetron with glass and plastics. Stability under different storage conditions.
Brigas F, Sautou-Miranda V, Normand B, Geneve S, Chopineau J.
1998
3813 Journal
Hosp Pharm 2015 ; 50, 8: 710-713.
Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery.
Teibel H.M, Knoderer C.A, Nichols K.R.
2015
1748 Journal
Int J Pharm Compound 1997 ; 1: 354-355.
Compatibility of vancomycin hydrochloride and famotidine in 5% dextrose injection.
Wang DP, Wang MT, Wong CY, Lee DKT.
1997
1228 Journal
Am J Hosp Pharm 1981 ; 38: 380-381.
Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2.
Allen LV, Stiles ML.
1981
730 Journal
Am J Hosp Pharm 1977 ; 34: 939-943.
Compatibility of various admixtures with secondary additives at Y-injection site of intravenous administration sets.
Allen LV, Saul Levinson R, Phisutsinthop D.
1977
1067 Journal
EJHP 1999 ; 5: 106-110.
Compatibility of various drugs used in intensive care medicine in polyethylene, PVC and glass infusion containers.
Zeidler C, Dettmering D, Schrammel W, Spieteller M.
1999
1057 Journal
Am J Hosp Pharm 1983 ; 40: 1205-1207.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Cutie MR.
1983
706 Journal
Am J Hosp Pharm 1981 ; 38: 231.
Compatibility of verapamil hydrochloride with other additives.
Cutie MR.
1981
371 Journal
Am J Hosp Pharm 1988 ; 45: 142-145.
Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
Thompson DF, Stiles ML, Allen LV, Tu YH.
1988
552 Journal
Int J Pharm Compound 1997 ; 1: 356-358.
Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
Martinez JF, Trissel LA, Gilbert DL.
1997
4319 Journal
Hosp Pharm 2019
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Lessard J-J, Caron E, Sch?rer H, Forest J-M, Leclair G.
2019
54 Journal
J Pharm Clin 1995 ; 14: 26-30.
Compatibility PVC-psychotropic drugs during an infusion.
Bureau A, Lahet JJ, D?Athis P, Vailleau JL, Cosmidis V, Martin L.
1995
1713 Journal
Int J Pharm Compound 2002 ; 6: 311-315.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA.
2002
1925 Journal
J Am Pharm Assoc 2000 ; 40: 515-519.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
Trissel LA , Williams KY, Gilbert DL.
2000
1662 Journal
J Oncol Pharm Practice 2002 ; 8: 33-37.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
2002
1712 Journal
Int J Pharm Compound 2002 ; 6: 230-233.
Compatibility screening of Precedex during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA.
2002
4404 Poster
JFSPH 2019 2019
Compatibility studies of seven commonly used drugs for parenteral administration in palliative care.
Müller U, Haller F, Wiedemeier P, Steuer C.
2019
162 Journal
Int J Pharm 1994 ; 105: 83-87.
Compatibility study of methotrexate with PVC bags after repackaging into two types of infusion admixtures.
Benaji B, Dine T, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Gressier B, Cazin M, Cazin JC.
1994
1888 Journal
Ziekenhuisfarmacie 1986 ; 2: 45-48.
Compatibility study of midazolam.
Janknegt R, Van den Berg TJ, De Jong M, Oldenhof HGJ, Steenhoek A.
1986
1468 Journal
Int J Pharm 1994 ; 107: 111-119.
Compatibility with medical plastics and stability of continuously and simultaneously infused isosorbide dinitrate and heparin.
Sautou V, Chopineau J, Gremeau I, Chevrier R, Bruneaux F.
1994
4023 Journal
Hosp Pharm 2017 ; 52,7 : 478-482.
Compounded Apixaban Suspensions for Enteral Feeding Tubes.
Carabello M, Donmez S, Nathan K, Zhao F.
2017
3983 Journal
EJHP 2016 ; 24: 157-161.
Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder.
Zaid A.N, Assali M, Zalmout S, Basheer A.
2016
2988 Journal
J Clin Pharm Ther 2007 ; 32: 489-496.
Compounding of vitamin A, D3, E, and K3 supplements for cystic fibrosis patients: formulation and stability study.
Huyghebaert N, de Beer J, Vervaet C et al.
2007
1278 Journal
Can J Hosp Pharm 1998 ; 51: 13-19.
Concentration and solution dependent stability of cloxacillin intravenous solutions.
Walker SE, Dufour A, Iazetta J.
1998
1674 Journal
Hosp Pharm 1998 ; 33: 1515-1522.
Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF.
1998
2490 Journal
Am J Hosp Pharm 1989 ; 46: 304-307.
Concentration uniformity of extemporaneously prepared ranitidine suspension
Karnes HT, Harris SR, Garnett WR, March C.
1989
1637 Journal
Can J Hosp Pharm 2000 ; 53: 24-31.
Concentration-dependant compatibility and stability of dexamethasone and midazolam.
Wong AH, Law S, Walker SE, Bowles SK.
2000
1070 Journal
Am J Health-Syst Pharm 1999 ; 56: 1891.
Concentration-dependent incompatibility of vinorelbine tartrate and heparin sodium.
Balthasar JP.
1999
269 Journal
Am J Health-Syst Pharm 1996 ; 53: 84-85.
Concentration-dependent precipitation of sodium bicarbonate with ciprofloxacin lactate.
Trissel LA.
1996
3262 Journal
J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
Conditions causing gemcitabine crystallization.
Manners S, Galettis P, de Souza P.
2011
3718 Manufacturer
Bayer Healthcare Corporation 2012
Conivaptan (Vaprisol®) - Summary of Product Characteristics
2012
2446 Journal
Am J Health-Syst Pharm 1998 ; 55: 1299-1301.
Content uniformity and stability of nifedipine in extemporaneously compounded oral powders
Helin MM, Kontra KM, Naaranlahti TJ, Wallenius KJ.
1998
2231 Journal
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
2008
3532 Manufacturer
Eusapharma 2011
Crisantaspase (Erwinase®) – Summary of Product Characteristics
2011
501 Journal
Am J Hosp Pharm 1985 ; 42: 129-130.
Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection.
Senholzi CS, Kerns MP.
1985
1371 Journal
Am J Hosp Pharm 1985 ; 42: 2436.
Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection.
Bornstein M, Templeton RJ.
1985
1302 Journal
Drug Intell Clin Pharm 1988 ; 22: 173-174.
Cyclosporine binding to components in medication administration sets.
Parr MD, Barton SD, Haver VM, Porter WH.
1988
3580 Manufacturer
Accord Healthcare France 2016
Cytarabine Accord - Résumé des caractéristiques du produit
2016
850 Journal
Drug Intell Clin Pharm 1982 ; 16: 765-767.
Cytosine arabinose stability in intravenous admixtures with sodium bicarbonate and in plastic syringes.
Munson J, Kubiak EJ, Cohon MS.
1982
3605 Manufacturer
Lipomed 2010
Dacarbazine (Dacarbazine Lipomed®) - Résumé des caractéristiques du produit
2010
3267 Manufacturer
Lipomed 2011
Dacarbazine Lipomed - Summary of Product Characteristics
Lipomed Laboratories
2011
3266 Manufacturer
Lipomed 2011
Dacarbazine solutions: In Use stability of dacarbazine lipomed®
Lipomed Laboratories
2011
4153 Manufacturer
Orphan Europe (UF) Limited 2014
Dactinomycin (Cosmegen Lyovac®) - Summary of Product Characteristics
2014
3752 Manufacturer
Durata Therapeutics Holding 2014
Dalbavancin (Dalvance®) - Summary of Product Characteristics
2014
1509 Manufacturer
Norgine 2014
Dantrolene sodium (Dantrium®) - Summary of Product Characteristics
2014
3218 Journal
Perit Dial Int 2011 ; 31: 492?495.
Daptomycin Compatibility in Peritoneal Dialysis Solutions
Peyro Saint Paul L, Albessard F, Gaillard C, Debruyn D, Ryckelynck J Ph, Antoine Coquerel, Lobbedez T
2011
2271 Manufacturer
Novartis 2006
Daptomycine (Cubicin®) Résumé des caractéristiques du produits
2006
4190 Manufacturer
Janssen 2018
Daratumumab (Darzalex®) - Summary of Product Characteristics.
2018
3604 Manufacturer
Sanofi Aventis France 2012
Daunorubicine (Cérubidine®) - Résumé des caractéristiques du produit
2012
3577 Manufacturer
Galen Limited
Daunorubicine (Daunoxome®) - Résumé des caractéristiques du produit
4355 Manufacturer
Jazz Pharmaceuticals UK 2019
Daunorubicine/cytarabine liposomale (Vyxeos®) - Summary of Product Characteristics
2019
2240 Manufacturer
Janssen Pharmaceuticals 2019
Décitabine (Dacogen®) - Summary of Product caracteristics
2019
1882 Journal
Ziekenhuisfarmacie 1993 ; 9: 97-101.
Decrease of sufentanil citrate concentration during formulation and application of an epidural infusion solution.
Bosch EH, Van Doorne H, Brouwers JRBJ, Marskamp A, Meevis RF.
1993
3671 Manufacturer
Teva UK Ltd 2016
Deferoxamine - Résumé des caractéristiques du produit
2016
3701 Manufacturer
Gentium SPa 2014
Defibrotide (Defitelio®) - Summary of Product Characteristics
2014
2291 Journal
Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.
Degradation kinetics of neostigmine in solution.
Yeh MK.
2000
3390 Journal
Int J Pharm 1993 ; 99: 73-78.
Degradation kinetics of the antitumor drug nimustin (ACNU) in aqueous solution.
Van der Houwen, O.AG.J, Beijnen J.H, Bult A, Bekers O, Goossen R.M.J, Underberg W.J.M.
1993
1157 Journal
Int J Pharm 1988 ; 43: 131-138.
Degradation kinetics of vinblastine sulphate in aqueous solutions.
Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM.
1988
2570 Journal
Am J Hosp Pharm 1994 ; 51: 1205-1207.
Degradation of captopril in solutions compounded from tablets and standard powder.
Chan DS, Sato AK, Claybaugh JR.
1994
3093 Journal
J Pharm Sci 2010 ; 99, 3 : 1288-1298.
Degradation of paclitaxel and related compounds in aqueous solutions III: Degradation under acidic pH conditions and overall kinetics
Tian J, Stella VJ.
2010
2243 Journal
Int J Pharm 1997 ; 146: 263-269.
Degradation pathway of carboplatin in aqueous solution.
Pujol M, Girona V, Prat J, Munoz M, De Bolos J.
1997
2884 Journal
Int J Pharm 2015 ; 487 : 270-273.
Design and stability study of a paediatric oral solution of methotrexate 2 mg/ml
Vrignaud S, Briot T, Launay A, Kempf M, Lagarce F.
2015
3886 Journal
Eur J Pharm Sci 2016 ; 92 : 220-223.
Design and stability study of an oral solution of amlodipine besylate for pediatric patients.
van der Vossen A.C, van der Velde I, Smeets O.S.N.M,. Postma D.J, Vermes A,. Koch B.C.P, Vulto A.G,.Hanff L.M.
2016
3361 Journal
Int J Pharm 2012 ; 423: 360-364.
Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide.
Santove?a A, Hern?ndez-Paiz Z, Fari?a J.B.
2012
2717 Journal
J Liquid Chrom 1995 ; 18: 3117-3128.
Determination of ceftazidime and pyridine by HPLC: application to a viscous eye drop formulation.
Barnes AR.
1995
835 Journal
Int J Pharm 1979 ; 4: 21-26.
Determination of the stability of mitomycin C by high performance liquid chromatography.
Edwards D, Selkirk AB, Taylor RB.
1979
2239 Journal
Chinese J New Drugs 2005 ; 14, 2: 189-191.
Determination of the stability of oxaliplatin for injection by dual wavelength spectrophotometry.
Wang C, Zhang X, Liu HY.
2005
3296 Journal
J Chromatographic Sci 2009 ; 47: 1-7.
Determination of Tramadol, Metamizole, Ropivacaine, and Bupivacaine in Analgesic Mixture Samples by HPLC with DAD Detection.
Salmer?n-Garc?a A, Navas N, Mart?n A, Rom?n E, Cabeza J, Capit?n-Vallvey L.F
2009
3971 Journal
Int J Pharm Compound 2017 ; 21, 2 : 164-170.
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs.
Gorman G, Sokom S, Coward L, Arnold J J.
2017
3875 Journal
EJHP 2016 ; 23: 4: 213-218.
Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus.
Estevez P, Boscolo O, Quiroga E, Penuto R.F, Buontempo F, Tripodi V, Lucangioli S.
2016
2317 Journal
EJHP Science 2009 ; 15, 1: 3-5.
Development and stability testing of a concentrated injectable clonidine solution for intrathecal analgesia.
Hollenwaeger M, Borquin Challandes I, Fallab L.C, Schaad N, Zelger G.
2009
3319 Journal
Int J Pharm 2012 ; 433, 1-2 : 119-120.
Development and validation of a paediatric oral formulation of clonidine hydrochloride
de Goede A.L, Boedhram R.R, Eckhardt M, Hanff L.M, Koch B.C.P, Vermaat C.H, Vermes A.
2012
2165 Journal
J Liquid Chrom Rel Technol 2006 ; 29, 16: 2353-2365.
Development and validation of an HPLC method for oxytocin in Ringer’s lactate and its application in stability analysis.
Kumar V, Madabushi R, Derendorf H, Boothby LA, Breland BD, Hatton RC, Doering PL.
2006
3399 Poster
EAHP Congress Paris 2013
Development of a hydrochlorothiazide 0.5 mg/mL oral solution for children.
Li Y.Y, Postma D.J, Wagenaar H.W.G.
2013
3297 Journal
Chromatographia 2008 ; 68, 9-10: 767-772.
Development of an LC–DAD Method for Analysis of Dexketoprofen, Tramadol, and Haloperidol. Study of the Stability of Mixtures Used for Patient-Controlled Analgesia.
Salmeron-Garcia A, Lopez-Lopez E, Roma E, Cabeza J, Navas N, Capitan-Vallvey L.F.
2008
2904 Journal
Ann Pharm Fr 2005 ; 63: 162-166.
Development of an oxybutynin chloride solution: from formulation to quality control.
Fratta A, Bordenave J, Boissinot C, Le Grand J, Esquirol C, Radideau E, Benoit G.
2005
650 Journal
Int J Pharm Compound 1997 ; 1: 274-277.
Development of clonidine hydrochloride injections for epidural and intrathecal administration.
Trissel LA, Hassenbusch SJ.
1997
3285 Journal
Yakugaku Zasshi 2009 129, 6: 767-771.
Development of New Mixing Method of Busulfex® Injecton for the Purpose of Improvement of Medical Safety Method; The Prefilled Syringe Method.
Senoo M, Tajika K, Shimizu H, Hamada M, Dobashi Y, Dan K, Katayama S.
2009
3569 Journal
EJHP 2014 ;21:34-38
Development of ready-to-use cefuroxime syringes for use in ophthalmology.
Fleury-Souverain S, Sadeghipour F, Bonnabry P.
2014
2287 Journal
EJHP Science 2008 ; 14, 1: 14-18.
Development of ready-to-use ketamine hydrochloride syringes for safe use in post-operative pain.
Stucki MC, Leury-Souverain S, Sautter AM, Sadeghipour F, Bonnabry P.
2008
2759 Journal
Pediatr Neurol 1999 ; 20: 195-197.
Development of two stable oral suspensions of gabapentin.
Nahata MC.
1999
2721 Journal
J Pad Ophtalmol Strabismus 2000 ; 37, 6: 333-337.
Development of Two Stable Oral Suspensions of Levodopa-Carbidopa for Children With Amblyopia
Nahata MC, Morosco RS, Leguire LE.
2000
2949 Journal
Pharmazie 2007 ; 62: 519-521.
Development validation and stability study of pediatric atenolol syrup.
Foppa T, Murakami FS, Silva MAS.
2007
3700 Journal
Braz J Pharm Sci 2010 ; 46, 1 : 109-114.
Development, stability and in vitro permeation studies of gels containing mometasone furoate for the treatment of dermatitis of the scalp.
Salgado A.C.G.B; Silva A.M.N.N; Machado M.C.J.C; Duarte MA.S.C; Ribeiro, Helena M.O.M.
2010
3668 Manufacturer
Hospira 2015
Dexamethasone - Summary of Product Characteristics
2015
3851 Journal
Can J Hosp Pharm 2016 ; 69, 1: 49-51.
Dexamethasone 1 mg/mL Suspension Prepared from Crushed Tablets: Stability in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D.
2016
28 Journal
PDA J Pharm Sci Technol 1996 ; 50: 261-267.
Dexamethasone phosphate stability and contamination of solutions stored in syringes.
Lau DWC, Law S, Walker SE, Iazzetta J.
1996
3581 Manufacturer
Clinigen Healthcare 2013
Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit
2013
2224 Journal
Bolletino SIFO 2007 ; 53: 178-180.
Dexrazoxane: Stabilià in soluzione.
Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P.
2007
1388 Journal
Pharm J 1982 ; 228: 238-239.
Diamorphine hydrochloride compatibility with saline.
Page J, Hudson S.
1982
1385 Journal
Pharm J 1985 ; 235: 171.
Diamorphine injection BP incompatibility.
Kirk B, Hain WR.
1985
506 Journal
J Pharm Pharmacol 1989 ; 41: 275-277.
Diamorphine stability in aqueous solution for subcutaneous infusion.
Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P.
1989
3885 Journal
Int J Pharm 2016 ; 506 : 414-419.
Diazepam sorption to PVC- and non-PVC-based tubes in administration sets with quantitative determination using a high-performance liquid chromatographic method.
Su-Eon Jin, Siwon You, Seungho Jeon, Sung-Joo Hwang.
2016
3613 Manufacturer
Primius Lab 2013
Dihydralazine (Nepressol®) - Résumé des caractéristiques du produit
2013
1809 Journal
EJHP 2003 ; 3: 34-42.
Diluted solution of sodium ioxitalamate in paediatrics: A stability and cost effectiveness study.
Arrault XL, Rieutord A, Hassan M, Brion F.
2003
2292 Journal
EJHP 2016 ;23:22-27
Diluting ferric carboxymaltose in sodium chloride infusion solution (0.9% w/v) in polypropylene bottles and bags: effects on chemical stability
Philipp E, Braitsch M, Bichsel T, M?hlebach S.
2016
2074 Journal
Ann Intern Med 1998 ; 128: 1049.
Dissolving phenytoin precipitate in central venous access device.
Tse T, Abdullah R.
1998
3606 Manufacturer
Wokhardt 2013
Dobutamine - Summary of Product Characteristics
2013
1352 Journal
Am J Hosp Pharm 1984 ; 41: 2588-2589.
Dobutamine-heparin mixture inadvisable.
Hasegawa GR, Eder JF.
1984
3130 Manufacturer
Sanofi Avantis France 2009
Docétaxel (Taxotere®) – Résumé des caractéristiques du produits
2009
3911 Journal
EJHP 2017 ; 24: 230-234.
Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes?
Closset M, Hecq J D, Gonzalez E, Bihin B, Jamart J, L Galanti L.
2017
3638 Manufacturer
Hospira 2010
Dopamin (Dopamine 40 mg/mL sterile concentrate®) - Summary of Product Characteristics
2010
1397 Journal
Pharm J 1990 ; 244: 218.
Dopamine dilutions.
Garner ST, Murdoch JM.
1990
2332 Manufacturer
Janssen-Cilag 2009
Doripenem (Doribax®) - Laboratoire informations
2009
3612 Manufacturer
Amdipharm Mercury Company 2012
Doxapram (Dopram) - Summary of Product Characteristics
2012
3645 Manufacturer
Accord Healthcare 2014
Doxorubicin - Summary of Product Characteristics
2014
3142 Manufacturer
SP Europe 2010
Doxorubicin hydrochloride liposome (Caelyx®) - Summary of Product Characteristics
2010
3143 Manufacturer
Teva Laboratoire 2015
Doxorubicin hydrochloride liposome (Myocet®) - Summary of Product Characteristics
2015
3144 Manufacturer
Ortho Biotech 2010
Doxorubicin liposome (Doxil®) - Product Information
2010
681 Journal
Can J Hosp Pharm 1991 ; 44: 71-78.
Doxorubicin stability in syringes and glass vials and evaluation of chemical contamination.
Walker S, Lau D, DeAngelis C, Iazetta J, Coons C.
1991
3402 Journal
J Oncol Pharm Practice 2013 ; 19, 1: 65-74.
Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: A stability assessment.
Hecq, J.-D., Lewis, A.L., Vanbeckbergen, D., Athanosopoulos, A., Galanti, L., Jamart, J., Czuczman, P., Chung, T.
2013
4009 Manufacturer
Panpharma 2017
Droperidol - Résumé des Caractéristiques du Produit
2017
1187 Journal
Am J Hosp Pharm 1983 ; 40: 94-97.
Droperidol stability in intravenous admixtures.
Ray JB, Newton DW, Nye MT, Leet WA.
1983
2146 Journal
Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
Drug compatibility with new polyolefin infusion solution containers.
Trissel LA, Xu QA, Baker M.
2006
763 Journal
Cancer Treat Rep 1985 ; 69: 1325-1326.
Drug precipitation within IV tubing : A potential hazard of chemotherapy administration.
Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH.
1985
817 Journal
Am J Health-Syst Pharm 1998 ; 55: 683-685.
Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device.
Stendal TL, Klem W, Tonnesen HH, Kjonniksen I.
1998
1928 Journal
J Pain Symptom Manage 2004 ; 28, 3: 268-272.
Drug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixture.
Alvarez JC, De Mazancourt Ph, Chartier-Kastler E, Denys P.
2004
1088 Journal
JAMA 1984 ; 252: 2392.
Drug trapping in intravenous infusion side arms.
Johnston A, McKenzie MA, Krasnow SH, Hood MA, Cohen MH.
1984
2348 Manufacturer
Alexion Europe SAS 2007
Eculizumab (Soliris®) – Summary of Product Characteristics
2007
348 Journal
Am J Hosp Pharm 1985 ; 42: 335-339.
Effect of a polyethylene-lined administration set on the avaibility of diazepam injection.
Hancock BG, Black CD.
1985
170 Journal
Am J Hosp Pharm 1975 ; 62: 44-45.
Effect of briefly heating cyclophosphamide solutions.
Brooke D, Scott JA, Bequette RJ.
1975
2396 Journal
Am J Health-Syst Pharm 2008 ; 65: 441-447.
Effect of buffer and antioxidant on stability of a mercaptopurine suspension
Aliabadi HM, Romanick M, Desai S, Lavasanifar A.
2008
351 Journal
Am J Hosp Pharm 1986 ; 43: 2795-2799.
Effect of flow rate and type of IV container on adsorption of diazepam to IV administration systems.
Yliruusi JK, Uotila JA, Kristoffersson ER.
1986
2361 Journal
J Clin Pharm Ther 2009 ; 34, 4 : 423-428.
Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags.
Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L.
2009
575 Journal
Am J Hosp Pharm 1982 ; 39: 104-108.
Effect of freezing and microwave thawing on the stability of six antibiotic admixtures in plastic bags.
Holmes CJ, Ausman RK, Kundsin RB, Walter CW.
1982
2020 Journal
Can J Hosp Pharm 2005 ; 58: 65-70.
Effect of freezing on stability of a fortified 5 mg/ml ticarcillin ophtalmic solution.
Blondeel S, Pelloquin A, Pointereau-Bellanger A, Thuillier A, Fernandez C.
2005
2110 Journal
EJHP Science 2006 ; 12, 3: 52-56.
Effect of freezing, long term storage and microwave thawing on the stability of ceftriaxone sodium in 5% dextrose infusion polyolefin bags at 2-8°C.
Hecq JD, Evrard JM, Vanbeckbergen DF, Jamart J, Galanti LM.
2006
2015 Journal
Ann Pharmacotherapy 2005 39: 1654-1658.
Effect of freezing, long term storage, and microwave thawing on the stability of ketorolac tromathamine.
Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM.
2005
3076 Journal
Ann Pharm Fr 2009 ; 67: 427-432.
Effect of freezing, long-term storage and microwave thawing on the stability of a mixture of diclofenac and sodium bicarbonate in glucose 5% polyolefin bags.
Fran?ois JH, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2009
1958 Journal
EJHP Science 2005 ; 11: 23-25.
Effect of freezing, long-term storage and microwave thawing on the stability of cefuroxime sodium in 5% dextrose infusion polyvinyl chloride bags.
Hecq JD, Schlesser V, Vanbeckbergen D, Jamart J, Galanti L.
2005
2320 Journal
EJHP Science 2009 ; 15, 1: 15-19.
Effect of freezing, long-term storage and microwave thawing on the stability of sodium folinate.
Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L.
2009
1892 Journal
Int J Pharm Compound 2004 ; 8, 2: 156-159.
Effect of freezing, long-term storage and microwave thawing on the stability of tramadol in 5% dextrose infusion in polyvinyl chloride bags.
Lebrun J, Hecq JD, Vanbeckbergen D, Jalart J, Galanti LM.
2004
2034 Journal
EJHP Science 2005 ; 11, 5: 111-113.
Effect of freezing, long-term storage and microwave thawing on the stability of vancomycin hydrochloride in 5% dextrose infusions.
Rodenbach MP, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2005
1648 Journal
Int J Pharm Compound 2002 ; 6: 391-394.
Effect of freezing, long-term storage, and microwave thawing on the stability of cefepime in 5% dextrose infusion polyvinyl chloride bags.
Schlesser V, Hecq J-D, Vanbeckbergen D, Jamart J, Galanti LM.
2002
1258 Journal
Am J Hosp Pharm 1981 ; 38: 537-540.
Effect of gentamicin on heparin activity.
Tyler LS, Rehder TL, Davis RB.
1981
510 Journal
Pharm World Sci 1993 ; 15: 269-275.
Effect of glucose 5% solution and bupivacaine hydrochloride on absorption of sufentanil citrate in a portable pump reservoir during storage and simulated infusion by an epidural catheter.
Roos PJ, Glerum JH, Schroeders MJH.
1993
3439 Journal
Perit Dial Int 2013 ; 33:458-461
Effect of Glucose Concentration on the Stability of Daptomycin in Peritoneal Solutions.
Parra M.A, Campanero M.A, S?daba B, Irigoyen A, Garc?a-L?pez L,Fernandez-Reyes M.J, Ramon Azanza J.
2013
729 Journal
Am J Hosp Pharm 1977 ; 34: 1071-1074.
Effect of inline filtration on the potency of drugs administered intravenously.
Rusmin S, Welton S, DeLuca P, DeLuca PP.
1977
703 Journal
Am J Hosp Pharm 1980 ; 37: 935-941.
Effect of inline filtration on the potency of low-dose drugs.
Butler LD, Munson JM, DeLuca PP.
1980
509 Journal
Pharm World Sci 1993 ; 15: 139-144.
Effect of pH absorption of sufentanil citrate in a portable pump reservoir during storage and administration under simulated epidural conditions.
Roos PJ, Glerum JH, Meilink JW, Zwang L.
1993
464 Journal
Am J Hosp Pharm 1986 ; 43: 2209-2213.
Effect of pretreatment with 0.9% sodium chloride or insulin solutions on the delivery of insuline from an infusion system.
Furberg H, Kruse Jensen A, Salbu B.
1986
160 Journal
Am J Hosp Pharm 1994 ; 51: 2701-2704.
Effect of sodium chloride concentration and temperature on melphalan stability during storage and use.
Pinguet F, Martel P, Rouanet P, Fabbro M, Astre C.
1994
2953 Journal
J Pharm Sci 1982 ; 71: 585-587.
Effect of some formulation adjuncts o the stability of benzoyl peroxide.
Gupta VD.
1982
587 Journal
Am J Hosp Pharm 1983 ; 40: 1024-1025.
Effect of storage temperature and time stability of cefmenoxime, ceftriaxone, and cefotetan in 5% dextrose injection.
Smith BR.
1983
347 Journal
Am J Hosp Pharm 1991 ; 48: 2627-2630.
Effect of syringe filter and IV administration set on delivery of propofol emulsion.
Bailey LC, Tang KT, Rogozinski BA.
1991
3284 Journal
Yakugaku Zasshi 2008 ; 128, 8: 1221-1226.
Effect of the Admixture of Tetracycline and Nadifloxacin Ointments on Their Stability and Their Antibacterial Activity.
Kawamoto T, Tayama Y, Sawa A, monde T, Sashima S, Yoshioka M, Miyake K, Morita S, Kihira K.
2008
2008 Journal
Ann Pharmacotherapy 2005 ; 39: 1244-1248.
Effect of the freezing conditions and microwave thawing power on the stability of cefuroxime in dextrose 5% infusion polyolefin bags at 4°C.
Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM.
2005
352 Journal
Am J Hosp Pharm 1986 ; 43: 2789-2794.
Effect of tubing length on adsorption of diazepam to polyvinyl chloride administration sets.
Yliruusi JK, Uotilo JA, Kristoffersson ER.
1986
2115 Journal
J Pain Symptom Manage 2006 ; 31, 6: 563-567.
Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion.
Schneider JJ, Good Ph, Ravenscroft PJ,.
2006
194 Journal
Am J Hosp Pharm 1990 ; 47: 1559-1562.
Effect of vehicle ionic strength on sorption of nitroglycerin to a polyvinyl chloride administration set.
Loucas SP, Maager P, Mehl B, Loucas ER.
1990
1349 Journal
Aust J Hosp Pharm 1987 ; 17: 31-34.
Effects of freezing, long term storage and microwave thawing on the stability of three antibiotics reconstituted in minibags.
Sanburg AL, LyndonRC, Sunderland B.
1987
1946 Journal
Can J Hosp Pharm 2004 ; 57, 5: 276-282.
Effects of freezing, long-term storage, and microwave thawing on the stability of piperacillin plus tazobactam in 5% dextrose for infusion.
Hecq JD, Berlage V, Vanbeckbergen D, Jamart J, Galanti L.
2004
2432 Journal
Am J Health-Syst Pharm 1997 ; 54: 2483-2487.
Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids
Lye MY, Yow KL, Lim LY, Chan SY, Chan E, Ho PC.
1997
1353 Journal
Am J Hosp Pharm 1984 ; 41: 1835-1837.
Effects of presaturation on nitroglycerin delivery by polyvinyl chloride infusion sets.
Nix DE, Tharpe WN, Francisco GE.
1984
592 Journal
J Pharm Clin 1989 ; 8: 101-106.
Effects of storage temperature and pH on the stability of cefotaxime in PVC bags.
Barthes D, Fauconneau B, Martin JP, Courtois P.
1989
1736 Journal
J Clin Pharm Ther 1999 ; 24: 145-150.
Effects of sucrose, citric buffer and glucose oxidase on the stability of captopril in liquid formulations.
Liu J, Chan Y, Ho PC.
1999
146 Journal
Clin Ther 1992 ; 14: 821-824.
Effects of temperature, solution composition, and type of container on the stability and absorption of carmustine.
Hadji-Minaglou-Gonzalvez MF, Gayte-Sorbier A, Airauto CB, Verdier M.
1992
4314 Journal
J Am Pharm Assoc 2017 ; 56, 4: 457-461.
Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for Injection.
DenHerder J.M, Reed R.L, Sargent J.L, Bobe G, Stevens J.F, Helen E Diggs H.E.
2017
3862 Journal
Hosp Pharm 2016 ; 51, 3: 246-251.
Enzymatic Stability of Alteplase Solution for Injection: Effect of Various Methods of Thawing Frozen Solutions.
Cutshall B.T, Gorman G.S, Freeman M.K ,. Kyle J.A.
2016
2307 Journal
Palliative Med 1995 ; 9, 4: 315-318.
Epidural diamorphine and bupivacaine stability study.
Kreeger L, Cowin P, Noble-Gresty J, Naysmith A.
1995
3642 Manufacturer
International Medication System (UK) 2013
Epinephrine - Résumé des Caractéristiques du Produit
2013
659 Journal
Can J Hosp Pharm 1996 ; 49: 62-65.
Epinephrine stability in plastic syringes and glass vials.
Donnely RF, Yen M.
1996
683 Journal
Can J Hosp Pharm 1990 ; 43: 265-272.
Epirubicin stability in syringes and glass vials and evaluation of chemical contamination.
Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C.
1990
3632 Manufacturer
Hospira 2017
Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics
2017
798 Journal
Ann Pharmacotherapy 1996 ; 30: 1501-1502.
Epoetin alfa loss with NaCl 0.9% dilution.
Widness JA, Schmidt R.
1996
3934 Manufacturer
GlaxoSmithKline Laboratoire 2016
Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit
2016
4446 Manufacturer
Tetraphase Pharmaceuticals 2019
Eravacycline (Xerava®) - Highlights of prescribing information
2019
3250 Manufacturer
Eisai Ltd 2011
Eribulin (Halaven®) - Summary of Product Characteristics.
2011
1912 Manufacturer
Merck Sharp Dohme 2016
Ertapenem (Invanz®) - Summary of Product Characteristics
2016
3674 Manufacturer
PanPharma 2016
Erythromycin lactobionate - Summary of Product Characteristics
2016
3607 Manufacturer
AOP Orphan Pharmaceuticals AG 2013
Esmolol hydrochloride for injection - Summary of Product Characteristics
2013
2284 Manufacturer
Astra Zenaca 2007
Esomeprazole sodium (Nexium IV®) – Summary of Product Characteristics
2007
3489 Journal
Farm Hosp 1998 ; 22, 5: 249-251.
Estabilidad de las soluciones orales de clohidrato de metadona al 0,1% y 0,5% en suero fisiologico.
Soy D, Roca M, Deulofeu R, Montes E, Codina C, Ribas J.
1998
2202 Journal
Investig Clin Farm 2005 ; 2, 4: 195-203.
Estabilidad de parecoxib en dilucion con ostros farmacos y administrado en perfusion continua IV para el control del dolor postoperatorio.
Acin Lazaro MP, bono Arino C, martinez Bazan R, manzanares Marin I, Faci Bouthelier A, Velamazan Blocona MJ, Facorro Gaspar E,
2005
2105 Journal
Farm Hosp 1999 ; 23: 357-360.
Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo.
Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C.
1999
3198 Journal
Farm Hosp 2008 ; 32, 6 : 344-348.
Estabilidad en suero fisiológico del busulfán intravenoso en un envase de poliolefinas.
Nebot Mart?nez J, Al?s Almi?ana M, D?ez Sales O.
2008
2100 Journal
Farm Hosp 1995 ; 19: 38-40.
Estabilidad fisica y quimica del sulfato magnesico combinado con heparina sodica en solucion salina al 0,9 por 100.
Gervas S, Gosalbez F.
1995
2103 Journal
Farm Hosp 1999 ; 23: 103-108.
Estabilidad y compatibilidad del metamizol en jeringa y en mezclas intravenosas.
Noguera Rodriguez A, Sancho Chust V, Medina Hernandez C, Medina Hernandez MJ, Jimenez Torrez NV.
1999
3706 Journal
Farm Hosp 2014 ;38, 3:154-161
Estudio de estabilidad de oxaliplatino y doxorrubicina para su administración intraperitoneal con hipertermia.
Escudero-Ortiz V, Duart-Duart M.J, P?rez-Ruixo C, P?rez-Ruixo J.J, Valenzuela B.
2014
3384 Journal
Farm Hosp 2013 ;37,1:10-14
Estudio de estabilidad de tiaprida en disolución para administración en perfusión intravenosa continua.
Otero F.M
2013
2104 Journal
Farm Hosp 2000 ; 24: 145-150
Estudio de la estabilidad de mezclas ciclofosfamida/mesna e ifosfamida/mesna en soluciones intravenosas de gran volumen.
Iriarte Izura MA, Gozalo garcia MJ, Marcotegui Ros F, Nagore Indurain C, Urdaniz Baztan AO.
2000
3655 Manufacturer
Bristol Myers Squibb 2016
Etoposide phosphate (Etopophos®) - Résumé des caractéristiques du produit
2016
2181 Journal
Bull Cancer 1995 ; 82: 189-195.
Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique.
Milano G, Ren?e N.
1995
3791 Poster
Apifh Congress, Paris November 2014 2014
Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y.
Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P.
2014
3240 Poster
Congr?s SFPO 2011
Etude de la stabilité d'une solution de bortézomib à 1 mg/mL conditionnée en seringue de polypropylène.
Perissutti M, Vigneron J, Zenier H, May I, Demor? B.
2011
504 Journal
Sci Tech Pharm 1987 ; 3: 33-40.
Etude de la stabilité dans des solutions diluées destinées à la perfusion de deux antimitotiques dérivés de la podophyllotoxine : l’étoposide (VP 16), le téniposide (VM 26).
Hamon M, Plas-Remoissenet D, Kubab-Alajati S.
1987
1455 Journal
J Pharm Clin 1995 ; 14: 178-179.
Etude de la stabilité de deux benzamides antiémétiques en poches PVC de chlorure de sodium 0.9% et de glucose 5% sur une période de 5 mois.
Demor? B, Raffy F, Commun N, Vigneron J, Hoffman MA, Hoffman M.
1995
4007 Poster
Hopipharm Congress 2017-Nancy 2017
Etude de la stabilité de la vancomycine à 40 mg/ml au cours d'une perfusion de 24 heures.
Masse M, Genay S, Carta N, Delannoy-Rousseli?re C, Moreau F, Barthelemy C, Faure K, Decaudin B, Odou P.
2017
3761 Book
Master en pharmacie - University of Geneva 2014
Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie.
Chavan E.
2014
3447 Poster
SFPO Congress, Mandelieu, France 2013
Etude de la stabilité d’une solution de bortézomib à 2,5 mg/mL par chromatographie liquide à haute performance couplée à un détecteur à barrettes de diodes et à un détecteur évaporatif à diffusion de lumière.
Giovanelli M, Vigneron J, May I, Nicolas A.
2013
3848 Poster
Thèse de doctorat en pharmacie 2014
Etude de stabilité d'un collyre à l'amphotéricine B 0,5%.
Dermu Marine.
2014
4041 Poster
SNPHPU Congress 12th 2017
Etude de stabilité d'un collyre de ceftazidime à 50mg/ml conditionné en flacon de polyéthylène basse densité.
Jobard M, Brandely-Piat M-L, El Deeb G, Labat L, Cros C, Chast F, Batista R.
2017
4424 Poster
11ème Recontres Convergences Santé Hôpital 2016
Etude de stabilité d'une suspension buvable de cloxacilline à usage pédiatrique.
Barbazan C, Le Daré, Lester M-A, Boivin P-N.
2016
1456 Journal
J Pharm Clin 1995 ; 14: 160-161.
Etude de stabilité de solutions de mesna destinées à la perfusion.
Lux M, Vigneron J, Perrin A, Hoffman MA, Hoffman M.
1995
3120 Poster
Congr?s HOPIPHARM 2010
Etude de stabilité de solutions intravitréennes de vancomycine à 10 mg/ml.
Maillot-Pyszczek V, Bourdeaux D, Sautou V, Chopineau J.
2010
1520 Manufacturer
B Braun 2001
Etude de stabilité des médicaments en Ecoflac®
2001
3118 Poster
Congr?s HOPIPHARM 2010
Etude de stabilité du doripeneme en solution injectable : Applications à la perfusion continue.
Mariescu Mosnier-Thoumas S, Gordien GB, Chapouly C, Rouault A, Xuereb F, Saux MC, Breilh D.
2010
2760 Journal
Pharm Hosp et Clin 2007 ; 42, 171 : 171-176.
Etude de stabilité d’un collyre à ,6 mg/ml de ticarciline.
Galvez O,Mullot JU, Mullot H, Simon L, Grippi R, Payen C, Bonneau D, Huart B, Gentes P.
2007
4320 Poster
Hopipharm Congress 2019
Étude de stabilité physico-chimique d’une solution de céfoxitine à 125 mg/mL en seringue polypropylène pour les services de soins intensifs.
Beiler B, D'Huart E, Charmillon A, Vigneron J, Demoré B.
2019
4453 Poster
Synprefh Congress (Hopipharm), 2020. 2020
Étude de stabilité physico-chimique d’une solution de cloxacilline à 250 mg/mL en seringues polypropylène et à 50-100 mg/mL en diffuseurs portables.
Polo C, Vigneron J, D’Huart E, Charmillon A , Demoré B.
2020
4066 Poster
APHIF 2017 - Congress 2017 2017
Etude de stabilité physico-chimique et microbiologique des collyres de ciclosporine à 0.5 ; 5 et 20 mg/mL conditionnés en flacons de polyéthylène basse densité.
Mordohay A, Chanat C, Bezia C, Fresneau J, Jobard M, Brandely-Piat M.L, Batista R.
2017
1289 Journal
Pharmakon 1998 ; 116: 145-148.
Etude de stabilité visuelle du chlorhydrate de chlorpromazine, du chlorure de potassium, de la furosémide et de l’héparine sodique en perfusion continue.
Hecq JD, Evrard JM, Gillet P, Grosdent N.
1998
3383 Journal
Farm Hosp 2013 ;37,1:4-9
Evaluación de la estabilidad de un jarabe de hidrato de cloral al 7% en envases mono y multidosis bajo condiciones ambiente y de refrigeración.
Bustos-Fierro C, Olivera M. E, Manzo P.G, Jimenez-Kairuz A.K.
2013
1645 Journal
EJHP 2010 ; 16: 42-47.
Evaluation of a diltiazem hydrochloride gel for the treatment of anal fissure.
Pinto JF, Salgado AC, Alves ML, Alves S, Neves C, Falcao F.
2010
2991 Journal
Drug Dev Ind Pharm 1997 ; 23: 285-291.
Evaluation of oil/water-type cyclosporine gel ointment with commercially available oral solution.
Tamura T, Takayama K, Satoh H et al.
1997
739 Journal
Am J Hosp Pharm 1978 ; 35: 402-406.
Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate.
Cradock JC, Kleinmann LM, Rahman A.
1978
3861 Journal
J Pharm Pract and Res 2016 ; 46: 28-33.
Evaluation of stability of melatonin in extemporaneously compounded oral suspensions.
Friciu M , Savji T , Zaraa S, Leclair G.
2016
4003 Journal
EJHP 2017 ; 25, 3: 157-164.
Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab).
Kim J, Chung J, Park S, Jung S, Kang D.
2017
3825 Journal
J Pharm Pract and Res 2015 ; 496: 421-431.
Evaluation of the physicochemical and functional stability of diluted REMSIMA(R) upon extended storage—A study compliant with NHS (UK) guidance.
Young B.L, Ali Khan M, Chapman T.J, Parry R,. Connolly M.A, Watts A.G.
2015
4252 Journal
Int J Pharm Compound 2019 ;23,2:163-166
Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit.
Lardinois B, Dimitriou A, Delcave C, Jamart J, Bihin B, Soumoy L, Hecq JD, Galanti LM.
2019
3345 Journal
Int J Pharm Compound 2012 ; 16, 5: 428-430.
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date.
Peacock G.F, Sauvageot J.
2012
3667 Journal
Int J Pharm Compound 2014 ; 18, 3: 253-255.
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F,Sauvageot Jurgita
2014
4117 Journal
Drug Design Dev Ther 2017 ;11:2087-2097
Evaluation of the stability of linezolid in aqueous solution and commonly used intravnous fluids.
Taylor R, Sunderland B, Luna G, Czarniak P.
2017
3843 Journal
Int J Pharm Compound 2016 ; 20, 1: 81-85
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
Peacock G.F, Sauvageot J, Hill A, Killian A.
2016
2828 Journal
J Clin Pharm Ther 2008 ; 33, 3: 263-271.
Evaluation of the stability of morphine sulphate in combination with Instillagel®.
Abdelmageed R, Labyad N, Watson DG, Pournamdari M, Cable CG, Stanley E.
2008
4373 Journal
EJHP 2020
Evaluation of the stability of vancomycin solutions at concentrations used in clinical services.
Masse M, Genay S, Martin Mena A, Carta N, Lannoy D, Barthélémy C, Décaudin B, Odou P.
2020
3408 Journal
Pharmactuel 2013 ; 46, 1 : 16-21.
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Tollec S, Touzin K, Pelletier E, Forest J.M.
2013
829 Journal
Int J Pharm 1988 ; 42: 41-46.
Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets.
Cartwright-Shamoon JM, McElnay JC, D?Arcy PF.
1988
3759 Journal
Yakugaku Zasshi 2014 ; 134, 2: 293-298.
Examination of the cause of changing solution color by mixing aminophylline and dopamine, the compatibility of which was indicated by the supplier.
Igarashi K, Kawahara M.
2014
3169 Journal
Pain Clinic 1999 ; 11: 213-216.
Experimentation about precipitation of pharmacological association: morphine and ketorolac.
Raffaeli W, Pari G, Visani L et al.
1999
2932 Journal
J Pharm Pract and Res 2005 ; 35: 181-182.
Extemporaneous isoniazid mixture: stability implications.
Haywood A, Mangan M, Grant G et al.
2005
2926 Journal
Am J Health-Syst Pharm 2006 ; 63: 254-257.
Extemporaneous sildefanil citrate oral suspensions for the treatment of pulmonary hypertension in children.
Nahata MC, Morosco RS, Brady MT.
2006
3682 Journal
EJHP 2016 ;23:33-37
Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
Klovrzov? S, Zah?lka L, Kr?? T, Zah?lkov? O, Matysov? L, ?klubalov? Z, Hor?k P.
2016
110 Journal
Int J Pharm 1989 ; 54: 181-189.
Extended stability of 5-fluorouracil and methotrexate solutions in PVC containers.
Vincke BJ, Verstraeten AE, El Eini DID, Mc Carthy TM.
1989
4191 Journal
GaBI Journal 2018
Extended stability of a biosimilar of trastuzumab (CT-P6) after reconstitution in vials, dilution in polyolefin bags and storage at varioustemperatures.
Vieillard V, Astier A, Paul M.
2018
1995 Journal
Am J Health-Syst Pharm 2005 ; 62: 1073-1074.
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Chin A, Liu S, Ting-Chan J, Gill MA.
2005
4026 Journal
Hosp Pharm 2017 ; 52, 8 : 570-573
Extended Stability of Epinephrine Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light-Blocking Bags.
Van Matre E.T, Ho K.C., Lyda C, Fullmer B.A, Oldlan A.R, Kiser T.H.
2017
88 Journal
J Acquired Immune Defic Syndr 1992 ; 5: 354-358.
Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis.
Mole L, Oliva C, O?Hanley P.
1992
3350 Journal
Am J Health-Syst Pharm 2012 ; 69:1999-2001
Extended stability of intravenous acetaminophen in syringes and opened vials.
Kwiatkowski J.L, Johnson C.E, Wagner D.S.
2012
3301 Journal
Hosp Pharm 2012 ; 47, 4: 289-292.
Extended Stability of Magnesium Sulfate Infusions Prepared in Polyolefin Bags.
Sayre B.E, Prettyman T, Kaushal G.
2012
3866 Journal
Int J Pharm Compound 2016 ; 30, 3 : 247-249.
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children.
Nahata M C.
2016
2097 Journal
Int J Pharm Compound 2006 ; 10: 156-158.
Extended stability of oxytocin in common infusion solutions.
Trissel LA, Zhang Y, Douglass K, Kastango E.
2006
2337 Journal
Can J Hosp Pharm 2009 ; 62, 2: 135-141.
Extended Stability of Pantoprazole for Injection in 0.9% Sodium Chloride or 5% Dextrose at 4°C and 23°C
Walker S.E, Iazzetta J, Law S.
2009
4271 Journal
Adv Ther 2019
Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties
Yun J, Kim J, Chung J, Hwang S-J, Park S-J.
2019
3329 Journal
Hosp Pharm 2012 ; 47, 7: 538-543.
Extended Stability of Sodium Bicarbonate Infusions Prepared in Polyolefin Bags.
Sayre B.E, Prettyman T, Kaushal G.
2012
3945 Journal
Can J Hosp Pharm 2017 ; 70,1 : 7-12.
Extended Stability of Sodium Phosphate Solutions in Polyvinyl Chloride Bags.
Perks W, Iazzetta J, Chan P.C, Brouzas A, Law S,Walker S.E.
2017
4016 Journal
Ann Pharm Fr 2017 ; 75, 6: 420-435.
Extended stability of the rituximab biosimilar CT-P10 in its opened vials and after dilution and storage in polyolefin bag.
Vieillard V, Paul M, Ibrahim T, Astier A.
2017
2642 Journal
Int J Pharm 1982 ; 11, 4: 329-336.
Factors affecting captopril stability in aqueous solution
Timmins P, Jackson IM, Yu-chang John Wang.
1982
1182 Journal
Am J Hosp Pharm 1981 ; 38: 1449-1454.
Factors affecting diazepam infusion: solubility, administration-set composition, and flow rate.
Mason NA, Cline S, Hyneck ML, Berardi RR, Ho NFH, Flynn GL.
1981
122 Journal
Int J Pharm Pract 1993 ; 2: 39-43.
Factors affecting the physical and chemical stability of morphine sulphate solutions stored in syringes.
Grassby PF, Hutchings L.
1993
3463 Journal
Nursing 2011 ; 29 :62-6
Fármacos en perfusión continua en la unidad de cuidados intensivos: estudio de compatibilidad.
Eva P?rez Juan, Mar?a Jos? Ar?valo Rubert , Silvia M?nica Amor?s Cerd? , Palau M.M, Nicolau B.R.
2011
3758 Journal
J Pharm Pract and Res 2014 ; 44, 89?94
Feasibility and stability of metaraminol in pre-filled syringes.
To T.P, Ching M.S, Booth J.C, Zeglinski P, McGrath A, Elli A.G,Garrett K.
2014
3819 Journal
J Pharm Biomed Anal 2015 ; 118: 105-112.
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend® SF PH4 oral suspensions.
Ferreiraa A.O, Poloninia H.C, Silva S.L, Patr?cio F.B, Brand?oa M.A.F, Raposoa N.R.B.
2015
3503 Manufacturer
Hameln Pharmaceuticals 2012
Fentanyl - Summary of product Characteristics
2012
3618 Manufacturer
Amgen 2014
Filgrastim (Neupogen®) - Summary of Product Characteristics
2014
1413 Journal
Int J Pharm Compound 1999 ; 3: 67-68.
Five-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperature.
Lieu CL, Chin A, Gill MA.
1999
3522 Manufacturer
Actavis 2013
Flucloxacillin - Summary of Product Characteristics.
2013
3565 Manufacturer
Aguettant 2008
Flumazenil Aguettant - Résumé des caractéristiques du produit.
2008
3474 Manufacturer
Accord Healthcare Limited 2009
Fluorouracil - Summary of Product Characteristics
2009
1998 Journal
Am J Health-Syst Pharm 1998 55: 1315-1316.
Fluorouracil precipitate.
Allwood MC.
1998
3992 Journal
Int J Pharm 2016 ; 509 : 279?284
Formulation and charaterization of 0,1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas.
Bougueon G, Lagarce F, Martin L, Pailhori?s H, Bastiat G, Vrignaud S.
2016
3800 Journal
Iranian J Pharm Res 2003 : 157-160.
Formulation and Clinical Evaluation of Povidone-Iodine Ophthalmic Drop.
Rahim Bahri Najafi, Soleyman Mohammadi Samania, Nahid Pishvab, Fateme Moheimania.
2003
2786 Journal
Am J Health-Syst Pharm 2005 ; 62, 5: 485-491.
Formulation and efficacy of triamcinolone acetonide mouthwash for treating oral lichen planus.
Ungphaiboon S, Nittayananta W, Vuddhakul V, Maneenuan D, Kietthubthew S, Wongpoowarak W, Phadoongsombat N.
2005
3321 Journal
Int J Pharm Compound 2012 ; 16, 4: 342-346.
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets.
Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa.
2012
3785 Journal
J Pain Palliat Care Pharm 2014 ;,28, 4: 367?370.
Formulation and Stability of an Extemporaneously Compounded Oral Solution of Chlorpromazine HCl
Prohotsky D.L, . Juba K.M, Zhao F.
2014
2682 Journal
Int J Pharm Pract 1991 ; 1: 19-22.
Formulation and stability of cefuroxime eye-drops.
Oldham GB.
1991
2476 Journal
Am J Hosp Pharm 1986 ; 43: 1489-1491.
Formulation and stability of diazepam suspension compounded from tablets
Strom JG, Jr, Kalu AU.
1986
2542 Journal
Ann Pharmacotherapy 1997 ;31:1291-1295.
Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone.
Fawcett JP, Morgan NC, Woods DJ.
1997
3669 Journal
Ann Pharm Fr 2015 ; 73, 1: 31-36.
Formulation and stability study of a pediatric 2% phenylephrine hydrochloride eye drop solution
Dreno C, Gicquel T, Harry .M, Tribut O, Aubin F, Brandhonneur N, Dollo G.
2015
4170 Journal
Int J Pharm Compound 2018 22,5:433-439
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
Zhao F, Dave V.S, Mar M, Perri J.
2018
4360 Journal
Hosp Pharm 2019
Formulation and Stability Study of Omeprazole Oral Liquid Suspension for Pediatric Patients.
Oriana Boscolo, Francesco Perra, Leandro Salvo, Fabiàn Buontempo, and Silvia Lucangioli.
2019
4008 Poster
Hopipharm Congress 2017-Nancy 2017
Formulation et étude de stabilité de crèmes au sirolimus dosées à 0,1, à 0,25 ou à 0,5% m/m.
Vrignaud S, Bougueon G, Briot T, Truffaut C, Martin L, Pailhori?s H, Bastiat G, Clerc M-A, Lagarce F.
2017
4104 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018
Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method.
Bonnet M, Dermu M, Roessle C, Bellaiche M, Abarou T, Vasseur V, Benakouche S, Storme T.
2018
3017 Journal
Eur Hosp Pharm 1996 ; 2: 176-180.
Formulation of a stable calcium gluconate gel for topical treatment of hydrofluoric acid burns.
Rotheli-Simmen B, Martinelli E, Muhlebach S.
1996
2720 Journal
J Ocular Pharm Ther 2007 ; 23, 3: 292-303.
Formulation of sirolimus eye drops corneal permeation studies.
Buech G, Bertelmann E, Pleyer U, Siebenbrodt I, Borchert HH.
2007
4079 Journal
J Pharm Anal 2017 ; 7, 4: 237-243.
Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial.
Filali S, Bergamelli C, Tall M.L, Salmon D, Laleye D, Dhelens C, Diouf E, Pivot C, Pirot F.
2017
2295 Manufacturer
Merck Sharp Dohme 2013
Fosaprepitant (Emend®) - Summary of Product Characteristics
2013
3662 Manufacturer
Clinigen 2014
Foscavir (Foscarnet®) - Summary of Product Characteristics
2014
3663 Manufacturer
Panpharma 2011
Fosfomycine (Fosfomycine Panpharma®) - Résumé des caractéristiques du produit
2011
1419 Journal
Int J Pharm Compound 1999 ; 3: 235-238.
Fosphenytoin Y-site stability studies with lorazepam and midazolam hydrochloride.
Riggs RM, English BA, Webster AA, McGuire JM, Riordan JM.
1999
2124 Journal
EJHP Science 2006 ; 12, 4: 72-75.
Freeze thaw treatment of ketorolac tromethamine in 5% dextrose infusion polyolein bags: effect of drug concentration and microwave power on the long-term stability at 4°C.
Hecq JD, Boitquin L, Lebrun C, Vanbeckbergen D, Evrard JM, Jamart J, Galanti L.
2006
1329 Journal
Br J Parent Ther 1986 ; march/april: 42-44.
Freeze-thaw stability of antibiotics used in an IV additive service.
Brown AF, Harvey DA, Hoddinott DJ, Britton.
1986
3639 Manufacturer
Wockhardt 2013
Furosemide - Summary of Product Characteristics
2013
1855 Journal
J Pharm Biomed Anal 2000 ; 23: 803-817.
Furosemide assay in pharmaceuticals by Micellar liquid chromatography: study of the stability of the drug.
Carla-Broch S, Esteve-Romero J, Garcia-Alvarez-Coque MC.
2000
4060 Journal
EJHP 2018 ;25,3:144-149
Furosemide ethanol-free oral solutions for paediatric use : formulation, HPLC method and stability study.
Zahalka L, Klovrzova S, Matysova L, Sklubalova Z, Solich P.
2018
3661 Manufacturer
Laboratoire L?o 2012
Fusidate de sodium (Fucidine®) - Résumé des caractéristiques du produit
2012
3496 Manufacturer
Actavis 2009
Gemcitabin Actavis solution - Stability Study
2009
3643 Manufacturer
Sanofi 2015
Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
2015
1395 Journal
Thromb Haemost 1980 ; 43: 67.
Glass adsorption of highly purified urokinase.
Toki N, Sumi H.
1980
3599 Manufacturer
Amco Amdipharm Mercry 2013
Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics
2013
1643 Journal
Hosp Pharm 1994 ; 29: 76.
Haldol-benztropine incompatibility.
Raleigh F, Gibler B.
1994
985 Journal
Ann Pharmacotherapy 1996 ; 30: 549.
Haloperidol and diphenhydramine compatibility.
Raleigh FR, Gibler BS.
1996
1022 Journal
Drug Intell Clin Pharm 1986 ; 20: 886.
Heparin and aminoglycosides instability.
Hutchinson SMW.
1986
3540 Manufacturer
Wockhardt 2010
Heparin sodium - Summary of Product Characteristics.
2010
3113 Book
Compendium Suisse des m?dicaments 2010
Herceptin
2010
3796 Journal
Br Ophtalmol 1995 ; 79: 753-755.
High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study.
Morlet N, Young S, Naidoo D et al.
1995
1151 Journal
J Chromatogr 1981 ; 212: 339-346.
High-performance liquid chromatographic determination of sodium nitroprusside.
Baaske DM, Smith MD, Karnatz N, Carter JE.
1981
3757 Journal
Antimicrob Agents Chemother 2014 ; 58 : 2849-2855.
How To Minimize Toxic Exposure to Pyridine during Continuous Infusion of Ceftazidime in Patients with Cystic Fibrosis?
Bourget P, Amin A, Dupont C, Abely M, Desmazes-Dufeu N, Dubus J.C, Jouani B.-L., Merlette C, Nov?-Josserand R, Pages J, Panzo R
2014
2166 Journal
J Liquid Chrom Rel Technol 2003 ; 26, 17: 2909-2929.
HPLC-DAD methods for studying the stability of solutions containing hydromorphone, ketorolac, haloperidol, midazolam, famotidine, metoclopramide, dimenhydrinate and scopolamine.
Nassr S, Dubuc MC, Lavoie P, Brazier JL.
2003
2011 Journal
Krankenhauspharmazie 2005 ; 26, 6: 206-210.
HPLC-stabilitätuntersuchungen zu rekonstituierten Bortezomib-Lösungen.
Friess D, Nguyen HC, Lipp HP.
2005
1733 Journal
Pharmazie 1999 ; 54: 542-544.
HPTLC-based stability assay for determination of amiodarone in intravenous admixtures.
Kopelent-Frank H, Schimper A.
1999
3617 Manufacturer
Wockhardt 2011
Hyaluronidase (Hyalase®) - Summary of Product Characteristics
2011
3184 Manufacturer
CP Pharmaceuticals 2005
Hyaluronidase (Hyalase®) - Summary of Product characteristics.
2005
2275 Journal
Int J Pharm 1998 ; 173: 221-232.
Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers.
Craig Dyar S, Notari RE.
1998
2215 Journal
Chem Pharm Bull 1984 ; 32, 3: 1113-1119.
Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5.
Boehm J.J, Poust R.I.
1984
2364 Poster
PharmSciFair 2009
Hydromorphone and dipyrone in PCA devices: Is still a therapy with hydromorphone?
M?ller S, Trittler R, Schubert R, Strehl E.
2009
120 Journal
Can J Hosp Pharm 1988 ; 41: 177-182.
Hydromorphone and morphine stability in portable infusion pump cassettes and minibags.
Walker SE, Coons C, Matte D, DeAngelis C, Iazzetta J, Kolos C, Birkhans B.
1988
3932 Manufacturer
Serb Laboratoire 2015
Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
2015
3600 Manufacturer
UCB Pharma SA 2009
Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit
2009
1380 Journal
Am J Hosp Pharm 1984 ; 41: 74.
Identification of labetolol precipitate.
Alam AS.
1984
1915 Manufacturer
Genzyme 2010
Imiglucerase (Cerezyme®) -Summary of product Characteristics
2010
3530 Manufacturer
Hospira 2013
Imipenem/Cilastatin – Summary of Product Characteristics
2013
2649 Journal
Int J Pharm 2002 ; 234, 1-2: 205-212.
Impact of deep freezing on the stability of 25 mg/ml vancomycin opgtalmic solutions.
Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.
2002
1871 Journal
Int J Pharm 2002 ; 234: 205-212.
Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions.
Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.
2002
2733 Journal
J Pharm Clin 1999 ; 18: 179-182.
Impact of deep-freezing on pefloxacin eye drops stability.
Gellis C, Sautou-Miranda V, Arvouet A.
1999
3500 Manufacturer
Lipomed 2011
In use stability of dacarbazine Lipomed® solutions.
2011
4352 Journal
J Clin Pharm Ther 2019 ; 44: 875-882.
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y.
2019
979 Journal
Int Pharm J 1995 ; 9: 57.
In vitro compatibility of granisetron with selected alkaline drugs.
D?Arcy PF.
1995
3294 Journal
EJHP 2012 ; 19: 57-64.
In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs
Humbert-Delaloye V, Berger M, Voirol P, Pannatier A.
2012
3381 Journal
EJHP 2013 ; 20:110-116.
In vitro compatibility of various cardioactive drugs during simulated Y-site administration.
Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Gattlen L, Pannatier A.
2013
4048 Journal
Hosp Pharm 2017 ;52,11:752-760
In vitro evaluation of eslicarbazepine delivery via enteral feeding tubes.
Reindel K, Zhao F, Hughes S, Dave V.
2017
643 Journal
Cancer Treat Rep 1987 ; 71: 1189-1192.
In vitro stability and compatibility of daunorubicin, cytarabine, and etoposide.
Seargeant LE, Kobrinsky NL, Sus CJ, Nazeravich DR.
1987
3205 Journal
AAPS Pharm Sci 2011 ; 15, 2 : 264-272.
in vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz, Y.K. , Joyce, M., Lam, X.
2011
3953 Journal
Hemodial Int 2011 ; 15, 2 : 364-272.
In vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz Y.K, Joyce M, Lam X.
2011
2793 Journal
Hosp Pharm 2015 ; 50, 4 : 296-303.
In Vitro Stability Evaluation of Different Pharmaceutical Products Containing Meropenem.
Tomasello C, Leggieri A, Cavalli R, Di Perri G, D?Avolio A.
2015
3149 Journal
Diabetes Tech and Ther 2006 ; 8, 3: 358-368.
In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion.
DeFelippis MR, Bell MA, Heyob JA, Storms SM.
2006
1037 Journal
J Pharm Sci 1984 ; 73: 838-839.
In vitro stability of sodium nitroprusside solutions for intravenous administration.
Mahony C, Brown JE, Stargel WW, Verghese CP, Bjornsson TD.
1984
1322 Journal
JPEN 1983 ; 7: 156-158.
In vitro study of inline filtration of medications commonly administered to pediatric cancer patients.
Ennis CE, Merritt RJ, Neff DN.
1983
4194 Journal
Bio Drugs 2018 32;619-625
In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion.
Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y.
2018
3812 Journal
Int J Pharm Compound 2015 ; 19, 5 : 432-436.
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers.
Bhattacharya S, Parekh S, Dedhiya M.
2015
2975 Poster
ESCP 2014 2014
In-Use stability of herceptin for subcutaneous injection with different administration materials.
Nalenz H, Schoenhammer K, Dietel E, Heynen S.R, Grauschopf U, Mahler H.C.
2014
264 Journal
Pharm Hosp Fr 1997 ; 121: 124.
Incompatibilité physico-chimique entre l’oméprazole et la vancomycine.
Leboucher G, Charpiat B.
1997
1625 Journal
Int J Pharm Compound 2001 ; 5: 314-321.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Trissel LA, Saenz C, Williams YW, Ingram D.
2001
4429 Journal
Medicine 2016 ; 95:25(e3824)
Incompatibilities of lornoxicam with 4 antiemetic medications in polyolefin bags during simulated intravenous administration.
Fang B-X, Li P, Shi X-Y, Chen F.C, Wang L.H.
2016
2630 Journal
Hosp Pharm 1981 ; 16: 486-487.
Incompatibilities with orally administered liquid neuroleptic medication combinations.
Raleigh F.
1981
921 Journal
Hosp Pharm 1998 ; 33: 284-292.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF.
1998
241 Journal
Am J Health-Syst Pharm 1996 ; 53: 2639.
Incompatibility between ceftriaxone sodium and labetolol hydrochloride.
Leader WG, Jones JM.
1996
1084 Journal
Lancet 1988 ; 1(8587): 700.
Incompatibility between fat emulsion and calcium plus heparin in parenteral nutrition of premature babies.
Raupp P, von Kriek R, Schmidt E, Pfahl HG, G?nther O.
1988
3873 Journal
Am J Health-Syst Pharm 2016 ; 73:755.
Incompatibility between irinotecan and fluorouracil injections
Tan X, Hu J.
2016
205 Journal
Am J Health-Syst Pharm 1996 ; 53: 184.
Incompatibility of amiodarone hydrochloride and evacuated glass bottles.
Strozyk WR, Williamson R, Thompson D.
1996
200 Journal
Am J Health-Syst Pharm 1995 ; 52: 2340.
Incompatibility of amiodarone hydrochloride and sodium bicarbonate injections.
Korth-Bradley JM, Ludwig S, Callaghan C.
1995
3868 Journal
J Oncol Pharm Practice 2016 ; 22: 571-572
Incompatibility of busulfan with 1?ml Luer-Lock syringes.
Loboda C, Lider P, Vigneron J.
2016
106 Journal
Am J Hosp Pharm 1990 ; 47: 519.
Incompatibility of cefoperazone and promethazine.
Scott SM.
1990
260 Journal
Am J Hosp Pharm 1993 ; 50: 2054, 2057.
Incompatibility of cefotaxime sodium and vancomycin sulfate during Y-site administration.
Szof C, Walker PC.
1993
103 Journal
Am J Health-Syst Pharm 1995 ; 52: 1347.
Incompatibility of cefotetan disodium and promethazine hydrochloride.
Erickson SH, Ulici D.
1995
1399 Journal
Pharm J 1987 ; 238: 577.
Incompatibility of ceftazidime and vancomycin.
Cairns CJ, Robertson J.
1987
1744 Journal
Am J Health-Syst Pharm 1999 ; 56: 384.
Incompatibility of ceftriaxone sodium with lactated Ringer’s injection.
Burkiewicz JS.
1999
95 Journal
Am J Hosp Pharm 1991 ; 48: 77.
Incompatibility of ceftriaxone with vancomycin.
Pritts D, Hancock D.
1991
3475 Journal
Am J Health-Syst Pharm 2013 ;70:1966-1970.
Incompatibility of ciprofloxacin and meropenem injections.
Chen L.Y, Chen J, Waters V, Boodhan S.
2013
1085 Journal
Radiology 1989 ; 173: 91-92.
Incompatibility of contrast agents with intravascular medications.
Irving HD, Burbridge BE.
1989
3486 Journal
Cardiovasc Intervent Radiol 2013 ; 36: 237-238.
Incompatibility of contrast medium and trisodium citrate.
Delcour C, Brunnix G.
2013
1607 Journal
Hosp Pharm 2000 ; 35: 1192-1196.
Incompatibility of erythromycin lactobionate and sulfamethoxazole/trimethoprim with linezolid injection.
Trissel LA, Zhang Y, Xu QA.
2000
3664 Journal
Am J Health-Syst Pharm 2014 ; 71:901-902.
Incompatibility of esmolol hydrochloride and furosemide in a central venous access port
Zhao B, Sun W.
2014
155 Journal
Am J Health-Syst Pharm 1995 ; 52: 710-715.
Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium.
Trissel LA, Martinez JF, Xu QA.
1995
1326 Journal
Am J Roentgenol 1986 ; 146: 1300-1301.
Incompatibility of Hexabrix and papaverine.
Pilla TJ, Beshany SE, Shields JB.
1986
2349 Journal
Am J Health-Syst Pharm 2009 ; 66: 1253-1254.
Incompatibility of imipenem–cilastatin and amoxicillin
Pourroy B, Milano Bausset E, Boulamery A, Gauthier Villano L, Braguer B.
2009
494 Journal
Am J Hosp Pharm 1992 ; 49: 836,838.
Incompatibility of injectable indomethacin with gentamicin sulfate or tobramycin sulfate.
Thompson DF, Heflin NR.
1992
228 Journal
Am J Hosp Pharm 1994 ; 51: 2964.
Incompatibility of ketorolac tromethamine with haloperidol lactate and triethylperazine maleate.
Mendenhall A, Hoyt DB.
1994
476 Journal
Am J Hosp Pharm 1992 ; 49: 2960-2962.
Incompatibility of ketorolac tromethamine with selected postoperative drugs.
Knapp AJ, Mauro VF, Alexander KS.
1992
89 Journal
Am J Hosp Pharm 1993 ; 50: 2521-2522.
Incompatibility of labetalol hydrochloride and furosemide.
Zeisler J, Alagna C.
1993
1079 Journal
Am J Hosp Pharm 1985 ; 42: 2651.
Incompatibility of morphine sulfate and prochlorperazine edisylate in syringes.
Stevenson JG, Patriarca C.
1985
3380 Journal
Ann Pharmacotherapy 2013 ;47:426-427.
Incompatibility of Piritramide with Cephalosporins.
Eckle V-S, Heim E, Hahn M, Grasshoff C.
2013
1646 Journal
Anaesthesia 2001 ; 56: 920.
Incompatibility of prochlorperazine and ketoprofen.
Kannan S.
2001
1672 Journal
Anesthesiology 1998 ; 89: 1609.
Incompatibility of propofol emulsion with anesthesic drugs.
Lamontagne C, Brouillette D, Hardy JF.
1998
3101 Journal
Perit Dial Int 2002 ; 22: 93-94.
Incompatibility of Vancomycin and Ceftazidime for Intraperitoneal Use.
Wazny LD, Blake PG.
2002
3930 Manufacturer
Serb laboratoire 2013
Indocyanine (Infracyanine®) - Résumé des caractéristiques du produit
2013
754 Manufacturer
Merck Sharp & Dohme 2019
Infliximab (Remicade®) – Summary of Product Characteristics
2019
3137 Journal
Retina 2010 ; 30, 1: 81-84.
Infliximab stability after reconstitution, dilution, and storage under refrigeration.
Beer PM, Wong SJ, Schartman JP, Kulas KE, Hartman CL, Giganti M, Falk NS.
2010
4452 Poster
Congrès Hopipharm 2019
Influence d'un ajout de L-carnitine dans les mélanges de nutrition parentérale destinés aux patients à domicile.
Sémély D, Bello W, Daupin J, Lebland C, Carrez L, Berger M, Sadeghipour F.
2019
3869 Journal
J Pharm Pharmacol 2016 ; 68: 433-438.
Influence of 5% dextrose volume on amphotericin B deoxycholate preparation
Sun P, Chen J, Zhang Z, Gao X, Chen P, Li X.
2016
951 Journal
PDA J Pharm Sci Technol 1998 ; 52: 129-133.
Influence of DL methionine and sodium metasulphite on the photostability of vitamin K1.
Ho PC, Wong VK.
1998
1147 Journal
J Pharm Pharmacol 1991 ; 43: 601-604.
Influence of intravenous administration set composition on the sorption of isosorbide dinitrate.
De Muynck C, Colardyn F, Remon JP.
1991
39 Journal
J Pharm Clin 1997 ; 16: 45-48.
Influence of intravenous admixtures on the stability of the new solution of 5-fluorouracil.
Farhang-Asnafi S, Callaert S, Barre J, Tillement JP, Thebault A.
1997
2134 Journal
J Pharm Sci 1998 ; 87, 12: 1572-1576.
Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions.
Fubara JO, Notari RE.
1998
2005 Journal
Am J Health-Syst Pharm 2005 ; 62: 1347-1348.
Influence of temperature and drug concentration on nafcillin precipitation.
Chan V.
2005
2463 Journal
Am J Hosp Pharm 1979 ; 50: 486-488.
Instability of aqueous captopril solutions
Anaizi NH, Swenson C.
1979
1167 Journal
Antimicrob Agents Chemother 1987 ; 31: 610-611.
Instability of vancomycin in infusaid drug pump model 100.
Grennberg RN, Saeed AM, Kennedy DJ, McMillian R.
1987
1091 Journal
Anesthesiology 1974 ; 40: 400-404.
Insulin adsorption by glass infusion bottles, polyvinylchloride infusion containers, and intravenous tubing.
Petty C, Cunningham NL.
1974
1175 Journal
Am J Hosp Pharm 1981 ; 38: 995-997.
Insulin adsorption to polyolefin infusion bottles and polyvinyl chloride administration sets.
Hirsch JI, Wood JH, Thomas RB.
1981
1245 Journal
JPEN 1989 ; 13: 539-543.
Insulin adsorption to three-liter ethylen vinyl acetate bags during 24-hour infusion.
Doglietto GB, Bellantone R, Bossola M, Perri V, Ratto C, Pacelli F, Sofo L, Migliore A, Manna R, Crucitti F.
1989
3935 Manufacturer
Sanofi Laboratoire 2016
Insuline glulisine (Insulines Sanofi Apidra®) - Résumé des caractéristiques du produit
2016
1359 Journal
Am J Hosp Pharm 1985 ; 42: 2420-2421.
Interaction between vancomycin and ticarcillin.
Perest M, Allison J.
1985
433 Journal
Am J Hosp Pharm 1986 ; 43: 2221-2224.
Interaction of aztreonam with nafcillin in intravenous admixtures.
Riley CM, Lipford LC.
1986
377 Journal
Am J Hosp Pharm 1988 ; 45: 1350-1352.
Interaction of heparin sodium and dopamine hydrochloride in admixtures studied by microcalorimetry.
Pereira-Rosario R, Utamura T, Perrin JH.
1988
1120 Journal
Am J Hosp Pharm 1974 ; 31: 72-78.
Interactions between drugs and plastic intravenous fluid bags. Part I: Sorption studies on 17 drugs.
Moorhatch P, Chiou WL.
1974
1173 Journal
Am J Hosp Pharm 1981 ; 38: 1308-1314.
Interactions between drugs and polyvinyl chloride infusion bags.
Kowaluk EA, Roberts MS, Blackburn HD, Polack AE.
1981
499 Journal
Hosp Pharm 1991 ; 26: 634-635.
Intramuscular antibiotic preparation and administration using a 1% lidocaine diluent: policies for the pediatric patient.
Rockwell K, Burch K.
1991
1109 Journal
Crit Care Med 1990 ; 18: 858-861.
Intravenous infusions of nitroprusside, dobutamine, and nitroglycerin are compatible.
Horrow JC, Digregorio J, Barbieri EJ, Rupp E.
1990
732 Journal
Am J Hosp Pharm 1975 ; 32: 575-578.
Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: Stability with common intravenous fluids.
Gardella LA, Zaroslinski JF, Possley LH.
1975
738 Journal
Am J Hosp Pharm 1978 ; 35: 581-584.
Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 3: Stability with miscellaneous additives.
Gardella LA, Kesler H, Amann A, Carter JE.
1978
2324 Journal
Int J Pharm 2009 ; 369, 1-2 : 30-37
Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application
Treleano A, Wolz G, Brandsch R, Welle F.
2009
3666 Journal
Int J Pharm Compound 2014 ; 18, 3: 248-252.
Investigation of Physical and Chemical Stability of an Ointment with Herbals
Zdoryk Oleksandr A,Khokhlova Kateryna O,Georgiyants Victoriya A,Vyshnevska Liliia I.
2014
1961 Journal
Int J Pharm 2005 ; 293: 303-310.
Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles.
Kim SC, Yoon HJ, Lee JW, Yu J, Park ES, Chi SC.
2005
4012 Journal
EJHP 2018 ; 25, e2
Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions.
Khaleel I, Tabish R Zaidi S, Shastri M, Suji Eapen M, Chiau Ming L, Wanandy T, P Patel R.
2018
2655 Journal
Int J Pharm 2008 ; 353, 1-2: 1-7.
Invitro release and stability of an artesunate rectal gel suitable for pediatric use.
Gaudin K, Barbaud A, Boyer C, Langlois MH, Lagueny AML, Dubost JP, Millet P, Fawaz F.
2008
4377 Journal
Radiology 1992 ; 184: 385-387.
Ionic lodinated Contrast Medium and Amobarbital Sodium Mixtures: Potential for Precipitation.
Monsein L.H, Miller T.J, Kuwahara S.K, Sostre S, Debrun G.M.
1992
3352 Manufacturer
Bristol Myers Squibb 2011
Ipilimumab (Yervoy®) - Summary of Product Characteristics
2011
3129 Manufacturer
Pfizer 2008
Irinotécan (Campto®) – Résumé des caractéristiques du produits
2008
1391 Journal
Can J Hosp Pharm 1998 ; 51: 271-272.
Is heparin always compatible with TPN and fat emulsion admixtures?
Vanstone GL.
1998
2864 Manufacturer
Astellas Pharma 2015
Isavuconazonium (Cresemba®) - Summary of Product Characteristics
2015
3660 Manufacturer
Hospira 2016
Isoprenaline (Isuprel®) - Résumé des caractéristiques du produit
2016
3341 Journal
Krankenhauspharmazie 2001 ; 7: 331-333.
Ist teurer immer auch besser? Analytiklabor der Apotheke unterstütz Einkauf sentcheidungen bei Carboplatin-Präparaten.
Trittler R, Jung B, Strehl E.
2001
1270 Journal
J Pharm Belg 1980 ; 35: 389-393.
IV infusion of glyceryl trinitrate. Study of the sorption on various plastic containers.
Mathot F, Bonnard J, Han P, Bosly J.
1980
3084 Manufacturer
Bristol Myers Squibb 2009
Ixabepilone (Ixempra®) – Summary of Product Characteristics
2009
3488 Journal
Farm Hosp 1995 ; 19, 1: 41-44.
Jarabe de midazolam: Estudio de estabilidad de una solucion oral para uso hospitaliaro.
Caldes R, Ciges S.M, Borras E, Calvelo R, Lisart F.
1995
3501 Manufacturer
Pfizer 2011
Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics
2011
3593 Manufacturer
Beacon Pharmaceuticals 2011
Ketorolac trometamol (Ketorolac®) - Summary of Product Characteristics
2011
1481 Journal
Krankenhauspharmazie 1994 ; 9: 337-340.
Kompatibilität von ofloxacin mit ampicillin.
Messerschmidt W.
1994
3686 Manufacturer
Eusapharma 2013
L asparaginase (Kidrolase®) - Résumé des caractéristiques du produit
2013
3609 Manufacturer
Aspen Pharma 2013
Labetalol (Trandate®) - Summary of Product Characteristics
2013
1014 Journal
Clin Pharmacol Ther 1988 ; 43: 183.
Lack of photodegradation but significant adsorption of nifedipine in administration systems.
Larsen JS, Uden DL, Zaske DE.
1988
1819 Journal
J Clin Pharm Ther 2002 ; 27: 139-142.
Leaching of diethyl hexyl phtalate from polyvinyl chloride bags into intravenous etoposide solution.
Demoré B, Vigneron J, Perrin A, Hoffman MA, Hoffman M.
2002
1984 Journal
Am J Health-Syst Pharm 2005 ; 62: 182-188.
Leaching of diethylhexyl phtalate from multilayer tubing into etoposide infusion solutions.
Bagel-Boithias S, Sautou-Miranda V, Bourdeaux D, Tramier V, Boyer A, Chopineau J.
2005
455 Journal
Am J Hosp Pharm 1986 ; 43: 2800-2802.
Leaching of diethylhexyl phtalate from polyvinyl chloride bags into intravenous cyclosporine solution.
Venkataramanan R, Burckart GJ, Ptachcinski RJ, Blaha R, Logue LW, Bahnson A, Giam CS, Brady JE.
1986
140 Journal
Am J Hosp Pharm 1993 ; 50: 1405-1409.
Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components.
Pearson SD, Trissel LA.
1993
165 Journal
Int J Pharm 1994 ; 105: 89-93.
Leaching of diethylhexyl phthlate from PVC bags into intravenous teniposide solution.
Faouzi MA, Dine T, Luyckx M, Gressier B, Goudaliez F, Mallevais ML, Brunet C, Cazin M, Cazin JC.
1994
3920 Manufacturer
Fresenius Kabi 2018
Levofloxacine - Résumé Caractéristique du Produit
2018
3369 Manufacturer
MEDAC France 2011
Levofolinate de sodium Medac - Résumé des caractéristiques du produits
2011
1126 Journal
Am J Hosp Pharm 1983 ; 40: 97-101.
Lidocaine stability in cardioplegic solution stored in glass bottles and polyvinyl chloride bags.
Lackner TE, Baldus D, Butler CD, Amyx C, Kessler G.
1983
3286 Journal
Yakugaku Zasshi 2010 ; 130, 10: 1369-1374.
Light-induced Deterioration Test of Carboplatin under Clinical Settings.
Okamoto Y, Tazumi K, Sanada Y, Tsugane M, Uejima E.
2010
3560 Manufacturer
Pharmacia 2013
Linezolid (Zyvox®) - Summary of Product Characteristics
2013
2163 Journal
Perit Dial Int 2002 ; 22: 419-422.
Linezolid stability in peritoneal dialysis solutions.
Manley HJ, McClaran ML, Bedenbaugh A, Peloquin CA.
2002
2654 Journal
Int J Pharm 2007 ; 344, 1-2: 150-153.
Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability.
Morand K, Bartoletti AC, Bochot A, Barratt G, Brandely ML, Chast F.
2007
1291 Journal
Int J Pharm Pract 1995 ; 3: 253-255.
Long term stability of heparin in dextrose-saline intravenous fluids.
Wright A, Hecker J.
1995
35 Journal
Am J Health-Syst Pharm 1995 ; 52: 2128-2130.
Long term stability of interferon alfa-2b diluted to 2 million units/mL.
Schepart BS, Burns BA, Evans S, Poleon G.
1995
1962 Journal
Pharmakon 2004 ; 36, 1: 8-14.
Long term stability of sufentanyl citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion P.V.C bags at 4°C.
Hecq JD, Boitquin L, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L.
2004
3115 Journal
Ann Pharm Fr 2010 ; 68: 157-162.
Long term stability of the hydrochloride of tramadol and alizapride in dextrose 5% polyolefin bags at 5 +/- 3°C.
Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2010
2174 Journal
EJHP Science 2006 ; 12, 6: 129-134.
Long-term physical and chemical stability of a generic paclitaxel infusion under simulated storage and clinical-use conditions.
Kattige A.
2006
3386 Journal
Int J Pharm 2013 ; 448: 101-104.
Long-term physico-chemical stability of diluted trastuzumab.
Paul M, Vieillard V, Da Silva Lemos R, Escalup L, Astier A.
2013
4374 Journal
Int J Pharm Compound 2020 ;24,1:64-68
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit.
Lardinois B, Dimitriou A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq J-H, Galanti L.M.
2020
4342 Journal
Int J Pharm Compound 2019 ;23,5:434-437
Long-term Physicochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics.
Lardinois B, Baltzis A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq JD, Galanti L.
2019
4148 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018
Long-Term Stability Comparison between an Original and a Generic Version of Piperacillin/Tazobactam in Dextrose 5% Infusion Polyolefin Bags at 5+/-3°C after Microwave Freeze-Thaw Treatment.
Huvelle S, Godet M, Galanti L, Closset M, Bihin B, Jamart J, Hecq J.D.
2018
4199 Journal
EJHP 2018
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas.
Le Guyader G, Vieillard V, Andrieux K, Rollo M, Thirion O, Wolkenstein P, Paul M.
2018
2323 Journal
Can J Hosp Pharm 2009 ; 62, 1
Long-Term Stability of 5-Fluorouracil in 0.9% Sodium Chloride after Freezing, Microwave Thawing, and Refrigeration
Galanti L, Lebitasy M.P, Hecq J.D, Cadrobbi J, Vanbeckbergen D, Jamart J.
2009
1475 Journal
J Pharm Biomed Anal 1996 ; 14: 395-399.
Long-term stability of 5-fluorouracil stored in PVC bags and in ambulatory pump reservoirs.
Martel P, Petit I, Pinguet F, Poujol S, Astre C, Fabbro M.
1996
2771 Journal
Skin Pharm Appl Skin Physiol 1999 ; 12: 266-270.
Long-term stability of 8-methoxypsoralen in ointments for topical PUVA therapy (Cream PUVA).
Martens-Lobenhoffer J, Rinke M, Losche D.
1999
2789 Journal
Bone Marrow Transplantation 2006 ; 37, 8: 781-784.
Long-term stability of a patient-convenient 1mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels.
Elefante A, Muindi J, West K, Dunford L, Abel S, Paplham P, Brown K, Hahn T, Padmanabhan S, Battiwalla M, McCarthy PL.
2006
3001 Journal
Ann Pharm Fr 2015 ; 73: 108-113.
Long-term stability of aciclovir in 0.9% NaCl infusion polyolefin bags at 2-8°C after freeze-thaw treatment: A generic product versus the brand name.
Dewulf J, Galanti L, Godet M, Gillet P, Jamart J, Hecq JD.
2015
3312 Journal
Ann Pharm Fr 2012 ; 70, 3: 139-154.
Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration.
Paul M, Vieillard V, Roumi E, Cauvin A, Despiau M.C, Laurent M, Astier A.
2012
656 Journal
J Clin Pharm Ther 1996 ; 21: 185-189.
Long-term stability of cefuroxime and cefazolin sodium in intravenous infusions.
Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J.
1996
2808 Journal
Int J Pharm Compound 2015 ; 19, 3: 268-270.
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles.
Dewulf J, Hecq J.D, Huvelle S, Godet M, Gillet P, Jamart J, Galanti L.M.
2015
3925 Journal
Ann Pharm Fr 2016 ; 75, 1 : 30-39.
Long-term stability of dexamethasone and alizapride or ondansetron in sodium chloride 0.9% polyolefin bag at 5±3 C.
Simar J, Godet M, Hecq J.-D, Closset M, Gillet P, Langhendries C, Bihin B, Jamart J, Galanti L.
2016
3323 Journal
Int J Pharm 2012 ; 436, 1-2: 282-290.
Long-term stability of diluted solutions of the monoclonal antibody rituximab.
Paul M, Vieillard V, Jaccoulet E, Astier A.
2012
2579 Journal
Ann Allergy Asthm Immun 2009 ; 102, 6, 500-503
Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxis
Rawas-Qalaji M ; Simons ER ; Collins D ; Simons KJ.
2009
2827 Journal
Am J Health-Syst Pharm 2009 ; 66: 1722-1725.
Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles
Brustugun J, Lao YE, Fagern?s C, Br?nden J, Kristensen S.
2009
4021 Journal
J Oncol Pharm Practice 2017 ;25,2: 303-308
Long-term stability of ganciclovir in polypropylene containers at room temperature.
Guichard N, Bonnabry P, Rudaz S, Fleury S.
2017
3874 Journal
Ann Pharm Fr 2016 ; 74: 283-287.
Long-term stability of ketamine hydrochloride 50 mg/ml injection in 3 ml syringes
Huvelle S, Godet M, Hecq J.D, Gillet P, Bihin B, Jamart J, Galanti L.
2016
4248 Journal
Hosp Pharm 2019 ; 55, 3: 199-193.
Long-Term Stability of Lorazepam in Sodium Chloride 0.9% Stored at Different Temperatures in Different Containers.
Colsoul M.L, Breuer A, Goderniaux N, Hecq J.D, Soumoy L, Bihin B, Jamart J, Galanti L.
2019
1885 Journal
Pharm World Sci 1999 ; 21: 144-146.
Long-term stability of morphine and bupivacaine mixture for spinal use.
Essink-Tjebbes CM, Burger DM, Beelen, Wuis EW, Heckster YA.
1999
3572 Journal
Int J Pharm Compound 2014 ; 18, 1 : 78-82.
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C.
Hecq J-D, Godet M, Gillet P, Jamart J, Galanti L.
2014
4201 Journal
Am J Health-Syst Pharm 2020 ; 77, 9: 681-689.
Long-term stability of ready-to-use 1-mg/mL midazolam solution.
Gilliot S, Masse M, Feutry F, Barthélémy C, Décaudin B, Genay S, Odou P.
2020
2204 Journal
J Oncol Pharm Practice 2007 ; 13: 99-103.
Long-term stability of sodium folinate in dextrose 5% polyolefin bags at 4°C.
Cadrobbi J, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2007
1908 Journal
J Pain Symptom Manage 2004 ; 28, 1: 4-6.
Long-term stability of sufentanil citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion PVC bags at 4°C.
Boitquin L, Hecq JD, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L.
2004
3255 Journal
Ann Pharm Fr 2011 ; 69, 6 : 296-301.
Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment
Rolin C, Hecq J.D, Tulkens P, Vanbeckbergen D, Jamart J, LGalanti L.
2011
3154 Journal
J Antimicrob Chemother 2010 ; 65, 9: 2045-2046.
Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients.
Carryn S, Couwenbergh N, Tulkens PM
2010
3082 Journal
J Oncol Pharm Practice 2009 ; 15: 195-200.
Long-term stability of tramadol chlorhydrate and metoclopramide hydrochloride in dextrose 5% polyolefin bag at 4°C.
Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2009
2814 Journal
Ann Pharm Fr 2009 ; 67: 272-277.
Long-term stability of tramadol hydrochloride and droperidol mixture in 5% dextrose infusion polyolefin bags at 5 +/- 3°C.
Lebitasy M, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2009
1899 Journal
Int J Pharm Compound 2004 ; 8, 3: 231-235.
Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Trissel LA, Zhang Y.
2004
931 Journal
J Clin Pharm Ther 1997 ; 22: 353-356.
Long-term stability of vancomycin hydrochloride in intravenous infusions.
Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J.
1997
2111 Journal
EJHP Science 2006 ; 12, 3: 57-59.
Long-term stability of voriconazole 4 mg/ml in dextrose 5% polyvinyl chloride bags at 4°C.
Cadrobbi J, Hecq JD, Lebrun C, Vanbeckbergen D, Jamart J, Galanti L.
2006
3856 Journal
Int J Pharm Compound 2016 ; 20, 2:164-166.
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Nahata M.C.
2016
3313 Journal
J Oncol Pharm Practice 2012 ; 18, 2: 218-221.
Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions.
Kaiser J, Krämer I.
2012
2495 Journal
Am J Hosp Pharm 1986 ; 43: 380-383.
Long-term stability study of histamine in sterile bronchoprovocation solutions
Marwaha RK, Johnson BF.
1986
532 Journal
Ann Pharmacotherapy 1996 ; 30: 343-346.
Lorazepam stability in parenteral solutions for continuous intravenous administration.
Hoey LL, Vance-Bryan K, Clarens DM, Wright DH, Konstantinides FN, Guay DRP.
1996
1980 Journal
Act Pharm Nord 1991 ; 3, 3: 131-136.
Loss of nitroglycerin during passage through two different infusion sets.
Hansen HC, Spillum A.
1991
1108 Journal
Crit Care Med 1983 ; 11: 50-52.
Loss of nitroglycerin to cardiopulmonay bypass apparatus.
Dasta JF, Jacobi J, Wu LS, Sokoloski T, Beckley P, Reilley TE, Howie MB.
1983
239 Journal
Am J Health-Syst Pharm 1996 ; 53: 655-658.
Loss of quinidine gluconate injection in a polyvinyl chloride infusion system.
Darbar D, Dell?Orto S, Wilkinson GR, Roden DM.
1996
1522 Manufacturer
Maco Pharma 2001
Macoflex N®
2001
3838 Manufacturer
Martindale Pharmaceuticals Ltd 2007
Magnesium Sulphate - Summary of Product Characteristics
2007
4344 Journal
EJHP 2018
Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessments.
Yay? HS, Faucheron A, Dupont L, El Kouari F, Fekkar A, Bellanger A, Tilleul P.
2018
3307 Journal
Hosp Pharm 2012 ; 47, 1: 27-30.
Managing the intravenous calcium shortage: Evaluation of calcium chloride stability in 0.9% sodium chloride and dextrose 5% water polyvinyl chloride bags.
Kiser T.H, Barber G.R, Robinson A.
2012
1861 Journal
Int J Pharm 1996 ; 127: 255-259.
Medical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixture.
Levadoux E, Sautou V, Bazin JE, Schoeffler P, Chopineau J.
1996
3584 Manufacturer
Aspen Pharma 2013
Melphalan (Alkéran®) - Résumé des caractéristiques du produit
2013
3602 Manufacturer
Baxter SAS 2013
Mesna (Uromitexan®)- Summary of Product Characteristics
2013
3637 Manufacturer
Hameln Pharmaceuticals 2014
Methotrexate (Methotrexate solution for injection®) - Summary of Product Characteristics
2014
978 Journal
Can J Hosp Pharm 1994 ; 47: 147.
Methotrexate and cytarabine for intrathecal administration.
Dick DM, Woloschuk DMM.
1994
1021 Journal
J Clin Hosp Pharm 1986 ; 11: 343-348.
Methotrexate in solutions - A stability test for the hospital pharmacy.
Dyvik O, Grislingaas AL, Tonnesen HH, Karlsen J.
1986
3594 Manufacturer
Zentiva 2013
Metronidazole (Flagyl®) - Summary of Product Characteristics
2013
3573 Manufacturer
Astellas 2013
Micafungin (Mycamine®) – Summary of Product Characteristics
2013
823 Journal
Am J Health-Syst Pharm 1998 ; 55: 1584-1587.
Microbial inhibitory properties and stability of topotecan hydrochloride injection.
Patel K, Craig SB, McBride MG, Palepu NR.
1998
3859 Journal
RRJHCP 2016 ; 1, 3: 31-37.
Microbiological and Physico-Chemical Stability of Ketamine Solution for Patient-Controlled Analgesia Systems.
Foy G, Poinsignon V, Mercier L, Laurent S, Paci A.
2016
2118 Journal
J Pain Symptom Manage 2006 ; 32, 1: 90-97.
Microbiological and physicochemical stability of fentanyl and sufentanil solutions for patient-controlled delivery-systems.
Chapalain-Pargade S, Laville I, Paci A, Chachaty E, Mercier L, Bourget Ph.
2006
3126 Journal
J Pain Symptom Manage 2010 ; 40, 1: 87-94.
Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems.
Amri A, Achour AB, Chachaty E, Mercier L, Bourget P, Paci A.
2010
2007 Journal
J Pharm Biomed Anal 2005 ; 38: 709-713.
Migration of diethylhexyl phtalate from PVC into intravenous cyclosporine solutions.
Gotardo MA, Monteiro M.
2005
1699 Journal
Krankenhauspharmazie 2000 ; 21: 107-109.
Mischbarkeit von serotonin-antagonisten mit dexamethason und heparin.
Plaas S, Heck C, K?brich M.
2000
3315 Poster
Communication orale Hopipharm 2012
Mise en évidence d'une incompatibilité physico-chimique entre la phénytoïne sodique et le paracétamol injectable en flacon.
Louvrier M, Dhennain S, Hocahrt S, Zawadski E, Bouffart S, Moquay E.
2012
3128 Manufacturer
Prostrakan 2013
Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
2013
3575 Manufacturer
Prostrakan 2013
Mitomycine (Ametycine®) - Résumé des caractéristiques du produit
2013
3640 Manufacturer
Hospira 2013
Mitoxantrone - Summary of Product Characteristics
2013
680 Journal
Can J Hosp Pharm 1991 ; 44: 143-151.
Mitoxantrone stability in syringes and glass vials and evaluation of chemical contamination.
Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C.
1991
465 Journal
Am J Hosp Pharm 1990 ; 47: 297-298.
More information on the visual compatibility of hetastarch with injectable critical-care drugs.
Wohlford JG, Wright JC, Wilson MR.
1990
2362 Poster
ADKA Congress 2009 2009
Morphin-Haloperidol mischungen in PCA Pumpen : Kompatibel?
Trittler R, M?ller S, Esteban M.
2009
2363 Poster
ADKA Congress 2006
Morphin-Metamizol mischungen zur kontinuierlichen parenteralen applikation : Sind sie immer inkompatibel?
M?ller S, Trittler R, Schubert R, von Hornstein W.F, Strehl E.
2006
3531 Manufacturer
Wockhardt 2014
Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics
2014
2055 Journal
Int J Pharm 2006 ; 307: 278-284.
Morphine, haloperidol and hyoscine N-butyl bromide combined in sc infusion solutions : compatibility and stability evaluation in terminal oncology patients.
Negro S, Reyes R, Azuara ML, Sanchez Y, Barcia E.
2006
626 Journal
Am J Hosp Pharm 1982 ; 39: 1495-1498.
Moxalactam disodium compatibility with intramuscular and intravenous diluents.
Bornstein M, Lo AY, Thomas PN, Wilham WL.
1982
3162 Manufacturer
Bayer HealthCare 2010
Moxifloxacine (Izilox®) - Résumé des caractéristiques du produits
2010
3109 Manufacturer
Bayer Schering Pharma 2010
Moxifloxacine (Izilox®) -Notice information
2010
1366 Journal
Am J Hosp Pharm 1981 ; 38: 462,464.
Nafcillin sodium incompatibility with acidic solutions.
Jeglum EL, Winter E, Kotos M.
1981
3672 Manufacturer
Mylan SAS 2016
Nalbuphine Mylan - Résumé des caractéristiques du produit
2016
3264 Poster
AAPS Congress - Washington, October 2011 2011
Nalbuphine stability at 1 mg/mL concentration.
Hammer C, Perello L, Dory A, Lev?que D, Ubeaud-S?quier G.
2011
2678 Journal
Int J Pharm Compound 2000 ; 4: 69-71.
Naratriptan hydrochloride in extemporaneously compounded oral suspensions.
Zhang YP, Trissel LA, Fox JL.
2000
4068 Manufacturer
2018 Biogen Idec Ltd
Natalizumab (Tysabri®) - Summary of Product Characteristics
2018
3938 Manufacturer
Lilly S.A 2016
Necitumumab (Portrazza®) – Résumé des caractéristiques du produits
2016
2311 Journal
J Clin Pharm Ther 2009 ; 34: 25-31.
Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C.
2009
2265 Journal
J Pharm Sci 1990 ; 79, 1: 48-52.
Nefopam hydrochloride degradation kinetics in solution.
Tu YH, Wang DP, Allen LV.
1990
958 Journal
Ann Pharmacotherapy 1990 ; 24: 440-442.
Netilmicin sulfate stability in combinaison with metronidazole or ranitidine hydrochloride in NaCl 0.9% infusion.
Vervloet E, Lammers J, Tan LSL, Van Mourik CH, Rots M.
1990
3306 Journal
EJOP 2012 ; 6, 1: 1-2.
New stability studies for fludarabine according to the European Pharmacopoeia 7.0
Trittler R.
2012
3941 Manufacturer
Concordia International 2017
Nicardipine - Summary of Product Characteristics
2017
3614 Manufacturer
American Regent Inc 2013
Nicardipine Injection - Summary of Product Characteristics
2013
3206 Journal
Int J Pharm Compound 2011 ; 15, 2: 166-169.
Nifedpine in Compounded Oral and Topical Preparations.
McCluskey Susan V, Brunn Gregory J.
2011
708 Journal
Am J Hosp Pharm 1980 ; 37: 201-205.
Nitroglycerin compatibility with intravenous fluid filters containers, and administration sets.
Baaske DM, Amann AH, Wagenknecht DM, Mooers M, Carter JE, Hoyt HJ, Stoll RG.
1980
1113 Journal
Am J Hosp Pharm 1989 ; 46: 2031-2035.
Nitroglycerin delivery through a polyethylene-lined intravenous administration set.
Tracy TS, Bowman L, Black CD.
1989
3863 Manufacturer
Bristol Myers Squibb 2016
Nivolumab (Opdivo®) - Summary of Products characteristics
2016
642 Journal
Hosp Pharm 1988 ; 23: 44,49, 59.
Norepinephrine stability in saline solutions.
Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA.
1988
3455 Journal
J Drug Deliv Sci Tecnol 2012 ; 22, 4: 347-352.
Novel formulation and clinical evaluation of nalidixic acid ointment in impetigo.
Tous S.S, El Sayed A.M, Abd El Mohsen M.G, Yoissef E.M.K, Agban M.N, Boushra M.F.
2012
3768 Manufacturer
Roche Products Limited 2014
Obinutuzumab (Gazyvaro®) - Summary of Product Characteristics
2014
4086 Manufacturer
Novartis Pharma 2017
Octréotide - (Sandostatine®)- Résumé des caractéristiques du produit
2017
3138 Manufacturer
GlaxoSmithKline 2009
Ofatumumab (Arzerra®) - Summary of Product Characteristics
2009
3562 Manufacturer
Sanofi 2014
Ofloxacin (Tarivid®) - Summary of Product Characteristics
2014
889 Journal
Pharm Weekbl [Sci] 1991 ; 13: 207-209.
Ofloxacin intravenous. Compatibility with other antibacterial agents.
Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM.
1991
3776 Manufacturer
Teva Pharmaceuticals 2014
Omecetaxine (Synribo®) - Summary of Product Characteristics
2014
3658 Manufacturer
Sandoz 2014
Omeprazole - Summary of Product Characteristics.
2014
3574 Manufacturer
Accord Healthcare France SAS 2013
Ondansetron - Résumé des caractéristiques du produit
2013
1396 Journal
J Clin Oncol 1993 ; 11: 197.
Ondansetron compatible with sodium acetate.
Hauser AR, Trissel LA, Martinez JF.
1993
3924 Journal
Ann Pharm Fr 2016 ; 75, 1 : 17-29.
One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C.
Vieillard V, Astier A, Sauzay C, Paul M.
2016
3949 Poster
JFSPH Congress, Bern, Switzerland. 2016
Optimisation du processus de préparation des solutions de melphalan destinées à l’administration intra-vitréenne dans le traitement du rétinoblastome et étude de leur stabilité
Br?nnimann C, Berger-Gryllaki M, Podilsky G, Sadeghipour F.
2016
3787 Manufacturer
The Medicines Company 2016
Oritavancin diphosphate (Orbactiv®) - Summary of Product Characteristics
2016
4211 Journal
PlosOne 2019
Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps.
Binson G, Grignon C, Le Moal G, Lazaro P, Lelong J, Roblot F, Venisse N, Dupuis A.
2019
3589 Manufacturer
PanPharma 2013
Oxacilline PanPharma – Résumé des caractéristiques du produits
2013
3413 Journal
Pharm Res 2004 ; 21, 5: 891-894.
Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex.
Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H.
2004
3634 Manufacturer
Accord Healthcare 2011
Oxaliplatine (Oxaliplatine Accord®) - Résumé des caractéristiques du produit
2011
2366 Poster
ADKA Congress 2009
Oxycodon-Metamizol in PCA pumpen : Kompatibel?
M?ller S, Trittler R, Schubert R.
2009
1903 Journal
Am J Obstet Gynecol 2002 ; 186: 496-498.
Oxytocin preparation stability in several common obstetric intravenous solutions.
Gard JW, Alexander JM, Bawdon RE, Albrecht JT.
2002
1956 Manufacturer
Hospira UK Limited 2015
Paclitaxel - Summary of Product Characteristics
2015
3157 Manufacturer
Celgene Europe Limited 2015
Paclitaxel albumin (Abraxane®) - Summary of Product Characteristics
2015
669 Journal
Ann Pharmacotherapy 1994 ; 28: 35-36.
Paclitaxel stability and compatibility in polyolefin containers.
Chin A, Ramakrishnan RR, Yoshimura NN, Jeong EWS, Nii LJ, DiMeglio LS.
1994
4101 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018
Paediatric formulation: budesonide 0.1 mg/mL viscous oral solution for eosinophilic esophagitis using cyclodextrins.
Ey C, Hosselet C, Villon B, Mar?on F.
2018
1955 Journal
Ann Pharmacotherapy 2005 ; 39: 280-283.
Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
Trissel LA, Zhang Y.
2005
2214 Journal
Int J Pharm Compound 2007 ; 11, 6: 520-524.
Palonosetron hydrochloride compatibility and stability with three beta-lactam antibiotics during simulated Y-site administration.
Ben M, Trusley C,Kupiec T.C, Trissel L.A.
2007
3619 Manufacturer
Wockhardt 2016
Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics
2016
755 Manufacturer
MSD France 2016
Pancuronium (Pavulon®) - Résumé des caractéristiques du produit
2016
3769 Manufacturer
B Braun laboratoire 2014
Paracatamol (Paracetamol B Braun®) - Résumé des caractéristiques du produit
2014
3504 Manufacturer
Pfizer 2012
Parecoxib (Dynastat®) - Summary of Product Characteristics
2012
4173 Manufacturer
Baxalta Innovations GmbH 2018
Pegaspargase (Oncaspar®) - Résumé des Caractéristiques du Produit
2018
3771 Manufacturer
Merck Sharp Dohme 2017
Pembrolizumab (Keytruda®) - Summary of Product Characteristics
2017
1914 Manufacturer
Eli Lilly 2016
Pemetrexed (Alimta®) - Summary of Product Characteristics
2016
3559 Manufacturer
Sanofi Aventis France 2013
Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit
2013
1235 Journal
Br J Pharm Pract 1988 ; 10: 22-23.
Pentamidine infusion stability.
Leigh PH, Buddle GC.
1988
4024 Poster
SFPO Congress 2017 - Nantes 2017
Pénurie mondiale d'Etopophos et conséquences pratiques : Intérêt des études de stabilité dans le choix d'un générique.
Sadou Yaye H, Rieber Z, HassaniI L, Hoffmann-Martinot C, Babiard M, Aouti H, Bellanger A, Tilleul P.
2017
3636 Manufacturer
Roche 2013
Pertuzumab (Perjeta®) - Summary of Product Characteristics
2013
3525 Manufacturer
AMCO Amdipharm Mercury 2012
Pethidine hydrochloride - Summary of product Characteristics
2012
3871 Poster
Synprefh Congress Clermont Ferrand, France 2016
Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ?
Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M.
2016
2175 Journal
J Pharm Clin 2006 ; 25, 3: 147-152.
Peut-on conditionner les solutions de docétaxel dans des poches en PVC ?
Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J.
2006
1317 Journal
Pharm J 1987 ; 238: 476-478.
Pharmaceutical aspects of home infusion therapy for cancer patients.
Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG.
1987
4283 Journal
Eur J Pharm Sci 2019
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate.
Lopalco A, Curci A, Lopedota A, Cutrignelli A, Laquintana V, Franco M, Denora N.
2019
1274 Journal
TAP Pharmazeutische Zeitung 1997 ; 31: 30-33.
Pharmazeutische aspekte von topotecan-infusionen.
Krämer I, Thiesen J.
1997
1692 Journal
Krankenhauspharmazie 1998 ; 19: 226-228.
Pharmazeutische kompatibilität von piperacillin mit metronidazol.
Messerschmidt W.
1998
1949 Journal
Clinical Cancer Research 2001 ; 7: 1569-1576.
Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies.
Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH.
2001
3620 Manufacturer
Beacon Pharmaceuticals 2012
Phenylephrine - Summary of Product Characteristics
2012
3770 Manufacturer
Eclat Pharmaceuticals 2014
Phenylephrine hydrochloride (Vazculep®) - Summary of Product Characteristics
2014
1169 Journal
Am J Hosp Pharm 1981 ; 38: 358-362.
Phenytoin sodium solubility in three intravenous solutions.
Pfeifle CE, Adler DS, Gannaway WL.
1981
3621 Manufacturer
Renaudin 2008
Phosphate dipotassique - Résumé des caractéristiques du produit
2008
1887 Journal
Int J Pharm 1995 ; 123: 229-235.
Photochemical decomposition of midazolam. IV . Study of pH dependant stability by high-performance liquid chromatography.
Andersin R, Tammilehto S.
1995
1265 Journal
J Clin Pharm Ther 1990 ; 15: 291-300.
Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography.
Wood MJ, Irwin WJ, Scott DK.
1990
2816 Journal
J Pharm Biomed Anal 1999 ; 25: 269-275.
Photodegradation of folic acid in aqueous solution
Aktar J, Khan A, Ahmad I.
1999
796 Journal
PDA J Pharm Sci Technol 1996 ; 50: 158-162.
Photodegradation of furosemide solutions.
Asker AF, Ferdous AJ.
1996
1918 Journal
J Pharm Sci 1997 ; 86, 12: 1410-1416.
Photodegradation of irinotecan (CPT-11) in aqueous solutions : identification of fluorescent products and influence of solution composition.
Dodds HM, Craik DJ, Rivory LP.
1997
1383 Journal
J Pharm Pharmacol 1978 ; 30: 47P.
Photodegradation of solutions of the antitumour drug DTIC.
Stevens MFG, Peatey L.
1978
948 Journal
J Pharm Sci 1994 ; 83: 463-467.
Photodegradation of some quinolones used as antimicrobial therapeutics.
Tiefenbacher EM, Haen E, Przybilla B, Kurz H.
1994
1920 Journal
Drug Stability 1996 ; 1: 118-122.
Photodegradation reactions of CPT-11, a derivative of campothecion, part i: chemical structure of main degradation products in aqueous solution.
Akimoto K, Kaway A, Ohya K et al.
1996
1921 Journal
Drug Stability 1996 ; 1; 141-146.
Photodegradation reactions of CPT-11, a derivative of campothecion, part ii: photodegradation behaviour of CPT-11 in aqueous solution.
Akimoto K, Kawai A, Ohya K.
1996
1696 Journal
J Pharm Biomed Anal 1999 ; 21: 851-857.
Photodegradation studies on Atenolol by liquid chromatography.
Andrisano V, Gotti R, Leoni A, Cavrini V.
1999
1284 Journal
Photochem Photobiol 1981 ; 34: 131-134.
Photoinactivation of anthracyclines.
Williams BA, Tritton TR.
1981
847 Journal
J Pharm Pharmacol 1980 ; 32: 860-862.
Photolytic degradation of adriamycin.
Tavoloni N, Guarino AM, Berck PD.
1980
145 Journal
J Pharm Clin 1992 ; 11: 285-295.
Photosensibility of 5-fluorouracile and methotrexate in translucent or opaque perfusers.
Lorillon P, Corbel JC, Mordelet MF, Basle B, Guesnier LR.
1992
1851 Journal
J Pharm Biomed Anal 2001 ; 25, 3-4: 589-597.
Photostability and phototoxicity studies on diltiazem.
Andrisano V, Hrelia P, Gotti R, Leoni A, Cavrini V.
2001
2089 Journal
Pharmazie 2004 ; 59: 457-463.
Photostability of epinephrine - the influence of bisulfite and degradation products.
Brustugun J, Kristensen S, Tonnesen HH.
2004
1965 Journal
PDA J Pharm Sci Technol 2004 ; 58, 6: 296-308.
Photostability of sympatomimetic agents in commonly used infusion media in the absence and presence of bisulfite.
Brustugun J, Kristensen S, Tonnesen HH.
2004
3571 Journal
Hosp Pharm 2014 ; 49, 1: 42-47.
Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration.
Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M.
2014
289 Journal
Ann Pharmacotherapy 1993 ; 27: 704-707.
Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.
Jim LK.
1993
4369 Journal
J Pharm Biomed Anal 2020 ;178:112896
Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate
Sadou Yayé H, Hassani L, Secrétan PH, Babiard M, Aouati H, Bellanger A, Tilleul P, Yagoubi N, Do B, Rietveld I.
2020
4001 Journal
Int J Pharm Compound 2017 ; 21:4 :322-329
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox).
Ip K,Carvalho M,Shan A,Banov D.
2017
4059 Journal
EJHP 2017 ; 25, e2
Physical and chemical stability of ceftaroline in an elastomeric infusion device.
Madfai F, Zaidi S, Ming L, Wanandy T, Patel R.
2017
3183 Journal
EJOP 2010 ; 4, 3: 11-13.
Physical and chemical stability of cisplatin infusions in PVC containers.
Sewell G
2010
4455 Journal
J Oncol Pharm Practice 2020 online first
Physical and chemical stability of cytarabine in polypropylene syringes.
Ben Ayed W, Drira C, Ali Soussi M, Ouesleti H, Hamdene B, Khrouf M, Safta F, Fradi I.
2020
1937 Journal
Ann Pharmacotherapy 2004 ; 38: 1612-1616.
Physical and chemical stability of daptomycin with nine medications.
Lai JJ, Brodeur SK.
2004
3195 Journal
EJHP 2011 ; 17, 2: 39-43.
Physical and chemical stability of docetaxel infusions.
MacLeod S, Sewell G.
2011
2270 Journal
Ann Pharmacotherapy 2008 ; 42, 9: 1247-1251.
Physical and chemical stability of esomeprazole sodium solutions.
Kupiec TC, Aloumanis V, Ben M, Trissel LA, Chan P, Patterson J.
2008
4174 Journal
Int J Pharm Compound 2018 ;22,6:504-511
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase).
Ip K, Shan A, Yan W, Banov D.
2018
1411 Journal
J Am Pharm Assoc 1999 ; 39: 146-150.
Physical and chemical stability of etoposide phosphate solutions.
Zhang Y, Trissel LA.
1999
1422 Journal
J Am Pharm Assoc 1999 ; 39: 509-513.
Physical and chemical stability of gemcitabine hydrochloride solutions.
Xu QA, Zhang Y, Trissel LA.
1999
3610 Journal
J Oncol Pharm Practice 2014 ; 20, 1: 51-57.
Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion.
Zhang, Y., Kawedia, J.D., Myers, A.L., McIntyre, C.M., Anderson, P.M., Kramer, M.A., Culotta, K.
2014
1706 Journal
Int J Pharm Compound 2002 ; 6: 74-76.
Physical and chemical stability of hydromorphone hydrochloride 1.5 and 80 mg/ml packaged in plastic syringes.
Trissel LA, Xu QA.
2002
1707 Journal
Int J Pharm Compound 2002 ; 6: 70-73.
Physical and chemical stability of low and high concentrations of morphine sulfate with bupivacaine hydrochloride packaged in plastic syringes.
Trissel LA, Xu QA, Pham L.
2002
1708 Journal
Int J Pharm Compound 2002 ; 6: 66-69.
Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes.
Xu QA, Trissel LA, Pham L.
2002
31 Journal
Hosp Pharm 1996 ; 31: 965-970.
Physical and chemical stability of methotrexate sodium, cytarabine, and hydrocortisone sodium succinate in Elliott’s B solution.
Zhang Y, Xu QA, Trissel LA, Gilbert DL.
1996
1661 Journal
J Oncol Pharm Practice 2002 ; 8: 27-32.
Physical and chemical stability of methotrexate, cytarabine, and hydrocortisone in Elliott’s B Solution for intrathecal use.
Trissel LA, King KM, Zhang Y, Wood AM.
2002
1709 Journal
Int J Pharm Compound 2002 ; 6: 62-65.
Physical and chemical stability of morphine sulfate 5 mg/ml and 50 mg/ml packaged in plastic syringes.
Trissel LA, Xu QA.
2002
2172 Journal
J Oncol Pharm Practice 2006 ; 12, 4: 211-222.
Physical and chemical stability of paclitaxel infusions in different container types.
Donyai P, Sewell GJ.
2006
1936 Journal
Ann Pharmacotherapy 2004 ; 38: 1608-1611.
Physical and chemical stability of palonosetron HCl in 4 infusion solusions.
Trissel LA, Xu QA.
2004
1950 Journal
J Oncol Pharm Practice 2004 ; 10: 191-195.
Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin and oxaliplatin during simulated Y-site administration.
Trissel LA, Yanping Z.
2004
2107 Journal
Int J Pharm Compound 2006 ; 10: 234-236.
Physical and chemical stability of palonosetron hydrochloride with dacarbazine and with methylprednisolone sodium succinate during simulated Y-site administration.
Trissel LA, Zhang Y, Xu QA.
2006
2279 Journal
Am J Health-Syst Pharm 2008 ; 65, 18: 1735-1759.
Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
Kupiec T, Trusley C, Ben M, Trissel LA.
2008
2196 Journal
Am J Health-Syst Pharm 2007 ; 64, 11: 1209-1213.
Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during Y-site administration.
Trissel LA, Trusley C, Ben M, Kupiec TC.
2007
2009 Journal
Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration.
Trissel LA, Zhang Y.
2005
2286 Journal
Int J Pharm Compound 2008 ; 12, 4: 368-371.
Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration.
Ben M, Trusley C, Kupiec TC, Trissel LA.
2008
1975 Journal
Int J Pharm Compound 2005 ; 9, 3: 235-237.
Physical and chemical stability of palonosetron hydrochloride with lorazepam and midazolam hydrochloride during simulated Y-site administration.
Trissel LA, Xu QA.
2005
1976 Journal
Int J Pharm Compound 2005 ; 9, 3: 238-241.
Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration.
Trissel LA, Xu QA.
2005
2179 Journal
Int J Pharm Compound 2007 ; 11, 1: 82-85.
Physical and chemical stability of palonosetron with metoclopramide and promethazine during simulated Y-site administration.
Trusley C, Ben M, Kupiec TC, Trissel LA.
2007
2114 Journal
Ann Pharmacotherapy 2006 ; 40, 6: 1082-1085.
Physical and chemical stability of pemetrexed in infusion solutions.
Zhang Y, Trissel LA.
2006
2036 Journal
Ann Pharmacotherapy 2005 ; 39, 12: 2026-2028.
Physical and chemical stability of pemetrexed solutions in plastic syringes.
Zhang Y, Trissel LA.
2005
3691 Journal
J Oncol Pharm Practice 2016 ; 22: 21-25
Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer
Kawedia L.D, Zhang Y-P, Myers A.L, Richards-Kortum R.R, Kramer M.A, Gillenwater A.M, Culotta K.S.
2016
3611 Journal
J Oncol Pharm Practice 2014 ; 20, 1: 58-64.
Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions.
Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T.
2014
3163 Journal
EJHP 2010 ; 16, 5: 26-28.
Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage.
Acott SR, Hart M.
2010
1898 Journal
Int J Pharm Compound 2004 ; 8, 3: 228-230.
Physical and chemical stability of treprostinil sodium injection packaged in plastic syringe pump reservoirs.
Xu QA, Trissel LA, Pham L.
2004
3881 Journal
Int J Pharm Compound 2016 ; 20, 4 : 343-346
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump.
Tomasello C, Leggieri A, Rabbia F, Veglio F, Baietto L,Fulcheri C, De Nicol? A, De Perri G, D'Avolio A.
2016
3849 Journal
Curr Pharm Biotech 2013 ; 14, 2: 220-225.
Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions.
Pabari R.M, Ryan B, Ahmad W, Ramtoola Z.
2013
2297 Journal
Int J Pharm Compound 2008 ; 11, 6: 550-552
Physical compatibility and chemical stability of a concentrated solution of atropine sulfate (2 mg/ml) for use as an antidote in nerve agent casualties.
Donnelly R.F, Corman C.
2008
561 Journal
Current Ther Res 1976 ; 20: 359-368.
Physical compatibility and chemical stability of amikacin sulfate in large-volume parenteral solutions. Part II.
Nunning BC, Granatek AP.
1976
682 Journal
Ann Pharmacotherapy 1991 ; 25: 123-126.
Physical compatibility and chemical stability of amphotericin B in combination with magnesium sulfate in 5% dextrose injection.
Raymond GG, Davis RL.
1991
865 Journal
Int J Pharm Compound 1998 ; 2: 79-81.
Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion.
Bhatt-Mehta V, Hirata S.
1998
1931 Journal
Can J Hosp Pharm 2004 ; 4: 230-235.
Physical compatibility and chemical stability of bupivacaine and hydromorphone in polypropylene syringes.
Donnely RF.
2004
4131 Journal
Hosp Pharm 2019 ;54,1:32-36.
Physical Compatibility and Chemical Stability of Injectable and Oral Ranitidine.
Fleming K, Donnelly R.
2019
2322 Journal
Can J Hosp Pharm 2009 ; 62, 1
Physical Compatibility and Chemical Stability of Ketamine–Morphine Mixtures in Polypropylene Syringes.
Donnelly R.F.
2009
2192 Journal
Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414.
Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.
Cochran BG, Sowinski KM, Fausel C, Overholser BR.
2007
1971 Journal
Support Care Cancer 2001
Physical compatibility and in vivo evaluation of drug mixtures forsubcutaneous infusion to cancer patients in palliative care.
Azuara ML, Sanchez Y, Reyes R, Barcia E.
2001
4245 Poster
2019
Physical Compatibility and Stability of Ascorbic acid Injection in Polyvinyl Chloride Minibags at 4ºC and Room Temperature (25ºC).
Iazetta J, Law S, Adhikari NKJ, Lamontagne F, Kanji S, Walker SE.
2019
3122 Journal
Am J Health-Syst Pharm 2010 ; 67: 1195-1198.
Physical compatibility of 4% sodium citrate with selected antimicrobial agents.
Dotson B, Lynn S, Savakis K, Churchwell MD.
2010
1822 Journal
Am J Health-Syst Pharm 2003 ; 60: 1650-1652.
Physical compatibility of antithymocyte globulin (rabbit) with heparin sodium and hydrocortisone sodium succinate.
Trissel LA, Seanz C.
2003
3470 Journal
Support Care Cancer 2012 ; 20: 2501-2509.
Physical compatibility of binary and tertiary mixtures of morphine and methadone with other drugs for parenteral administration in palliative care.
Destro M, Ottolini L, Vicentini L, Boschetti S.
2012
3268 Journal
Am J Health-Syst Pharm 2012 ;69: 98.
Physical compatibility of calcium gluconate and magnesium sulfate injections.
Beauregard N, Bertrand N, Dufour A, Blaizel O, Leclair G
2012
3429 Journal
Am J Health-Syst Pharm 2015 ; 72:483-486
Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration
Foushee J.A, Fox L.M, Gormley L.R, Lineberger M.S.
2015
4055 Journal
Am J Health-Syst Pharm 2018 , 75, 1:36-44
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
2018
4254 Journal
Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40
Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs
D'Huart E, Vigneron J, Demor? B.
2019
4108 Journal
Am J Health-Syst Pharm 2018 ;75;8:510-512
Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine.
Cruz K, Chrchwell M, Mauro V, Boddu.
2018
4411 Journal
Int J Pharm Compound 2020 ;24,3:238-241
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions.
Wilder A.G, Foushee J.A, Fox L.M, Navalle J, Wright A.M, Greer M.A.
2020
169 Journal
Am J Hosp Pharm 1993 ; 50: 2359-2363.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1993
2346 Journal
Am J Health-Syst Pharm 2009 ; 66: 986-987.
Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents
Newland A.M, Mauro V.F, Alexander K.S.
2009
4144 Journal
EJHP 2018 ;75,14:1010-1012
Physical compatibility of milrinone with levofloxacin and ceftriaxone injection.
Ross A, Boddu S, Mauro V, Churchwell M.
2018
1902 Journal
Can J Hosp Pharm 2004 ; 57, 2: 90-96.
Physical compatibility of pantoprazole with selected medications during simulated Y-site administration.
Walker SE, Wyllie A, Law S.
2004
1953 Journal
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
2004
4145 Journal
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
2018
58 Journal
Can J Hosp Pharm 1985 ; 38: 160-161.
Physical compatibility of ranitidine HCl with preoperative injectable medications.
Parker WA.
1985
3254 Journal
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
2011
3967 Journal
J Pharm Pharmacol 2017 ;69,7:448-462
Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents.
Staven V, Herra I, Wang S, Grönlie I,Tho I.
2017
3379 Journal
Am J Health-Syst Pharm 2013 ;70:520-524.
Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
Fox L.M, Wilder A.G, Foushee J.A.
2013
1034 Journal
Hosp Pharm 1984 ; 19: 475-478.
Physical compatibility update of preoperative medications.
Parker WA.
1984
1647 Journal
Anaesthesia 2001 ; 56: 294.
Physical incompatibility between atracurium and intravenous diclofenac.
Ackland G.
2001
3557 Journal
Can J Hosp Pharm 2013 ; 66, 5: 310-312
Physical Incompatibility between Parenteral Cloxacillin and Vancomycin.
Chan A, Tawfik G, Cheng W.
2013
2117 Journal
Ann Pharmacotherapy 2006 ; 40, 7: 1289-1292.
Physical instability of frozen pemetrexed solutions in PVC bags.
Zhang Y, Trissel LA.
2006
4370 Journal
EJHP 2018 2018;0:1-7
Physical stability of an all-in one parenteral nutrition admixture for preterm infants upon mixing with micronutrients and drugs
Staven V, Wang S, Gronlie I, Tho I.
2018
4368 Journal
J Pharm Health Care Sci 2019 ; 5: 25.
Physical, chemical, and microbiological stability study of diluted atropine eye drops.
Saito J, Imaizumi H, Yamatani A.
2019
1660 Journal
Pharm World Sci 1999 ; 21: 137-141.
Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.
Thiesen J, Krämer I.
1999
3707 Journal
J Oncol Pharm Practice 2014 ; 20: 183-189
Physico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutions.
Spindeldreier K, Thiesen J, Lipp H.P, Krämer I.
2014
1723 Journal
Pharmazie 1998 ; 53: 386-391.
Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine.
Sattler A, Jage J, Krämer I.
1998
2825 Journal
Int J Pharm Compound 2015 ; 19, 3: 261-267.
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials.
Mueller C, Dietel E, Heynen S, Nalenz H, Goldbach P, Mahler H, Schmidt J, Grauschopf U, Schoenhammer K.
2015
3225 Journal
EJHP Science 2011 ; 17, 1: 7-12.
Physico-chemical stability of nelarabine infusion solutions in EVA infusion bags.
Kaiser J, Krämer I.
2011
4126 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,3:135-142
Physico-Chemical Stability of Sodium Thiosulfate Infusion Solutions in Polyolefin Bags at Room Temperature over a Period of 24 Hours.
D'Huart E, Vigneron J, Ranchon F, Vantard N, Rioufol C, Demor? B
2018
3241 Poster
ECCO Congress Stockholm 2011
Physicochemical and biological stability of diluted rituximab solutions stored 6 months at 4°C.
Paul M, Vieillard V, Jaccoulet E, Astier A.
2011
3041 Journal
Acta Pol Pharm 2006 ; 63: 293-299.
Physicochemical and microbiological properties of eye drops containing cefuroxime.
Kodym A, Zawiswa T, Taberska J , Kukula H.
2006
3755 Journal
Int J Pharm Compound 2014 ; 18, 5: 427-431.
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition.
Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R.
2014
4052 Journal
Pharmaceutical Technology in Hospital Pharmacy 2017
Physicochemical and microbiological stability of a new paediatric oral solution of clonidine.
Verhlac C, Bourdon F, Titecat M, Frealle E, Dhorne C, Berneron C, Odou P.
2017
3789 Journal
Int J Pharm Compound 2015 ; 19, 1: 73-77.
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions.
Amin A, Bourget P, Vidal F, Cartier F, Beauvais R, Do Nascimento Afonso V.
2015
4272 Journal
Pharm Dev Technol 2019
Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients.
Merino-Boh?rquez, Delgado-Valverde M, Garc?a-Palomo M, D?vila- Pousa MC, Ca?ete C, Villaronga M, Rodriguez-Marrod?n B, L?pez-Ro
2019
761 Journal
EJHP 2015 ;22:89-93
Physicochemical and microbiological stability studies of a melatonin oral suspension in a commercially available vehicle for paediatric use.
Zerbit J, Bordenave J, Benoit G.
2015
4011 Journal
EJHP 2016 2016;0:1-11
Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit.
Gersonde F, Eisend S, Haake N, Kunze T.
2016
4461 Journal
Molecules 2019 24, 1242.
Physicochemical Compatibility and Stability of Linezolid with Parenteral Nutrition.
Tomczak S, Stawny M, Dettlaff K, Kieliszek, M, Słominska D, Jelinska A.
2019
1859 Journal
Il Farmaco 2002 ; 57: 925-930.
Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy.
Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G.
2002
4371 Journal
Journal of Parenteral and Enteral Nutrition 2018
Physicochemical Compatibility of Amiodarone with Parenteral Nutrition.
Mediavilla MM, Molina A, Navarro L, Grau L, Pujol MD, Cardenete J, Cardona D, Riera P.
2018
3705 Journal
EJHP 2014 ;21:161-166
Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine.
Knudsen L, Eisend S, Haake N, Kunze T.
2014
4357 Journal
Nutrition in clinical Practice 2019
Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition.
Campos-Baeta, Saavedra-Mitjans M, Garin N, Cardenete J, Cardona D, Riera P.
2019
2790 Journal
Int J COPD 2007 ; 1, 4: 599-607.
Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
Kamin W, Schwabe A, Krämer I.
2007
1506 Journal
EJHP 2015 ;22:107-112.
Physicochemical compatibility of high concentration drugs usually Y-site administered in intensive care units.
L?pez-Cabezas C, Guerrero L, Molas G, Anglada H, Soy D.
2015
150 Journal
J Pharm Clin 1993 ; 12: 31-35.
Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens.
Aujoulat P, Coze C, Braguer D, Raybaud C.
1993
3334 Journal
EJHP 2013 ;20:36-41
Physicochemical compatibility of nebuliser solution admixtures containing colistimethate and hypertonic saline or colistimethate, fluticasone-17-propionate, ipratropium bromide and salbutamol sulfate.
Krämer I, Walz-Jung H, Stanko C, Kamin W.
2013
3440 Journal
Pharmazie 2013 ; 68: 744-748.
Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin.
Wollstadt A, Krämer I, Kamin W.
2013
2770 Journal
Pharmazie 2007 ; 62, 10: 760-766.
Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
Krämer I, Schwabe A, Lichtinghagen R, Kamin W.
2007
126 Journal
Am J Health-Syst Pharm 1996 ; 53: 2606-2610.
Physicochemical compatibility of propofol with thiopental sodium.
Prankerd RJ, Jones RD.
1996
2053 Journal
Anesth Analg 2003 ; 97: 1646-1651.
Physicochemical compatibility of propofol-lidocaine mixture.
Masaki Y, Tanaka M, Nishikawa T.
2003
4077 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018
Physicochemical Stability of 5 mg/mL Pediatric Prednisone Oral Suspensions in Syrspend® SF PH4.
Bonnaure Anne-Claire, Bellay R, Rault P, Lester M.A, Boivin P.N.
2018
3124 Journal
EJHP Science 2010 ; 16, 1: 17-22.
Physicochemical stability of a 1mg/ml dexamethasone acetate oral suspension.
Tiphine T, Armand A, Navas D, Dailly E, Menanteau M, Thomare P.
2010
4096 Journal
Pharm Dev Technol 2014
Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma.
Merino-Bohorquez V, Casas M, Caracuel F, Camean M, Fernandez-Anguita M.J, Ramirez*Soto G, Lucero M.J.
2014
4350 Journal
EJHP 2019 ;0:1-5
Physicochemical stability of an admixture of lidocaine and ketamine in polypropylene syringe used in opioid-free anaesthesia.
Beiler B, Barraud D, Vigneron J, Demor? B.
2019
4030 Journal
Int J Pharm Compound 2017 ; 21, 5 : 430-435
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt.
Graves R, Phan K, Bostanian L, Mandal T, Pramar Y.
2017
4451 Poster
EAHP 2020
Physicochemical Stability of Aztreonam in Polypropylene Syringes at High Concentration for Intensive Care Units.
Nisse YE, Vigneron J, Blaise F, D'Huart E, Charmillon A, Demoré B.
2020
3804 Journal
EJHP 2014 ;22:150-155
Physicochemical stability of cabazitaxel and docetaxel solutions.
Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A.
2014
4097 Journal
Pharm Dev Technol 2013
Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
Casas M, Alvarez J, Lucero M.
2013
4047 Journal
J Oncol Pharm Practice 2017 ;25,2: 339-350
Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period.
Kim S.H, Krämer I.
2017
4468 Poster
EAHP 2020
Physicochemical stability of Cefazolin in Polypropylene Syringes and in Elastomeric Devices.
D'Huart E, Sobalak N, Vigneron J, Charmillon A, Demoré E.
2020
4268 Journal
Pharmaceutical Technology in Hospital Pharmacy 2019
Physicochemical Stability of Cefotaxime Sodium in Polypropylene Syringes at High Concentrations for Intensive Care Units.
D'Huart E, Vigneron J, Blaise F, Charmillon A, Demor? B.
2019
4251 Journal
Int J Pharm Compound 2019 ;23,2:157-162
Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base, SuspendIt.
Pramar YV, Mandal TK, Bostanian LA, Nguyen ATQ, Morris TC, Graves RA.
2019
3258 Journal
Int J Pharm Compound 2011 ; 15, 6 : 515-520.
Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags.
Kaiser J, Krämer I.
2011
3343 Poster
ECOP Congress, Budapest, Hungary 2012
Physicochemical stability of diluted trastuzumab solutions stored 6 months at 4°C.
Vieillard V, da Silva R, Astier A, Paul M.
2012
4125 Journal
EJHP 2018
Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bags.
D'Huart E, Vigneron J, Lider P, Demor? B.
2018
4353 Journal
J Clin Pharm Ther 2019
Physicochemical stability of extemporaneously prepared clonidine solutions for use in neonatal abstinence syndrome.
Lu D, Harmanjeet H, Wanandy T, Paine M, . PetersonG.M, Patel R.
2019
4107 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018
Physicochemical Stability of Extemporaneously Prepared Oral Suspension of Fluconazole 50 mg/mL in SuspendIt.
Ip K, Shan A, Carvalho M, Baker S, Banov D.
2018
2241 Journal
J Oncol Pharm Practice 2000 ; 6, 3: 115-121.
Physicochemical stability of irinotecan injection concentrate and diluted infusion solutions in PVC bags.
Thiesen J, Krämer I.
2000
3896 Journal
Pharmaceutical Technology in Hospital Pharmacy 2016 ;1,2:73-81
Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period
Kim S.H, Thiesen J, Krämer I.
2016
4267 Journal
EJHP 2019
Physicochemical stability of nefopam and nefopam/droperidol solutions in polypropylene syringes for intensive care units.
D'Huart E, Vigneron J, Clarot I, Demor? B.
2019
4250 Journal
Ann Pharm Fr 2019 ;77,3:212-221.
Physicochemical stability of norepinephrine bitartrate in polypropylene syringes at high concentrations for intensive care units.
D'Huart E, Vigneron J, Clarot I, Demor? B.
2019
2883 Journal
Am J Health-Syst Pharm 2009 ; 66, 21: 1929-1933.
Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags.
Eiden C, Philibert L, Bekhtari K, Poujol S, Malosse F, Fr?d?ric Pinguet F.
2009
4143 Journal
EJHP 2016 ; 25, 4
Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia use.
Daouphars M, Hervou?t C.H, Bohn P, Martin D, Rouvet J, Basuyau F, Varin R.
2016
4334 Journal
J Oncol Pharm Practice 2019 ; 26, 3: 641-646.
Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag.
Sundaramurthi P, Sean Chadwick S, Narasimhan C.
2019
3397 Poster
EAHP Congress Paris 2013
Physicochemical stability of ready-to-administer epinephrine injection solutions 20 µg/mL, 50 mL.
Heeb R.M, Krämer I.
2013
4043 Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4: 145-157.
Physicochemical Stability of Reconstituted Decitabine (Dacogen®) Solutions and Ready-to-Administer Infusion Bags when Stored Refrigerated or Frozen.
Kim S, Heeb R, Krämer I.
2017
4115 Journal
Drug Design Dev Ther 2016 ;10:3873-3878
Physicochemical stability of ternary admixtures of butorphanol, ketamine, and droperidol in polyolefin bags for patient-controlled analgesia use.
Fang B, Wang L, Gu J, Chen F, Shi X.
2016
4348 Journal
Can J Hosp Pharm 2019 ;72(5):360-8
Physicochemical Stability of Vancomycin at High Concentrations in Polypropylene Syringes.
D'Huart E, Vigneron J, Charmillon A, Clarot I, Demor? B.
2019
4035 Journal
EJHP 2017 ;0:1-5
Physicochemical stability of voriconazole in elastomeric devices.
Harmanjeet H, Zaidi S.T.R, Ming L.C, Wanandy T, Patel R.P.
2017
3448 Journal
Ann Pharm Fr 2013 ; 71, 5: 358-363.
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.
2013
3895 Journal
Ann Pharmacotherapy 2016 ; 50: 790-792.
Physicochemical Stability Study of Polymyxin B in Various Infusion Solutions for Administration to Critically Ill Patients
Lim Tze-Peng, Kim-Hor Hee D, Lee W, Qi-Min Teo J, Cai Y,Yu-Hng Chia S, Yee-Kiat Leaw J, Jing-Yi Lee S, Soon-U Lee L, Kwa A.L.
2016
3472 Journal
Krankenhauspharmazie 2007 ; 28, 5: 170-178.
Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten.
Krämer I, Schwabe A, Kamin W.
2007
3538 Journal
Krankenhauspharmazie 2013 ; 11: 524-525.
Physikalisch-chemische Stabilität einer Metoprolol-Injektionslösung 1 mg/ml, 50 ml.
Gilcher Th, Heeb R M, Krämer I.
2013
3986 Journal
Krankenhauspharmazie 2017 ;38:377-82.
Physikalisch-chemische Stabilität von Carfilzomib (Kyprolis®) im Originalbehältnis nach Erstanbruch und in applikationsfertigen Zubereitungen.
Kim S, Krämer I.
2017
3110 Poster
Poster ADKA Congress May 2010 2010
Physikalisch-chemische Stabilität von Clofarabin-Zubereitungen.
Kaiser J, Krämer I.
2010
4004 Journal
Krankenhauspharmazie 2017 ;38,7:334?340.
Physikalisch-chemische Stabilität von Oxaliplatin-beta-Infusionslösungskonzentrat und Infusionslösungen in 5 % Glucose in Polyolefin-Infusionsbeuteln.
Krämer I, Sarakbi I, Thiesen J, Mainz.
2017
4018 Journal
Krankenhauspharmazie 2017 ;38:423-429
Physikalisch-chemische Stabilität von rekonstituierten Trabectedin-haltigen Lösungen.
Lipp H-P, Gfrörer W
2017
999 Journal
JPEN 1985 ; 9: 220-224.
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
Watson D.
1985
3586 Manufacturer
Actavis France 2010
Piperacilline tazobactam Actavis® - Résumé des caractéristiques du produit
2010
3590 Manufacturer
Dakota Pharm 2011
Piperacilline - Résumé des caractéristiques du produit
2011
3320 Manufacturer
CTI Life Sciences Limited 2012
Pixantrone (Pixuvri®) - Summary of Product Characteristics
2012
1223 Journal
Am J Hosp Pharm 1980 ; 37: 618.
Plastic IV container for nitroglycerin.
Amann AH, Baaske DM, Wagenknecht DM.
1980
2078 Journal
J Ped Surg 2000 ; 35: 1775-1781.
Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers.
Loff S, Kabs F, Witt K, Sartoris J, Mandl B, Niessen KH, Waag KL.
2000
4380 Manufacturer
Merck Sharp & Dohme Limited 2019
Posaconazole (Noxafil®) - Summary of Product Characteristics
2019
3839 Journal
Current Ther Res 2015 ; 77: 105-110.
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions.
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T.
2015
1941 Journal
Am J Health-Syst Pharm 2004 ; 61: 1586-1589.
Potency and stability of frozen urokinase solutions in syringes.
Dedrick SC, Ramirez-Rico J.
2004
892 Journal
Am J Hosp Pharm 1992 ; 49: 1156-1164.
Practical guidelines for preparing and administering amphotericin B.
Kintzel PE, Smith GH.
1992
1959 Journal
Hosp Pharm 2005 ; 40, 2: 154-155.
Precipitate formation after subconjonctival administration of ceftazidime and vancomycin.
Mac Lellan C, Papadopoulos A.
2005
2073 Journal
Can J Anesth 1998 ; 45: 347-351.
Precipitate formed by thiopentone and vecuronium causes pulmonary embolism.
Taniguchi T, Yamamoto K, Kobayashi T.
1998
3377 Journal
Anaesthesia 1983 ; 38: 601-602.
Precipitation betwen meptazinol and thiopentone.
Huddy NC, Durcan JJ.
1983
3372 Journal
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
2013
3374 Journal
Anaesthesia 2001 ; 56: 494-495.
Precipitation in Manchester: ketorolac/cyclizine
Smith R.P.R, Jones M.
2001
270 Journal
Am J Health-Syst Pharm 1997 ; 54: 1449.
Precipitation of amphotericin B from IV fat emulsion.
Heide PE.
1997
138 Journal
Am J Health-Syst Pharm 1997 ; 54: 1845-1848.
Precipitation of fluorouracil in elastomeric infusers with a polyisoprene reservoir and in polypropylene syringes with an elastomeric joint.
Corbrion V, Crauste-Manciet S, Allain P, Brossard D.
1997
233 Journal
Am J Health-Syst Pharm 1996 ; 53: 1850.
Precipitation of lorazepam during infusion by volumetric pump.
Grillo JA, Barie PS.
1996
780 Journal
Ann Pharmacotherapy 1996 ; 30: 1037-1038.
Precipitation of lorazepam infusion.
Boullata J, Gelone SP, Mancano MA, Borenstein MR, Zitterman R.
1996
969 Journal
N Engl J Med 1991 ; 325: 1315-1316.
Precipitation of ondansetron in alkaline solutions.
Jarosinski PF, Hirschfeld S.
1991
1741 Journal
Am J Hosp Pharm 1993 ; 50: 2518-2521.
Precipitation of paclitaxel during infusion by pump.
Pfeifer RW, Hale KN, Cronquist SE, Daniels M.
1993
173 Journal
J Infus Chemother 1994 ; 4: 140-142.
Precipitation of paclitaxel from continuous infusion fluids.
Williams DA, Naik A.
1994
2071 Journal
Anesth Analg 2002 ; 95: 785.
Precipitation of protamine by cefazolin.
Ng HP, Koh KF.
2002
3373 Journal
J R Soc Med Sh Rep 2011 ; 2: 58.
Precipitation of thiopental with muscle relaxants: a potential hazard.
Khan S, Stannard N, Greijn J.
2011
1099 Journal
Ann Intern Med 1984 ; 101: 880.
Precipitation of verapamil in an intravenous line.
Tucker R, Gentile JF.
1984
1351 Journal
Am J Hosp Pharm 1984 ; 41: 2588.
Precipitation of verapamil with nafcillin.
Tucker R, Gentle JF.
1984
1100 Journal
Ann Intern Med 1982 ; 97: 619.
Precipitation of verapamil.
Bar-Or D, Kulig K, Marx JA, Rosen P.
1982
2557 Journal
Aust J Hosp Pharm 1991 ; 21: 239-241.
Prednisolone stability in a hydroalcoholic prednisolone mixture.
Sullivan JA.
1991
1424 Journal
Am J Emerg Med 1999 ; 17: 333-337.
Prehospital stability of diazepam and lorazepam.
Gottwald MD, Akerd LC, Liu PK, Orsulak PJ, Corry M, Bacchetti P, Fields SM, Loxenstein DH, Alldredge BK.
1999
2051 Journal
Br J Anaesth 2003 ; 90: 179-182.
Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability.
Sanchez del Aguila MJ, Jones MF, Vohra A.
2003
4050 Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4:193-201
Preparation and physico-chemical stability of dexamethasone oral suspension.
Binson G, Venisse N, Bacle A, Beuzit K, Dupuis A.
2017
4256 Journal
Pharmaceutics 2019 ;11,190:
Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients.
Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A.
2019
3624 Journal
Int J Pharm Compound 2014 ; 18, 2 : 169-174.
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets.
Zaid Abdel Naser, Assali M, Qaddomi A, Ghanem M, Zaaror Yara Abu.
2014
2998 Journal
J Pharm Technol 1989 ; 5: 202-205.
Preparation and stability of an oral suspension of dipyridamole.
Ameer B, Callahan RJ, Dragotakes SC et al.
1989
2692 Journal
J Am Pharm Assoc 2007 ; 47, 6; 747-755.
Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules.
Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K.
2007
2810 Journal
Antimicrob Agents Chemother 2009 ; 53, 2: 798-799.
Preparation and stability of voriconazole eye drop solution.
Dupuis A, Tournier N, Le Moal G, Venisse N.
2009
2567 Journal
Pakistan J Biol Sci 2000 ; 3, 10: 1755-1757.
Preparation and stability study of diclofenac sodium suppositories.
Ahmed M, Jalil R, Islam MA, Shaheen SM.
2000
4163 Journal
Int J Pharm Compound 2018 22;5:417-423
Prolonged In-Use Stability of Reconstituted Herceptin in Commercial Intravenous Bags.
Nalenz H, K?pf E, Dietel E.
2018
3956 Journal
ASAIO Journal 2005 ; 51,6:761-763.
Prolonged Stability of Stored Vancomycin, Gentamicin, and Heparin for Use in the Antibiotic-Lock Technique.
Bastani B; Amin K; Herr A.
2005
3659 Manufacturer
AstraZeneca 2016
Propofol (Diprivan®) - Résumé des caractéristiques du produit
2016
3502 Manufacturer
Astra Zeneca 2012
Propofol (Diprivan®) - Summary of Products Characteristics
2012
919 Journal
Anesth Analg 1998 ; 86: 422-426.
Propofol and thiopental in a 1:1 volume mixture is chemically stable.
Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS.
1998
660 Journal
Ann Pharmacotherapy 1996 ; 30: 228-232.
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Michaels MR, Stauffer GL, Haas DP.
1996
4044 Journal
Pharm Sci Communications 2017 ;9:5:28-35
Quality assessment and stability study of compounded furosemide syrup.
Alfred-Ugbendo D, Zdoryk O.A, Georgiyants V.A.
2017
4192 Journal
Pediatric Anesthesia 2018
Quality control and stability of ketamine, remifentanil and sufentanil syringes in a pediatric operating theater.
Bourdon F, Simon N, Lannoy D, Berneron C, D?caudin B, Reumaux L, Duhamel A, Richart P, Odou P.
2018
2000 Journal
J Pharm Biomed Anal 2005 ; 38: 180-185.
Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
Bouligand J, Storme T, Laville I, Mercier L, Oberlin O, Vassal J, Bourget Ph, Paci A.
2005
653 Journal
Int J Pharm Compound 1997 ; 1: 125-127.
Quantification of metoprolol tartrate and propranolol hydrochloride in pharmaceutical dosage forms : stability of metoprolol in aqueous mixture.
Das Gupta V.
1997
1357 Journal
Ann Pharmacotherapy 1989 ; 23: 91-92.
Quinolones and penicillins incompatibility.
Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM.
1989
1513 Manufacturer
Monarch Pharmaceuticals Ireland 2006
Quinupristine / dalfopristine (Synercid®) - Résumé des caractéristiques du produit
2006
1518 Manufacturer
Hospira UK Ltd 2013
Raltitrexed (Tomudex®) - Summary of Product Characteristics
2013
3773 Manufacturer
Eli Lilly 2014
Ramicirumab (Cyramza®) - Summary of Product Characteristics
2014
1166 Journal
Int J Pharm 1980 ; 6: 63-76.
Rapid adsorptive loss of nitroglycerin from aqueous solution to plastic.
Sokoloski TD, Wu CC, Burkman AM.
1980
514 Journal
Ann Pharmacotherapy 1997 ; 31: 297-302.
Rapid loss of fentanyl citrate admixed with fluorouracil in polyvinyl chloride containers.
Xu QA, Trissel LA, Martinez JF.
1997
4255 Journal
J Pharm Anal 2013 ;3,6:408-414
Rapid, simple and stability-indicating determination of polyhexamethylene biguanide in liquid and gel-like dosage forms by liquid chromatography with diode-array detection.
Kusters M, Beyer S, Kutschera S, Schlesingera H, Gerhartzb M.
2013
1517 Manufacturer
Sanofi-Aventis 2015
Rasburicase (Fasturtec®) - Summary of Product Characteristics
2015
4 Journal
Act Pharm Biol Clin 1995 ; 8: 525-528.
Reconstitution centralisée du ganciclovir : méthode de contrôle et étude de stabilité.
Zazempa V, Morgenszejn J, Paul M, Astier A.
1995
353 Journal
Am J Hosp Pharm 1987 ; 44: 2519-2524.
Reductive destruction of dacarbazine, procarbazine hydrochloride, isoniazid, and iproniazid.
Lunn G, Sansone EB.
1987
2341 Poster
Poster ESCP Stockholm May 2005
Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions
Bourlon S, Sautou-Miranda V, Dalle M.
1271 Journal
J Pharm Belg 1982 ; 37: 153-156.
Reliable continuous IV perfusion system for diazepam.
Mathot F, Bonnard J, Paris P, Bosly J.
1982
3519 Manufacturer
Glaxo Smith Kline 2011
Remifentanil hydrochloride(Ultiva®) - Summary of Product Characteristics
2011
2212 Manufacturer
Actavis UK Ltd 2015
Reteplase (Rapilysin®) - Summary of Product Characteristics
2015
3541 Manufacturer
Sanofi 2011
Rifampicin (Rifadin®) – Summary of Product Characteristics
2011
3968 Manufacturer
Fresenius Kabi 2015
Ringer lactate - Résumé des Caractéristiques du Produit
2015
3657 Manufacturer
Roche 2014
Rituximab (Mabthera®) - Résumé des caractéristiques du produit
2014
3564 Manufacturer
B Braun 2012
Rocuronium B Braun - Résumé des caractéristiques du produit.
2012
3432 Manufacturer
Celgene Corporation 2013
Romidepsin (Istodax®) - Summary of Product Characteristics
2013
2360 Journal
Int J Pharm Compound 2008 ; 12, 1: 83-85.
Room temperature stability of injectable succinylcholine dichloride.
Roy J.J, Boismenu D, Mamer O.A, Nguyen B.T, Forest J.M, Hildgen P.
2008
1516 Manufacturer
Mercury Pharmaceuticals Limited 2012
Ropivacaine (Naropeine®) - Summary of Product Characteristics
2012
4103 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018
Safe use of Dexamethasone in pediatrics: design and evaluation of a novel stable oral suspension.
Santovena--Estevez A, Dorta-Vera D, Gonzelez-Garcia I, Suarez-Gonzalez J, Teigell-Perez N, Farina J.
2018
3781 Journal
EJHP 2015 ;22:1 56-58
Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide.
Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Testa B, Pannatier A
2015
905 Journal
Hosp Pharm 1994 ; 29: 1010-1017.
Screening teniposide for Y-site physical incompatibilities.
Trissel LA, Martinez JF.
1994
2014 Journal
J Clin Pharm Ther 2005 ; 30: 455-458.
Seventy-two-hour stability of Taxol® in 5% dextrose or 0.9% sodium chloride in Viaflo®, Freeflex®, Ecoflac® and Macoflex N® non PVC bags.
Pourroy B, Botta C, Solas C, Lacarelle B, Braguer D.
2005
2683 Journal
Int J Pharm Pract 1993 ; 23: 163-167.
Shelf life of cefuroxime eye-drops when dispensed in artificial tear preparations.
Hebron B, Scott H.
1993
1050 Journal
Am J Hosp Pharm 1984 ; 41: 300-302.
Shelf life of unrefrigerated succinylcholine chloride injection.
Boehm JJ, Dutton DM, Poust RI.
1984
2001 Journal
J Pharm Biomed Anal 2005 ; 38: 332-336.
Shelf lives of aseptically prepared medicines - stability of hydrocortisone sodium succinate in PVC and non-PVC bags and in polypropylene syringes.
Rigge DC, Jones MF.
2005
1929 Journal
J Pharm Biomed Anal 2004 ; 35: 1251-1256.
Shelf lives of aseptically prepared medicines - stability of netilmicin injection in polypropylene syringes.
Rigge DC, Jones MF.
2004
2026 Journal
J Pharm Biomed Anal 2005 ; 39: 339-343.
Shelf lives of aseptically prepared medicines - stability of piperacillin/tazobactam in PVC and non-PVC bags.
Rigge D, Jones MF.
2005
119 Journal
J Clin Pharm Ther 1994 ; 19: 361-369.
Shelf-lives and factors affecting the stability of morphine sulphate and meperidine (pethidine) hydrochloride in plastic syringes for use in patient-controlled analgesic devices.
Strong ML, Schaaf LJ, Pankaskie MC, Robinson DH.
1994
4137 Journal
Newsletter Stabilis 2018 41;2-6
Short Report : Extended Stability Studies on Bortezomib Injection and Infusions of Cisplatin and Pemetrexed (all Accord Healthcare).
Patel T, Sewell G.
2018
3456 Journal
Curr Med Res Opin 2011 ; 27, 12: 2241-2243.
Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
Baribeault D.
2011
3772 Manufacturer
Janssen Biotech 2017
Siltuximab (Sylvant®) - Summary of Product Characteristics
2017
2475 Journal
Hosp Pharm 2015 ; 50: 376-379.
Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam
Wade J, Cooper M, Ragan R.
2015
2340 Journal
Can J Hosp Pharm 2005 ; 58, 4: 212-222.
Simulation of Y-Site Compatibility of Irinotecan and Leucovorin at Room Temperature in 5% Dextrose in Water in 3 Different Containers
Walker S.E, Law S, Puodziunas A.
2005
3745 Journal
Am J Hosp Pharm 1979 ; 36: 881.
Sodium chloride residue provides potential for drug incompatibiities.
Kuenhle C, Moore
1979
2028 Journal
EJHP Science 2005 ; 11, 4: 88-90.
Sodium nitroprusside stability at 1 µg/ml in aqueous solutions.
Kaisserlian CE, Razzouq N, Astier A, Paul M.
2005
1316 Journal
Pharm J 1987 ; 239: 599-601.
Sodium nitroprusside stability in light-protective administration sets.
Davidson SW, Lyall D.
1987
3969 Journal
Neuromodulation 2017
Solubility and stability of Baclofen 3 mg/mL intrathecal formulation and its compatibility with implantable programmable intrathecal infusion systems.
Yue B, Brendel R, Lukitsch A, Prentice T, Doty B.
2017
707 Journal
Am J Hosp Pharm 1980 ; 37: 95-98.
Solubility and stability of phenytoin sodium when mixed with intravenous solutions.
Carmichael RR, Mahoney CD, Jeffrey LP.
1980
4282 Journal
Drugs R D 2017
Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration.
Myers A-L, Zhang Y-P, Kawedia J-D, Zhou X,. Sobocinski S-M, Metcalfe M-J, Kramer M-A, Dinney C.P.N, Kamat A-M.
2017
2868 Journal
Int J Pharm Compound 2000 ; 4, 2: 146-149.
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution.
Kommanaboyina B, Lindauer RF, Rhodes CT, Grady LT.
2000
379 Journal
Am J Hosp Pharm 1985 ; 42: 2679-2683.
Sorption of amiodarone to polyvinyl chloride infusion bags and administration sets.
Weir SJ, Szucs Myers VA, Bengtson KD, Ueda CT.
1985
190 Journal
Am J Hosp Pharm 1986 ; 43: 1945-1950.
Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets.
Lee MG.
1986
1161 Journal
Int J Pharm 1987 ; 39: 183-188.
Sorption of parenteral nitrates during administration with a syringe pump and extension set.
Allwood MC.
1987
350 Journal
Am J Hosp Pharm 1990 ; 47: 369-373.
Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers.
Martens HJ, De Goede PN, Van Loenen AC.
1990
896 Journal
J Clin Pharm Ther 1992 ; 17: 223-227.
Sorption studies of dipotassium clorazepate salt (Tranxene®) and midazolam hydrochloride (Hypnovel®) in polyvinyl chloride and glass infusion containers.
Bianchi C, Airaudo CB, Gayte-Sorbier A.
1992
621 Journal
Am J Hosp Pharm 1982 ; 39: 1018-1021.
Sorptive loss of diazepam and nitroglycerin from solutions to three types of containers.
Yliruusi JK, Sothmann AG, Laine RH, Rajasilta RA, Kristoffersson ER.
1982
1472 Journal
Int J Pharm 1994 ; 110: 197-201.
Sorptive loss of diazepam, nitroglycerin and warfarin sodium to polypropylene-lined infusion bags (Softbags).
Salomies HEM, Heinonen RM, Toppila MAI.
1994
2168 Journal
Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution.
Ozdemir FA, Anilanmert B, Pekin M.
2005
3563 Manufacturer
Sanofi Aventis France 2013
Spiramycine adipate (Rovamycine®) - Résumé des caractéristiques du produit
2013
1700 Journal
Krankenhauspharmazie 1996 ; 17: 398-399.
Stabilität hochkonzentrierter dobutaminlösungen.
Ritter C.
1996
1691 Journal
Krankenhauspharmazie 1999 ; 20: 121-125
Stabilität und kompatibilität von zytostatika-zubereitungen mit infusionlösungsbehältern aus polyethylen.
Beitz C, Einberger C, Wehling M.
1999
3235 Poster
ADKA Congress 2011 2011
Stabilität von Argatroban-Dauerinjektionslösungen in applikationsfertigen Konzentrationen.
Klemmer A, Krämer I.
2011
2289 Journal
Pharmazie 1994 ; 49, 10: 775-777.
Stabilität von bendamustinhydrochloride in infusion lösungen.
Maas B, Huber C, Krämer I.
1994
1698 Journal
Krankenhauspharmazie 1997 ; 18: 474-478.
Stabilität von dopaminhydrochlorid (Dopamine Solvay°) in mischungen mit infusionlösungen.
K?rner A, Bonnacker I.
1997
1687 Journal
Krankenhauspharmazie 2000 ; 21: 435-438.
Stabilität von gemcitabin.
M?ller H-J, Frank C.
2000
3346 Journal
Krankenhauspharmazie 2012 ; 33: 427-431.
Stabilität, Qualität und Analytik individueller Noradrenalin-Zubereitungen.
H?llein L, Bennack E, Holzgrabe U.
2012
4323 Poster
ADKA Kongress 2019
Stabilitätsprüfung von applikationsfertigen Adrenalin- und Noradrenalinverdünningen.
Wethmar U, Hochbr?gge H, Strobel HG.
2019
1688 Journal
Krankenhauspharmazie 1999 ; 20: 55-58.
Stabilitätsstudie zu alizaprid im PVC-infusionbeutel.
M?ller H-J, Frank C.
1999
1689 Journal
Krankenhauspharmazie 1997 ; 18: 468-473.
Stabilitätsstudie zu apomorphin-hydrochlorid im PVC-infusionbeutel.
M?ller H-J, Berg J.
1997
1694 Journal
Krankenhauspharmazie 1998 ; 19: 553-557.
Stabilitätsstudie zu fosfomycin-dinatrium (Fosfocin° p.i. 5.0) in applikationsfertigen perfusorspritzen.
Stahlmann SA, Frey OR, Kovar K-A.
1998
1685 Journal
Krankenhauspharmazie 1998 ; 19: 229-234.
Stabilitätsstudie zu metamizol-natrium im PVC-infusionbeutel.
M?ller H-J, Berg J.
1998
1684 Journal
Krankenhauspharmazie 1998 ; 19: 469-472.
Stabilitätsstudie zu pentoxifyllin im PVC-infusionbeutel.
Müller H-J, Frank C.
1998
1690 Journal
Krankenhauspharmazie 1997 ; 18: 75-79.
Stabilitätsstudie zu tramadolhydrochlorid im PVC-infusionbeutel.
M?ller H-J, Berg J.
1997
1697 Journal
Krankenhauspharmazie 2000 ; 21: 615-617.
Stabilitätsuntersuchung von Dipidolor°-zubereitungen.
Witt C, Wolkewitz B, Lorenz C.
2000
3244 Poster
SFPO Congress Mandelieu, France 2011
Stabilité chimique et microbiologique d'une suspension de mercaptopurine à 5 mg/mL.
Sutra C, Guillemot C, Monnier S, Puiset F, Canonge JM.
2011
2881 Poster
SFPO Congress 2009
Stabilité d'un anticorps monoclonal d'intérêt thérapeutique après reconstitution: le rituximab.
Jaccoulet E, Guirao S, Morand K, Astier A, Paul M.
2009
3317 Poster
APHIF Congress 2009
Stabilité de l'infliximab en solutions diluées.
Guirao S, Paul M, Jaccoulet E, Morand K, Astier A.
2009
4128 Poster
GRITA Symposium Perfusion 2017, Lille, France. 2017
Stabilité de la vancomycine à des doses méningées dans les seringues au cours d'une perfusion de 24 heures.
Masse M, Genay S, Carta N, Moreau F, Delannoy-Rousseli?re C, Barth?l?my C, D?caudin B, Faure K, Odou P.
2017
3119 Poster
Congr?s HOPIPHARM 2010
Stabilité de la vincristine sans conservateurs.
Henriet Th, El Kateb N, Jourdan N, Faure P, Bellenger P.
2010
2882 Poster
SFPO Congress 2009
Stabilité de solutions diluées de bévacizumab en fonction de la température.
Morand K, Paul M, Lahlou A, Blanchet B, Astier A.
2009
604 Manufacturer
Baxter 1998
Stabilité des médicaments dans l'Intermate® SV50, 100, 200
1998
3816 Poster
SFPO Congress, Nantes, France 2015
Stabilité des poches d'azacitidine pour injection intraveineuse (1- 4 et 2,4 mg/mL) conservées à 4°C.
Balouzet C, Chanat C, Jobard M, Brandely-Piat ML, Chast F.
2015
3723 Journal
Archives de Pédiatrie 1998 ; 5, 10: 1170-1171.
Stabilité des préparations extemporanées de doxapram (Doprams®) à usage néonatal.
Barb? F, Legagneur H, Boisseau D, Badonnel Y, Boutroy M.J.
1998
2130 Journal
Bull Cancer 1999 ; 86, 11: 946-954.
Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique.
Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J.
1999
3516 Poster
SFPO Congress, Mandelieu, France. 2013
Stabilité du melphalan à 2 mg/ml dans le chlorure de sodium 0,9% dans des conditions pratiques d'utilisation.
Vigneron J, Zenier H, May I, Nicolas A.
2013
4119 Poster
Hôpitaux Universitaire de Genève 2004
Stabilité et compatibilité de solutions injectables d'amiodarone (Cordarone®)
Marcoz N, Ing H, Sautter AM, Saadi JF, Roulin JF, Bonnabry P.
2004
1868 Journal
Nutr Clin Metab 2003 ; 17: 8-14.
Stabilité galénique de mélanges commercialisés de nutrition parentérale en présence de médicaments: médicaments dans le mélange.
Husson E, Crauste-Manciet S, Hadj-Salah E, ,Segier JC, Broissard D.
2003
2344 Manufacturer
Ebewe Pharma 2009
Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution.
2009
3246 Poster
SFPO Congress Mandelieu, France 2011
Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C.
Vieillard V, Appudurai O, Voytenko S, Astier A, Paul M.
2011
4025 Poster
SFPO Congress 2017 - Nantes 2017
Stabilité physico-chimique de solutions de Nivolumab à 1 mois.
Vieillard V, Bardo P, Akrout W, Le Guyader G, Astier A, Paul M.
2017
4358 Journal
Ann Fr Anesth Réanim 2014 ; 33, 5: 304-309.
Stabilité physico-chimique des solutions injectables de bésilate de cisatracurium dans les conditions cliniques d'utilisation
Pignard J, Bourdeaux D, Kauffmann S, Constantin J.M, Sautou V.
2014
3265 Poster
SFPO Congress, France 2011
Stabilité physico-chimique du bévacizumab à 25 mg/mL conservée à 4°C en seringue polypropylène.
Vieillard V, Cauvin A, Roumi E, Despiau MC, Laurent M, Voytenko S, Astier A, Paul M.
2011
4454 Poster
Synprefh Congress (Hopipharm),2020. 2020
Stabilité physicochimique de l’aztreonam à 50 mg/mL en diffuseur portable à 37°C.
Nisse Y-E, Vigneron J, Blaise F, Elise D'Huart E, Charmillon A, Demoré B.
2020
3446 Poster
SFPO Congress, Mandelieu, France 2013
Stabilité physicochimique de solutions diluées d'ipilimumab : résultats préliminaires à 1 mois.
Bardo P, Vieillard V, Astier A, Paul M.
2013
3344 Poster
ECOP Congress, Budapest, Hungary 2012
Stabilité physicochimique du bevacizumab 5 mg/mL dilué dans le chlorure de benzalkonium 0.1 mg/mL.
Moine M, Vieillard V, Astier A, Paul M.
2012
196 Journal
J Clin Pharm Ther 1991 ; 16: 203-207.
Stabilities of dobutamine, dopamine, nitroglycerin and sodium nitroprusside in disposable plastic syringes.
Pramar Y, Das Gupta V, Neal Gardner S, Yau B.
1991
1239 Journal
Pharm Weekbl [Sci] 1986 ; 8: 286-288.
Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use.
Stolk LML, Fruijtier A, Umans .
1986
240 Journal
Am J Health-Syst Pharm 1995 ; 52: 1904-1909.
Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
Lam XM, Ward CA, de C du M?e CPR.
1995
1318 Journal
Pharm J 1987 ; 238: 116-118.
Stability and administration of intravenous Augmentin.
Ashwin J, Lynn B, Taskis CB.
1987
2046 Journal
Antimicrob Agents Chemother 2003 ; 47: 1991-1994.
Stability and antibacterial activity of cefepime during continuous infusion.
Sprauten PF, Beringer PM, Louie ST, Synold TW, Gill MA.
2003
4264 Journal
Acta Ophtalmol 2008
Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
Karampatakis V, Papanikolaou T, Giannousis M, Goulas A, Mandraveli K, Kilmpasani M, Alexiou-Daniel S, Mirtsou-Fidani V.
2008
454 Journal
Am J Hosp Pharm 1986 ; 43: 94-97.
Stability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injection.
Ptachcinski RJ, Logue LW, Burckart GJ, Venkataramanan R.
1986
453 Journal
Am J Hosp Pharm 1986 ; 43: 692-694.
Stability and availability of cyclosporine stored in plastic syringes.
Ptachcinski RJ, Walker S, Burckart GJ, Venkataramanan R.
1986
1469 Journal
Int J Pharm 1996 ; 128: 283-286.
Stability and compatibility of 2.5 mg/ml methotrexate solution in plastic syringes over 7 days.
Jacolot A, Arnaud P, Lecompte D, Alamercery S, Caroff E, Naveau C, Guillot T, Bousselet M, Brion F.
1996
1817 Journal
J Oncol Pharm Practice 2003 ; 9: 109-112.
Stability and compatibility of 5-fluorouracil infusions in the Braun Easypump®.
Roberts S, Sewell GJ.
2003
2184 Journal
J Pain Symptom Manage 2006 ; 32, 4: 297-299.
Stability and compatibility of a meperidine-clonidine mixture in portable pump reservoirs for the management of cancer pain syndromes.
Vranken JH, van Kan HJM, ven der Vegt MH.
2006
152 Journal
Pharm Acta Helv 1995 ; 70: 141-148.
Stability and compatibility of a mixture of the anti-cancer drugs etoposide, cytarabine and daunorubicine for infusion.
Chevrier R, Sautou V, Pinon V, Demecop F, Chopineau J.
1995
285 Journal
Clin Ther 1996 ; 18: 246-255.
Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs.
Elmore RL, Contois ME, Kelly J, Noe A, Poirier A.
1996
2086 Journal
J Pharm Pract and Res 2003 ; 33: 279-281.
Stability and compatibility of alfentanil hydrochloride and morphine sulfate in poypropylene syringes.
Sharley NA, Burgess NG.
2003
2648 Journal
Int J Pharm 1999 ; 190, 1: 103-107.
Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone
Rieutord A, Arnaud P, Dauphin JF, Brion F.
1999
1178 Journal
Am J Hosp Pharm 1981 ; 38: 1914-1918.
Stability and compatibility of antitumor agents in glass and plastic containers.
Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL.
1981
1467 Journal
Int J Pharm 1995 ; 118: 181-189.
Stability and compatibility of baclofen and morphine admixtures for use in an implantable infusion pump.
Sitaram BR, Tsui M, Rawicki HB, Lam S, Courage P, Sitaram M, Chapman CB.
1995
1966 Journal
Support Care Cancer 2005 ; 13, 4: 239-245.
Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide.
Barcia E, Reyes R, Azuara L, S?nchez Y, Negro S.
2005
1759 Journal
Antimicrob Agents Chemother 2001 ; 45: 2643-2647.
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
Servais H, Tulkens PM.
2001
539 Journal
Drug Intell Clin Pharm 1988 ; 22: 592-593.
Stability and compatibility of cimetidine hydrochloride and aminophylline in dextrose 5% in water injection.
Baptista RJ, Mitrano FP.
1988
164 Journal
J Clin Pharm Ther 1994 ; 19: 95-100.
Stability and compatibility of cisplatin and carboplatin with PVC infusion bags.
Benaji B, Dine T, Luyckx M, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Gressier B, Cazin JC.
1994
226 Journal
Can J Hosp Pharm 1991 ; 44: 289-295.
Stability and compatibility of combinations of hydromorphone and a second drug.
Walker SE, DeAngelis C, Iazzetta J.
1991
1497 Journal
Can J Hosp Pharm 1993 ; 46: 61-65.
Stability and compatibility of combinations of hydromorphone and dimenhydrinate lorazepam or prochlorperazine.
Walker SE, Iazetta J, DeAngelis C, Lau DWC.
1993
4185 Journal
Hosp Pharm 2019 ; 54, 5: 330-334.
Stability and Compatibility of Diphenhydramine Hydrochloride in Intravenous Admixtures : A New Look at an Old Drug.
Sabins D, Diep T, McCartan P, Patel S, Zhao F
2019
3172 Journal
J Clin Pharm Ther 2011 ; 36, 1: 99-102.
Stability and compatibility of doxofylline with phentolamine mesilate in 0·9% sodium chloride or 5% dextrose injection for intravenous infusion.
Xu F, Xu G, LSu L, Feng E.
2011
2305 Journal
Anaesthesia 2008 63, 9: 972-978.
Stability and compatibility of drug mixtures in an implantable infusion system.
Bianchi F, Ginggen A, Tardy Y.
2008
161 Journal
Am J Hosp Pharm 1994 ; 51: 2706-2709.
Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers.
Barthes DM, Rochard EB, Pouliquen IJ, Rabouan SM, Courtois PY.
1994
1613 Journal
Can J Hosp Pharm 2000 ; 53: 338-345.
Stability and compatibility of etoposide in normal saline.
Lepage R, Walker SE, Godin J.
2000
262 Journal
Am J Hosp Pharm 1993 ; 50: 703-706.
Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
Johnson CE, Jacobson PA, Pillen HA, Woycik CL.
1993
411 Journal
Am J Hosp Pharm 1991 ; 48: 2158-2160.
Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
Woloschuk DMM, Wermeling JR, Pruemer JM.
1991
513 Journal
Ann Pharmacotherapy 1996 ; 30: 756-761.
Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride.
Xu QA, Trissel LA, Martinez JF.
1996
148 Journal
Pharm Weekbl [Sci] 1992 ; 14: 365-369.
Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I.
1992
70 Journal
Am J Hosp Pharm 1991 ; 48: 2641-2643.
Stability and compatibility of ganciclovir sodium in 5% dextrose injection over 35 days.
Silvestri AP, Mitrano FP, Baptista RJ, Williams DA.
1991
1633 Journal
Can J Hosp Pharm 2002 ; 55: 27-38.
Stability and compatibility of granisetron alone and in combination with dexamethasone in 0.9% sodium chloride and 5% dextrose in water solutions.
Walker SE, Law S.
2002
57 Journal
Am J Health-Syst Pharm 1996 ; 53: 294-304.
Stability and compatibility of granisetron hydrochloride in IV solutions and oral liquids and during simulated Y-site injection with selected drugs.
Mayron D, Gennaro AR.
1996
1867 Journal
J Pain Symptom Manage 2001 ; 22, 6: 1042-1047.
Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system.
Hildebrand KR, Elsberry DE, Anderson VC.
2001
1678 Journal
Int J Pharm 1997 ; 153: 13-24.
Stability and compatibility of intrathecal admixtures containing baclofen and high concentrations of morphine.
Sitaram BR, Tsui M, Rawicki HB, Lam S, Sitaram M.
1997
1988 Journal
Am J Health-Syst Pharm 2005 ; 62: 88-92.
Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration.
Sprandel KA, Styrszula DE, Deyo K, Sibley C, Rodvold KA.
2005
619 Journal
Am J Hosp Pharm 1982 ; 39: 1013-1015.
Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drugs additives.
Kirschenbaum HL, Aronoff W, Perentesis GP, Plitz GW, Cutie AJ.
1982
1620 Journal
Am J Health-Syst Pharm 2001 ; 58: 1753-1756.
Stability and compatibility of methylprednisolone acetate and ropivacaine hydrochloride in polypropylene syringes for epidural administration.
Saverio Robustelli della Cuna F, Mella M, Magistrali G, Ricci M, Losurdo A, Goglio AM.
2001
211 Journal
Am J Hosp Pharm 1991 ; 48: 1237-1241.
Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection.
Strom JG, Miller SW.
1991
263 Journal
Am J Hosp Pharm 1993 ; 50: 698-702.
Stability and compatibility of minocycline hydrochloride and rifampicin in intravenous solutions at various temperatures.
Pearson SD, Trissel LA.
1993
1276 Journal
Can J Hosp Pharm 1998 ; 51: 110-116.
Stability and compatibility of morphine with bupivacaine.
Shiffman E, Walker SE, Yoon T, Yeung M.
1998
2083 Journal
J Pharm Pract and Res 2002 ; 32: 65-68.
Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion.
La Forgia SP, Sharley NA, Burgess NG, Doecke CJ.
2002
1869 Journal
J Pain Symptom Manage 2003 ; 25, 5: 464-471.
Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system.
Hildebrand KR, Elsberry DD, Hassenbusch SJ.
2003
1069 Journal
Am J Health-Syst Pharm 1999 ; 56: 1835-1838.
Stability and compatibility of promethazine hydrochloride and dihydroergotamine mesylate in combination.
Peek BT, Webster KD, Da Camara CC.
1999
3140 Journal
Int J Pharm Compound 2010 ; 14, 5 : 436-439.
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device.
Tsiouris M, Ulmer M, Yurcho J F, Hooper K L, Gui M.
2010
1906 Journal
Am J Health-Syst Pharm 2004 ; 61: 38-45.
Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions.
McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ.
2004
66 Journal
Can J Hosp Pharm 1996 ; 49: 140-145.
Stability and compatibility of reconstituted hydromorphone with potassium chloride or heparin.
Avelar MA, Walker SE.
1996
345 Journal
Can J Hosp Pharm 1996 ; 49: 290-298.
Stability and compatibility of reconstituted sterile hydromorphone with midazolam.
Walker SE, Meinders A, Tailor H.
1996
1421 Journal
J Am Pharm Assoc 1999 ; 39: 505-509.
Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride.
Johnson CE, Truong NM.
1999
2140 Journal
EJHP Science 2006 ; 12, 5: 91-95.
Stability and compatibility of the ready-to-use solution of paracetamol admixted with phloroglucinol for intravenous infusion.
Kambia NK, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C.
2006
2890 Journal
Acta Pharm 2000 ; 50: 219-228.
Stability and compatibility of thiamine hydrochloride in liquid dosage forms et various temperatures.
El-Khawas M, Boraie NA.
2000
1603 Journal
Am J Health-Syst Pharm 2001 ; 58: 1218-1223.
Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.
Bergquist PA, Manas D, Hunke WA, Reed RA.
2001
1075 Journal
J Pharm Biomed Anal 1997 ; 16: 199-205.
Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers.
Craig SB, Bhatt UH, Patel K.
1997
1026 Journal
Am J Health-Syst Pharm 1999 ; 56: 875-881.
Stability and compatibility of topotecan hydrochloride with selected drugs.
Mayron D, Gennaro AR.
1999
3385 Journal
J Antimicrob Chemother 2013 ; 68: 1179-1182.
Stability and compatibility of vancomycin for administration by continuous infusion.
Raverdi V, Ampe E, Hecq JD, Tulkens PM.
2013
1656 Journal
Pharmazie 1994 ; 49: 425-427.
Stability and compatibility studies of cefaloridine, cefuroxime and ceftazidime with PVC infusion bags.
Faouzi A, Dine T, Luyckx M, Gressier B, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Cazin JC.
1994
40 Journal
Pharm Sci Communications 1994 ; 4: 97-101.
Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
Dine T, Lebegue S, Benaji B, Gressier B, Segard V, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Kablan J, Cazin M, Cazin JC.
1994
144 Journal
Int J Pharm 1991 ; 77: 279-285.
Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags.
Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML.
1991
1667 Journal
Int J Pharm 1996 ; 138: 125-128.
Stability and compatibility study of a carboplatin solution in syringes for continuous ambulatory infusion.
Vali?re C, Arnaud P, Caroff E, Dauphin JF, Cl?ment G, Brion F.
1996
166 Journal
Int J Pharm 1994 ; 101: 257-262.
Stability and compatibility study of carboplatin with three portable infusion pump reservoirs.
Rochard E, Barthes D, Courtois P.
1994
2141 Journal
J Antimicrob Chemother 2003 ; 51: 651-658.
Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units.
Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM.
2003
2122 Journal
EJHP Science 2006 ; 12, 4: 81-84.
Stability and compatibilityy of paracetamol injection admixed with ketoprofen.
Kambia NK, Luyckx M, Dine T, Dupin-Sriet T, Gressier B, Brunet C.
2006
423 Journal
Am J Hosp Pharm 1985 ; 42: 332-335.
Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours.
Mansur JM, Abramowitz PW, Lerner SA, Smith RB, Townsend RJ.
1985
2120 Journal
J Pharm Biomed Anal 2006 ; 41: 1363-1366.
Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample.
Mendez A.S.L, Dalomo J, Steppe M; Schapoval E.E.S.
2006
4289 Journal
Photochemical & Photobiological Sciences 2018
Stability and degradation of indocyanine green in plasma, aqueous solution and whole blood.
Mindt S, Karampinis I, John M, Neumaier M, Nowak K.
2018
4298 Journal
Biomed Chromatogr 2019 ; 33, 4:e4471
Stability and degradation products of imipenem applying High-Resolution Mass Spectrometry: an analytical study focused on solutions for infusion.
F?bio de Souza Barbosa F, Capra Pezzi L, Tsao M, Franco de Oliveira T, Dias Macedo S.M, Schapoval E.E.S, Mendez A.S.L.
2019
2057 Journal
J Antimicrob Chemother 2003 ; 51: 849-855.
Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis.
Droste JC, Jeraj HA, MacDonald A, Farrington K.
2003
3754 Journal
Int J Pharm Compound 2014 ;18, 5: 418-426.
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation.
Robert M.C, Spurr-Michaud S, Frenette M, Young D, Gipson Ilene K, Dohlman Claes H.
2014
1379 Journal
Aust J Hosp Pharm 1986 ; 16: 55-56.
Stability and light sensitivity of sodium nitroprusside infusions.
Saunders A.
1986
2076 Journal
Ann Emerg Med 2003 ; 42: 9-13.
Stability and microbiology of inhalant N-acetylcysteine used as an intravenous solution for the treatment of acetaminophen poisoning.
Dribben WH, Porto SM, Jeffords BK.
2003
3844 Journal
Ann Pharmacotherapy 2016 ; 50: 243-244.
Stability and Osmolality of Extemporaneously Prepared Clonidine Oral Liquid for Neonates.
Sauberan J.B, Phuong P, Ilog N.D, Rossi S.S.
2016
1904 Journal
Am J Health-Syst Pharm 2003 ; 60: 916-922.
Stability and preservative effectiveness of treprostinil sodium after dilution in common intravenous diluents.
Phares KR, Weiser WE, Miller SP, Myers MA, Wade M.
2003
305 Journal
Am J Hosp Pharm 1992 ; 49: 1463-1466.
Stability and sorption of calcitriol in plastic tuberculin syringes.
Pecosky DA, Parasrampuria J, Li LC, Stelmach A.
1992
475 Journal
Am J Hosp Pharm 1992 ; 49: 119-122.
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
Taormina D, Abdallah HY, Venkataramanan R, Logue L, Burckart GJ, Ptachcinski RJ, Todo S, Fung JJ, Starzl TE.
1992
468 Journal
Am J Hosp Pharm 1991 ; 48: 2631-2634.
Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days.
Tarr BD, Campbell RK, Workman TM.
1991
1346 Journal
Am J Hosp Pharm 1981 ; 38: 881-883.
Stability and sterility of cimetidine admixtures frozen in minibags.
Walker SE, Paton TW, Fabian TM, Liu CC, Coates PE.
1981
1986 Journal
Am J Health-Syst Pharm 2005 ; 62: 896-899.
Stability and sterility of dolasetron mesylate in syringes stored at room temperature.
Steiner ME, Lensmeyer G, Vermeulen LC.
2005
4413 Journal
J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326.
Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution.
Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J.
2016
1679 Journal
Int J Pharm 2001 ; 212: 93-99.
Stability and sterility of meglumine gadoterate injection repackaged in plastic syringes.
Micard S, Rieutord A, Prognon P, Hassan M, Brion F.
2001
2402 Journal
Am J Health-Syst Pharm 2006 ; 63: 2240-2247.
Stability and viscosity of a flavored omeprazole oral suspension for pediatric use
Burnett JE, Balkin ER.
2006
1193 Journal
Am J Hosp Pharm 1983 ; 40: 1010-1012.
Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
Perentesis GP, Plitz GW, Kirschenbaum HL, Navalakha P, Aronoff W, Cutie AJ.
1983
3810 Journal
Int J Pharm Compound 2015 ; 19, 5 : 420-427.
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
Geiger C M, Sorenson B, Whaley P.
2015
4449 Journal
J Pharm Pract and Res 2020
Stability assessment of levofloxacin in three different suspension vehicles.
Tardif V.,Lepage O.,Friciu M., St-Jean I., Forest J.M.
2020
4215 Journal
Int J Pharm Compound 2019 ;23,1:82-87
Stability Assessment of Topical Amitriptyline HCl Extemporaneously Compounded with Lipoderm Base and PLO Gel Mediflo 30.
Shakshuki A, Agu R.U.
2019
4183 Poster
Professional Practice Conference - the Canadian So 2018
Stability if 4 and 10 mcg/mL Remifentanil Solutions Stored in Syringes at Room Temperature (23°C).
Hook R, Riss V, Scharrer E, Law S, Walker S.E.
2018
4403 Journal
J Pharm Biomed Anal 2020
Stability in clinical use and stress testing of meropenem antibiotic by direct infusion ESI-Q-TOF: Quantitative method and identification of degradation products.
De Souza Barbosa F, Capra Pezzi L, Tsao M, Manoela Dias Macedo S, Franco de Oliveira T, Schapoval EES, Mendez ASL.
2020
3188 Journal
J Clin Pharm Ther 2011 ; 36, 2: 161-165.
Stability indicating HPLC assay for the determination of piritramide and droperidol in PCA solutions.
Selbach S, Diederich WE, Fett, Fr?nd SD, Koch T, Eberhart LHJ.
2011
3798 Journal
Analytical Letter 1994 . 27: 1159-1164.
Stability indicating HPLC assay of zidovudine in extemporaneously syrup.
Radwan M.A.
1994
2865 Journal
Int J Pharm 2001 ; 223: 49-54.
Stability indicating HPLC method for the estimation of oxycodone and lidocaine in rectal gel
Gebauer MG, McClure AF, Vlahakis TL.
2001
4230 Poster
Prof Practice Conference - Canadian Society of PH 2017
Stability of 0.2 and 10 mg/mL Hydromorphone Solutions In CADD reservoirs, PVC and Ethylene/Propylene Co-Polymer (PAB) Bags at Room Temperature (23°C°).
Perls W, Law S, Iazetta J, Walker S.
2017
2494 Journal
Am J Hosp Pharm 1986 , 43: 2225-2228.
Stability of 1% rifampin suspensions prepared in five syrups
Krukenberg CC, Mischler PG, Massad EN, Moore LA, Chandler AD.
1986
4221 Poster
Prof Practice Conference - Canadian Society of PH 2019
Stability of 1.0 and 2.5 mg/mL Bortezomib in Vials and Syringes Following Reconstitution with Sodium Chloride at 4°C and 23°C.
scott.walker@sunnybrook.ca
2019
4216 Poster
Sunnybrook 2019
Stability of 1.0, 0.2 and 0.025 mg/mL Milrinone Solutions Stored in Syringes at 4ºC and at Room Temperature (25ºC).
Hook R, Riss V, Scharrer E, Robillard J, Law S, Walker SE.
2019
4228 Poster
Prof Practice Conference - Canadian Society of PH 2017
Stability of 10 and 50 microg/mL Fentanyl Solutions in CADD Reservoirs, PVC containers and Ethylene/Propylene Co-Polymer (PAB) Bags at Refrigerated (4°C) and Room Temperature (23°C).
Law S, Perks W, Iazetta J, Walker S.
2017
1972 Journal
Drug Dev Ind Pharm 2016 ; 42, 1: 166-174.
Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC–UV stability-indicating method.
Feutry, F., Simon, N., Genay, S., Lannoy, D., Barthelemy, C., Decaudin, B., Labalette, P., Odou, P.
2016
4219 Poster
Professional Practice Conference - Canadian Societ 2019
Stability of 100 microg/mL Ertapenem at 4°C and 23°C.
Law S, Iazetta J, Perks B, Walker S.E.
2019
133 Journal
Am J Health-Syst Pharm 1996 ; 53: 2740-2743.
Stability of 14 drugs in the latex reservoir of an elastomeric infusion device.
Allen LV Jr, Stiles ML, Prince SJ, Smeeding J.
1996
4070 Journal
Hosp Pharm 2018 ;53, 2: 73-74.
Stability of 2 mg/mL Adenosine Solution in Polyvinyl Chloride and Polyolefin Infusion Bags.
DeAngelis M, Ferrara A, Gregory K, Zammit K, Zhao F.
2018
4246 Poster
2019
Stability of 2.5mg/mL Indocyanine Green (ICG) Solutions Stored in Syringes at 25ºC, 4ºC, -20ºC and -67ºC.
Perks W, Law S, Marchesano R, Walker SE.
2019
4223 Poster
Prof Practice Conference - Canadian Society of PH 2019
Stability of 20,40 and 50 microg/mL Fentanyl Solutions Stored in Syringes at Room Temperature (23°C).
Riss V, Hook R, Neault A, Scharrer E, Law s, Walker S.E.
2019
3818 Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2, 1:11-16.
Stability of 25 mg/mL 5-azacitidine suspension kept in fridge after freezing.
Balouzet C, Chanat C, Jobard M, Brandely-Piat M-L, Chast F.
2017
4231 Poster
Professional Practice Conference - Canadian Societ 2018
Stability of 4 and 10 mcg/mL Remifentanil Solutions Stored in Syringes at Room Temperature (23°C)
Roxanne Hook, Vera Riss, Erica Scharrer, Shirley Law and Scott E. Walker
2018
1675 Journal
Int J Pharm Compound 2002 ; 6, 2: 155-157.
Stability of 4-Aminopyridine and 3,4-Diaminopyridine oral capsules
Trissel LA, Zhang Y, Xu QA.
2002
4087 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:31-37
Stability of 5 mg/mL Nitrendipine Oral Suspension in SyrSpend® SF PH4.
Bellay R, Bonnaure A.C, Rault P, Pertuisel S, Lester M.A, Boivin P.N.
2018
2496 Journal
Am J Hosp Pharm 1986 ; 43: 118-120.
Stability of 5-aminosalicylic acid suspension
Montgomery HA, Smith FM, Scott BE, White SJ, Gerald KB.
1986
840 Journal
Can J Hosp Pharm 1986 ; 39: 60-66.
Stability of 5-fluorouracil and flucytosine in parenteral solutions.
Biondi L, Nairn JG.
1986
2331 Journal
Hospital Pharmacy Europe 2009 ; 42 : 30-31.
Stability of 5-fluorouracil and sodium folinate admixture.
Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L.
2009
1812 Journal
Int J Pharm Compound 2000 ; 4, 4: 320-323.
Stability of 5-fluorouracil in an extemporaneously compounded ophtalmic solution.
Fuhrman LC, Godwin DA, Davis RA.
2000
842 Journal
J Pharm Clin 1990 ; 9: 155-158.
Stability of 5-fluorouracil to heat and light.
Pinguet F, Favre G, Canal P, Pujol A, Soula G.
1990
3975 Poster
EAHP congress - Cannes 2017
Stability of 50 and 100 µg/0,1mL intraocular solutions of voriconazole at 2-8°C.
Roche M, Simon N, Bourdon F, Dhorne C, Berneron C, Lannoy D, Odou P.
2017
2221 Journal
Am J Health-Syst Pharm 2007 ; 64, 23: 2480-2482.
Stability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapy.
Cober M.P, Johnson C.E.
2007
4284 Journal
Journal of Chemotherapy 2018 ; 30, 6-8: 371-374.
Stability of 90 mg/mL cefuroxime sodium solution for administration by continuous infusion.
Vercheval C, Streel S, Servais A-C, Fillet M, Van Hees T.
2018
4197 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,4:219-226
Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation.
Gautier E, Saillard J, Deshayes C, Vrignaud S, Lagarce F, Briot T.
2018
1601 Journal
Hosp Pharm 2001 ; 36: 950-954.
Stability of a baclofen and clonidine hydrochloride admixture for intrathecal administration.
Godwin DA, Kim NH, Zuniga R.
2001
442 Journal
Am J Hosp Pharm 1989 ; 46: 732-737.
Stability of a concentrated trimethoprim-sulfamethoxazole admixtures.
Jarosinski PF, Kennedy PE, Gallelli JF.
1989
2395 Journal
Am J Health-Syst Pharm 2008 ; 65: 558-561.
Stability of a flavored formulation of acetylcysteine for oral administration
Siden R, Johnson CE.
2008
2191 Journal
J Oncol Pharm Practice 2007 ; 13: 33-37
Stability of a heparin-free 50% ethanol lock solution for central venous catheters.
Pomplum M, Johnson JJ, Johnston S, Kolesar JM.
2007
3473 Journal
Int J Pharm 2015 ; 495, 2: 956-962.
Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization.
Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B.
2015
4392 Poster
Sunnybrook Health Sciences Centre 2020
Stability of a New generic Formulation of Bortezomib Injection (Apotex brand) in Vials and Syringes Stored at 4°C and Room Temperature (25°C).
Charbonneau L.F, Iazetta J, Ma N.H, Law S, Walker S.E.
2020
4391 Poster
Sunnybrook Health Sciences Centre 2020
Stability of a New Generic Formulation of Bortezomib Injection (MDA brand) In Vials and Syringes Stored at 4°C and Room Temperature (25°C).
Charbonneau L.F, Iazetta J, Ma N.H, Law S, Walker S.E.
2020
4053 Journal
Am J Health-Syst Pharm 2017 ;74,24:2060-2064
Stability of a pyrimethamine suspension compounded from bulk powder.
Lewis P, Cluck D, Huffman J, Ogle A, Brown S.
2017
4229 Poster
Professional Practice Conference - Canadian Societ 2017
Stability of a Simple Finasteride 0.33 mg/mL Suspension Using Tablets in Water and an Oral Mix Vehicle.
Perks W, Law S, Iazetta I, Ma N, Walker S.
2017
2591 Journal
Can J Hosp Pharm 1988 ; 41: 121-123.
Stability of a sotalol hydrochloride oral liquid formulation.
Dupuis LL, James G, Bacola G.
1988
460 Journal
Am J Hosp Pharm 1987 ; 44: 358-360.
Stability of acetazolamide sodium in 5% dextrose and 0.9% sodium chloride injection.
Parasrampuria J, Das Gupta V, Stewart KR.
1987
3999 Journal
Int J Pharm Compound 2017 ; 21:4 :339-346
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4.
De Oliveira Ferreira, Polonini H, Loures da Silva S, Buzinari Aglio N.C, Abreu J, Fernandes Brand?o M.A.
2017
2426 Journal
Am J Health-Syst Pharm 1997 ; 54: 549-553.
Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution
Anaizi NH, Swenson CF, Dentinger PJ.
1997
2400 Journal
Am J Health-Syst Pharm 2007 ; 64: 762-766.
Stability of acetylcysteine solution repackaged in oral syringes and associated cost savings
Kiser TH, Oldland AR, Fish DN.
2007
822 Journal
Am J Health-Syst Pharm 1998 ; 55: 574-577.
Stability of acyclovir sodium 1, 7, and 10 mg/ml in 5% dextrose injection and in 0.9% sodium chloride injection.
Zhang Y, Trissel LA, Martinez JF, Gilbert DL.
1998
1717 Journal
Int J Pharm Compound 2001 ; 5: 75-77.
Stability of acyclovir sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V.
2001
68 Journal
J Clin Pharm Ther 1989 ; 14: 451-456.
Stability of acyclovir sodium in dextrose and sodium chloride injections.
Das Gupta V, Pramar Y, Bethea C.
1989
2216 Journal
J Pharm Biomed Anal 1998 ; 17: 415-418.
Stability of adenosin infusion.
Proot P, Schepdael A.V, Raymakers A.A, Hoogmartens J.
1998
820 Journal
Am J Health-Syst Pharm 1998 ; 55: 1161-1164.
Stability of adenosine 6 microg/ml in 0.9% sodium chloride solution.
Naud C, Marti B, Fernandez C, Astier A, Paul M.
1998
1948 Journal
J Pain Symptom Manage 2004 ; 28, 6: 603-611.
Stability of admixtures containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system.
Classen AM, Wimbish GH, Kupiec TC.
2004
930 Journal
J Clin Pharm Ther 1997 ; 22: 339-345.
Stability of admixtures of pethidine and metoclopramide in aqueous solution, 5% dextrose and 0.9% sodium chloride.
Hor MMS, Chan SY, Yow KL, Lim LY, Chan E.
1997
824 Journal
Am J Health-Syst Pharm 1998 ; 55: 1602-1605.
Stability of albumin-free interferon alfa-2b for 42 days.
Appenheimer MM, Schepart BS, Poleon GP, Evans SS.
1998
2960 Journal
Respiratory Care 1991 ; 36: 1387-1390.
Stability of albuterol and tobramycin when mixed for aerosol administration.
Gooch MD.
1991
2670 Journal
Int J Pharm Compound 1998 ; 2: 394-396.
Stability of albuterol in continuous nebulization.
Hunter DA, Yoo SD, Fox JL.
1998
2564 Journal
Pharmazie 2009 ; 64, 9: 622-623.
Stability of alemtuzumab in infusion bags.
Kupfer M, Scriba G, Hartmann M.
2009
2255 Manufacturer
Ebewe Pharma 2007
Stability of Alexan "Ebewe" infusion solutions.
2007
3902 Journal
Int J Pharm Compound 2016 ; 20, 5 : 426-434.
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
Polonini Hudson C, Loures Sharlene,de Araujo Edson Peter, Brand?o Marcos Ant?nio F, Ferreira Anderson O.
2016
3994 Journal
Int J Pharm Compound 2017 ; 3: 255-263
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions.
De Oliveira Ferreira A, Polonini H C, Loures da Silva S, Cerqueira de Melo V Augusto, de Andrade L, Fernandes Brand?o Marcos A.
2017
2422 Journal
Am J Health-Syst Pharm 1998 ; 55: 1915-1920.
Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA,
1998
3961 Journal
Int J Pharm Compound 2017 ; 21, 2: 150-153.
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers.
McCluskey S.V,Kirkham K,Munson J.M.
2017
1816 Journal
Int J Pharm Compound 2003 ; 7, 3: 230-232.
Stability of amikacin sulfate in autodose infusion system bags.
Zhang Y, Trissel LA.
2003
550 Journal
Int J Pharm Compound 1997 ; 1: 132-134.
Stability of aminocaproic acid injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection.
Zhang YP, Trissel LA.
1997
478 Journal
Am J Hosp Pharm 1992 ; 49: 2962-2963.
Stability of aminophylline in bacteriostatic water for injection stored in plastic syringes at two temperatures.
Nahata MC, Morosco RS, Hipple TF.
1992
242 Journal
Am J Hosp Pharm 1986 ; 43: 917-921.
Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
Campbell S, Nolan PE, Bliss M, Wood R, Mayersohn M.
1986
2541 Journal
Ann Pharmacotherapy 1997 ;31:851-852.
Stability of amiodarone in an oral suspension stored under refrigeration and at room temperature.
Nahata MC.
1997
2689 Journal
J Am Pharm Assoc 1999 ; 39: 375-377.
Stability of amlodipine mesylate in two liquid dosage form.
Nahata MC, Morosco RS, Hipple TF.
1999
2951 Journal
J Clin Pharm Ther 1994 ; 19: 313-315.
Stability of amoxicillin and potassium clavulanate in co-amoxiclav oral suspension.
Mehta AC, Hart-Davies S, Payne J, Lacey RW..
1994
2508 Journal
Am J Hosp Pharm 1988 ; 45: 1092-1099.
Stability of amoxicillin trihydrate-potassium clavulanate in original containers and unit dose oral syringes
Tu YH, Stiles ML, Allen LV, Jr, Olsen KM, Barton CI, Greenwood RB.
1988
3362 Journal
J Pharm Pract and Res 2012 ; 42, 3: 218-222.
Stability of amoxicillin, clindamycin and meropenem in peritoneal dialysis solution.
Tran M.D, Sharley N, Ward M.
2012
12 Journal
Am J Health-Syst Pharm 1997 ; 54: 683-686.
Stability of amphotericin B 0.05 and 0.5 mg/ml in 20% fat emulsion.
Owens LC, Fleming RA, Restino MS, Cruz JM, Hurd DD.
1997
2820 Journal
J Pharm Biomed Anal 2006 ; 42: 362-366.
Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate
Groeschke J, Solassol I, Bressolle F, Pinguet F.
2006
1407 Journal
Hosp Pharm 1998 ; 33: 1203-1207.
Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture.
Xu QA, Trissel LA, Gilbert DL.
1998
497 Journal
Am J Hosp Pharm 1991 ; 48: 1681.
Stability of amphotericin B in 5% dextrose injection at 25°C.
Kintzel PE, Kennedy PE.
1991
439 Journal
Am J Hosp Pharm 1991 ; 48: 283-285.
Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line.
Kintzel PE, Kennedy PE.
1991
283 Journal
Am J Hosp Pharm 1994 ; 51: 394-396.
Stability of amphotericin B in 5% dextrose injection stored at 4 or 25°C for 120 hours.
Lee MD, Hess MM, Boucher BA, Apple AM.
1994
2867 Journal
Int J Pharm Compound 1999 ; 3, 4: 316-320.
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution.
Peyron F, Elias R, Ibrahim E, Amirat-Combralier V, Bu?s-Charbit M, Balansard G.
1999
2940 Journal
Am J Health-Syst Pharm 2001 ; 58: 1021-1024.
Stability of amphotericin B in an extemporaneously compounded oral suspension.
Dentinger PJ, Swenson CF, Anaizi NH.
2001
435 Journal
Am J Hosp Pharm 1991 ; 48: 2430-2433.
Stability of amphotericin B in four concentrations of dextrose injection.
Wiest DB, Maish WA, Garner SS, El-Chaar GM.
1991
3069 Journal
Eur Hosp Pharm 1997 ; 3: 59-60.
Stability of amphotericin B in water solution for inhalation.
Juarez JC, ,Lopez RM, Hucto M et al.
1997
3777 Journal
Am J Health-Syst Pharm 2015 ; 72:13-14
Stability of ampicillin and amoxicillin in peritoneal dialysis solutions
Patel R.P, Li K, Shastri M, Wanandy T, Jose M.D.
2015
3880 Journal
Int J Pharm Compound 2016 ; 20, 4 : 338-342
Stability of Ampicillin in Normal Saline and Buffered Normal Saline.
Maher M, Jensen Kara J,Lee David, Nix David E
2016
1705 Journal
Int J Pharm Compound 2002 ; 6: 226-229.
Stability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in autodose system bags.
Zhang Y, Trissel LA.
2002
4063 Journal
Int J Pharm Compound 2018 ;22,1:66-75
Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension.
Manchanda A, Laracy M, Savji T, Bogner R.
2018
342 Journal
Am J Hosp Pharm 1985 ; 42: 339-342.
Stability of an analgesic-sedative combination in glass and plastic single-dose syringes.
Conklin CA, Kerege JF, Christensen JM.
1985
3780 Journal
EJHP 2015 ;22:7-11
Stability of an epidural analgesic admixture containing butorphanol tartrate and ropivacaine hydrochloride
Chen F, Peng L, Zhou B, Fang B, Yang Y.
2015
2306 Journal
Anaesthesia 2004 ; 59, 10: 979-983.
Stability of an epidural analgesic admixture containing epinephrine, fentanyl and bupivacaine.
Priston M.J, Hughes J.M, Santillo M, Christie I.W.
2004
3401 Journal
J Clin Pharm Ther 2013 ;38, 2: 104-108
Stability of an epidural analgesic admixture of levobupivacaine, fentanyl and epinephrine.
Helin-Tanninen, M., Lehtonen, M., Naaranlahti, T., Ven?l?inen, T., Pentik?inen, J., Laatikainen, A., Kokki, H.
2013
1875 Journal
Acta Anaesthesiol Scand 2000 ; 44: 864-867.
Stability of an epidural analgesic solution containing adrenaline, bupivacaine and fentanyl.
Kjonniksen I, Brustugun J, Breivik H, Anderssen E, Klem W.
2000
3187 Journal
Am J Health-Syst Pharm 2011 ; 68:420-423.
Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE, Cober MP, Thome T, Rouse E.
2011
2773 Journal
Support Care Cancer 2009 ; 17, 6: 701-706.
Stability of an extemporaneous oral liquid aprepitant formulation.
Dupuis LL, Lingertat-Walsh K, Walker SE.
2009
2478 Journal
Am J Hosp Pharm 1993 ; 50: 2353-2355.
Stability of an extemporaneously compounded baclofen oral liquid
Johnson CE, Hart SM.
1993
2502 Journal
Am J Hosp Pharm 1992 ; 49: 122-125.
Stability of an extemporaneously compounded clonidine hydrochloride oral liquid
Levinson ML, Johnson CE.
1992
4075 Journal
Am J Health-Syst Pharm 2018 ;75,5: 309-315
Stability of an extemporaneously compounded minoxidil oral suspension.
Song Y, Whey Chin Z, Ellis D, Mon Phyo Lwin E, Turner S, Williams D, Garg S.
2018
3872 Journal
Hosp Pharm 2016 ; 51: 389-395.
Stability of an Extemporaneously Compounded Oral Suspension of Bosentan.
Malik A, Gorman G, Coward L ,. Arnold J.J.
2016
2851 Journal
Int J Pharm Compound 2005 ; 9, 1: 82-86.
Stability of An Extemporaneously Compounded Propylthiouracil Suspension
Alexander KS, Mitra P.
2005
2503 Journal
Am J Hosp Pharm 1991 ; 48: 293-295.
Stability of an extemporaneously compounded terbutaline sulfate oral liquid
Horner RK, Johnson CE.
1991
2657 Journal
Int J Pharm Compound 1997 : 60-63.
Stability of an extemporaneously formulated levothyroxine sodium syrup compounded from commercial tablets.
Alexander KS, Kothapalli MR, Dollimor D.
1997
2401 Journal
Am J Health-Syst Pharm 2007 ; 64: 644-646.
Stability of an extemporaneously prepared alcohol-free phenobarbital suspension
Cober MP, Johnson CE.
2007
3420 Journal
J Oncol Pharm Practice 2014 ; 21, 3: 178-187.
Stability of an extemporaneously prepared bleomycin-lidocaine-epinephrine intradermal admixture used in dermatology
El Kateb N, Chaussard M, Bellenger P, Petit A, Faure P.
2014
3298 Journal
Am J Health-Syst Pharm 2012 ; 69: 592-594
Stability of an extemporaneously prepared tadalafil suspension
Pettit R.S, Johnson C.E, Caruthers R.L.
2012
3269 Journal
Am J Health-Syst Pharm 2012 ; 69:56-58.
Stability of an extemporaneously prepared thalidomide suspension.
Kraft S, . Johnson C.E, Tyler R.P.
2012
1341 Journal
Pharm J 1983 ; 230: 495-497.
Stability of an intrathecal morphine injection formulation.
Deeks T, Davis S, Nash S.
1983
444 Journal
Am J Hosp Pharm 1992 ; 49: 2756-2760.
Stability of an ofloxacin injection in various infusion fluids.
Bornstein M, Kao SH, Mercorelli M, Verma S.
1992
4249 Journal
PeerJ 2018
Stability of an ophtalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multi dose eyedroppers.
Bouattour Y, Chennell P, Wasiak M, Jouannet M, Sautou V.
2018
2833 Journal
Int J Pharm Compound 2001 ; 5, 6: 480-481.
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets
Das Gupta V.
2001
3336 Journal
EJHP 2013 ;20:46-49
Stability of an oral ranitidine suspension (15 mg/ml).
Petit-Jean E, Perello L, Hernandez C, Gairard Dory A.C, Gourieux B, Ubeaud-Sequier G.
2013
2925 Journal
Am J Health-Syst Pharm 2005 ; 62: 2518-2520.
Stability of anhydrous theophylline in extemporaneously prepared alcohol-free oral suspensions.
Johnson CE, vanDe Koppel S, Myers E.
2005
632 Journal
J Parenter Sci Technol 1985 ; 39: 220-222.
Stability of anthracycline antitumour agents in infusion fluids.
Beijnen JH, Rosing H, De Vries PA, Underberg WJM.
1985
573 Journal
Drug Intell Clin Pharm 1977 ; 11: 542-548.
Stability of antibiotic admixtures frozen in minibags.
Dinel BA, Ayotte DL, Behme RJ, Black BL, Whitby JL.
1977
3888 Journal
Perit Dial Int 2016 ; 36:421-426.
Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).
Ranganathan D, Naicker S,. Wallis S.C, Lipman J, . Ratanjee S.K, Roberts J.A
2016
574 Journal
Am J Hosp Pharm 1980 ; 37: 1087-1088.
Stability of antibiotics frozen and stored in disposable hypodermic syringes.
Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ.
1980
427 Journal
Am J Hosp Pharm 1986 ; 43: 3027-3030.
Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states.
Concannon J, Lovitt H, Ramage M, Tai LH, McDonald C, Sunderland VB.
1986
960 Journal
Can J Hosp Pharm 1990 ; 43: 57-60.
Stability of aqueous solutions of deferoxamine.
Koren G, Tesoro A, Leeder JS, Bentur Y, Olivieri N.
1990
2469 Journal
Am J Hosp Pharm 1981 ; 38: 363-364.
Stability of aqueous suspensions of disulfiram
Das Gupta V.
1981
2345 Journal
Can J Hosp Pharm 2009 ; 62, 3: 226-231.
Stability of aseptically prepared Tazocin solutions in polyvinyl chloride bags.
Donnelly R.F.
2009
3857 Journal
Int J Pharm Compound 2016 ; 20, 2: 167-174.
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini H.C, Sharlene L, Claudio L,Ferreira A.O,Brand?o M.A.F.
2016
1093 Journal
Anesthesiology 1984 ; 61: 347-348.
Stability of atracurium administered by infusion.
Fisher DM, Canfell, Miller RD.
1984
462 Journal
Br J Anaesth 1988 ; 60: 344-345.
Stability of atracurium in dilute solutions.
Harper NJN, Pollard BJ, Edwards D, Wilson A.
1988
1039 Journal
Am J Hosp Pharm 1984 ; 41: 1156-1159.
Stability of azacitidine in infusion fluids.
Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP.
1984
414 Journal
Am J Hosp Pharm 1989 ; 46: 2500-2505.
Stability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringes.
Den Hartigh J, Brandenburg HCR, Vermeij P.
1989
3351 Journal
Can J Hosp Pharm 2012 ; 65, 5: 352-359
Stability of Azacitidine in Sterile Water for Injection.
Walker S.E, Charbonneau L.F, Law S, Earle C.
2012
4227 Poster
Prof Practice Conference - Canadian Society of PH 2019
Stability of Azacitidine Solutions In Sterile Water for Injection.
Tyono I, Law S, Charbonneau L.F, Walker S.E.
2019
3204 Journal
Ann Pharmacotherapy 2011 ;45, 4:546.
Stability of Azacitidine Suspensions.
Duriez A, Vigneron J.H, Zenier H.A, May I, Demor? B.M.
2011
4301 Journal
Oncotarget 2017 ;8, 63: 106249-106257.
Stability of azasetron-dexamethasone mixture for chemotherapyinduced nausea and vomiting administration.
Fang B-X, Chen F-C, Zhu D, Guo J, Wang L-H.
2017
4408 Journal
Int J Pharm Compound 2020 ;24,3:252-262
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF PH4.
Polonini H, Loures da Silva S, Neves Cunha C, de Oliveira Ferreira A, Anagnostou K, Dijkers E.
2020
258 Journal
Am J Hosp Pharm 1994 ; 51: 901-904.
Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection.
Belliveau PP, Nightingale CH, Quintiliani R.
1994
1064 Journal
Pharm World Sci 1996 ; 18: 74-77.
Stability of aztreonam in a portable pump reservoir used for home intravenous antibiotic treatement (HIVAT).
Vinks AATMM, Touw DJ, van Rossen RCJM, Heijeiman HGM, Bakker W.
1996
2263 Journal
Il Farmaco 2005 ; 60: 599-603.
Stability of aztreonam in AZACTAM.
Zajac M, Jelinska A, Cielecka-Piontek J, Osqczapowicz I.
2005
2433 Journal
Am J Health-Syst Pharm 1996 ; 53: 2179-2184.
Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA,
1996
3342 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:13-21
Stability of Bendamustine Solutions: Influence of Sodium Chloride Concentration, Temperature and Container.
Vigneron J, D'Huart E, Demor? B.
2018
2056 Journal
J Antimicrob Chemother 2004 ; 53: 675-677.
Stability of benzylpenicillin during continuous home intravenous therapy.
Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST.
2004
3449 Journal
Ann Pharmacotherapy 2013 ; 47: 1237-1238.
Stability of Betaxolol Suspensions in Oral Syringes and Glass Bottles.
Auvity S, Chiadmi F.M, Cisternino S, Fontan J.E, Schlatter J.
2013
2421 Journal
Am J Health-Syst Pharm 1998 ; 55: 1804-1809.
Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids
Allen LV, Jr, MA Erickson
1998
252 Journal
Am J Hosp Pharm 1990 ; 47: 2528-2529.
Stability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containers.
Koberda M, Zieske PA, Raghavan NV, Payton RJ.
1990
2010 Journal
Ann Pharmacotherapy 2005 ; 39: 1462-1466.
Stability of bortezomib 1 mg/ml solution in plastic syringe and glass vial.
Andr? P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE.
2005
3688 Journal
Can J Hosp Pharm 2014 ; 67, 2: 102-107
Stability of bortezomib 2.5 mg/mL in vials and syringes stored at 4°C and room temperature (23°C).
Walker S.E, Charbonneau L.F, Law S.
2014
3337 Journal
EJHP 2012 ; 19: 428-431.
Stability of bortezomib reconstituted under clinical use conditions in original vials and polypropylene syringes at 4 °C and room temperature.
Carati D, Masini C, Minguzzi M, Petocchi B, Romanazzi C, Rondoni C, Sangiorgi E, Sferra S, Simonetta S, Stancari A, Locchi F, Z
2012
2232 Journal
Can J Hosp Pharm 2008 ; 61, 1: 14-20.
Stability of Bortezomib Reconstituted with 0.9% Sodium Chloride at 4°C and Room Temperature (23°C)
Walker SE, Milliken D, Law S.
2008
3702 Journal
J Pharm Pract and Res 2014 ; 44, 1: 26-28.
Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy.
McDougall D.A.J, McWhinney.
2014
3263 Journal
Can J Hosp Pharm 2011 ; 64, 4: 289-290.
Stability of buffered lidocaine in glass vials.
Donnelly R.F.
2011
42 Journal
Am J Health-Syst Pharm 1997 ; 54: 422-423.
Stability of bumetanide in 5% dextrose injection.
Cornish LA, Montgomery PA, Johnson CE.
1997
306 Journal
Am J Health-Syst Pharm 1996 ; 53: 170-173.
Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration.
Christen C, Johnson CE, Walters JR.
1996
293 Journal
Am J Hosp Pharm 1993 ; 50: 2364-2365.
Stability of bupivacaine hydrochloride in polypropylene syringes.
Jones JW, Davis AT.
1993
512 Journal
Pharm World Sci 1995 ; 17: 87-92.
Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion.
Barnes AR, Nash S.
1995
217 Journal
Am J Hosp Pharm 1993 ; 50: 714-715.
Stability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirs.
Allen LV, Stiles ML, Wang DP, Tu YH.
1993
2113 Journal
Pharm World Sci 1999 ; 21, 6: 272-274.
Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution.
J?ppinen A, Kokki H, Naaranlahti TJ, Rasi AS.
1999
658 Journal
J Oncol Pharm Practice 1996 ; 2: 101-105.
Stability of busulfan injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection.
Xu QA, Zhang YP, Trissel LA, Martinez JF.
1996
4033 Journal
Am J Health-Syst Pharm 2017 ;74,22:1887-1894
Stability of busulfan solutions in polypropylene syringes and infusion bags as determined with an original assay.
Guichard N, Bonnabry P, Rudaz S, Fleury-Souverain S.
2017
691 Journal
J Clin Pharm Ther 1989 ; 14: 53-55.
Stability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutions.
Nahata MC, Zingarelli JR, Durell DE.
1989
43 Journal
Am J Health-Syst Pharm 1997 ; 54: 1106-1108.
Stability of caffeine citrate injection in polypropylene syringes at room temperature.
Fraser BD, Berod T, Whitney HAK.
1997
698 Journal
Ann Pharmacotherapy 1989 ; 23: 466-467.
Stability of caffeine injection in intravenous admixtures and parenteral nutrition solutions.
Nahata MC, Zingarelli JR, Durell DE.
1989
990 Journal
Ann Pharmacotherapy 1989 ; 23: 1035.
Stability of caffeine injection stored in plastic and glass syringes.
Nahata MC, Zingarelli JR, Hipple TF.
1989
2705 Journal
J Clin Pharm Ther 1994 ; 19, 6: 391-396.
Stability of caffeine oral formulations for neonatal use.
Barnes AR, Hebron BS, Smith J.
1994
2531 Journal
J Oncol Pharm Practice 2020
Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags.
Sanogo S, Silimbani P, Gaggeri R, Masini C.
2020
3802 Journal
J Clin Pharm Ther 1998 ; 23: 451-456.
Stability of captopril in invert sugar solution
Sam W.J, Ho P.C.
1998
2522 Journal
Am J Hosp Pharm 1994 ; 51: 1707-1708.
Stability of captopril in liquid containing ascorbic acid or sodium ascorbate
Nahata MC, Morosco RS, Hipple TF.
1994
2488 Journal
Am J Hosp Pharm 1990 ; 47: 1799-1801.
Stability of captopril in powder papers under three storage conditions
Taketomo CK, Chu SA, Cheng MH, Corpuz RP.
1990
3436 Journal
Int J Pharm Compound 2013 ; 17, 4: 336-338.
Stability of Captopril in SyrSPend SF.
Geiger C. M, Sorenson B, Whaley P. A.
2013
601 Journal
Am J Hosp Pharm 1978 ; 35: 310-312.
Stability of carbenicillin and oxacillin frozen in syringes.
Kresel JJ, Mc Dermott JS, Huffer LM, Smith AL.
1978
2245 Journal
Int J Pharm 1996 ; 129: 275-277.
Stability of carboplatin in 5% glucose solution exposed to light.
Torres F, Girona V, Puiol M, Prat J, de Bolos J.
1996
2244 Journal
J Pharm Biomed Anal 1994 ; 12, 1: 81-84.
Stability of carboplatin in 5% glucose solution in glass, polyethylene and polypropylene containers.
Prat J, Pujol M, Girona V, Munoz M, Sol? L-A.
1994
4205 Journal
J Kor Soc Hosp Pharm 2006 ;23,3:219-224
Stability of Carboplatin in normal saline : dependence on initial dilution concentration and storage time.
Choi S, O La H, Kim K, Kim S, Hwangbo S.
2006
486 Journal
Am J Health-Syst Pharm 1998 ; 55: 602, 604.
Stability of carboplatin in polyvinyl chloride bags.
Diaz Amador F, Sevilla Azzati E, Herreros de Tajeda y Lopez-Coterilla A.
1998
4120 Journal
J Oncol Pharm Practice 2018 25,5:1076?1081
Stability of carboplatin infusion solutions used in desensitization protocol.
Vazquez-Sanchez R, Sanchez-Rubio-Ferrandez J, Cordoba-Diaz D, Cordoba-Diaz M, Molina-Garcia T.
2018
3277 Journal
Int J Pharm Compound 2012 ; 16, 1 : 82-85.
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration.
Yang Z, Cameron S, Paul H.
2012
837 Journal
Acta Pharm Suec 1986 ; 23: 115-124.
Stability of carmustine - kinetics and compatibility during administration.
Fredriksson K, Lundgren P, Landersjo L.
1986
1622 Journal
Am J Health-Syst Pharm 2001 ; 58: 238-241.
Stability of carmustine in polyvinyl chloride bags and polyethylene-lined trilayer plastic containers.
Favier M, De Casanove F, Coste A, Cherti N, Bressolle F.
2001
715 Journal
Am J Hosp Pharm 1980 ; 37: 677-678.
Stability of carmustine in the presence of sodium bicarbonate.
Colvin M, Hartner J, Summerfield M.
1980
2486 Journal
Am J Hosp Pharm 1991 ; 48: 992-993.
Stability of cefadroxil in reconstituted suspension under refrigeration and at room temperature
Nahata MC, Jackson DS.
1991
612 Journal
Am J Hosp Pharm 1982 ; 39: 622-627.
Stability of cefamandole nafate injection with parenteral solutions and additives.
Frable RA, Klink PR, Engel GL, Mundell EE.
1982
1979 Journal
Am J Health-Syst Pharm 2002 ; 59: 1537-1538.
Stability of cefazolin in heparinized and nonheparinized peritoneal dialysis solutions.
Wu CC, Wang DP, Wong CY, Lin YF.
2002
4247 Journal
Clin Ther 2018 ;40,4:664-667
Stability of Cefazolin in Polyisoprene Elastomeric Infusion Devices.
Patel R, Jacob J, Sedeeq M, Ming L.C, Wanandy T, Zaidi S.T.R, Peterson G.M.
2018
582 Journal
Am J Hosp Pharm 1980 ; 37: 211-215.
Stability of cefazolin sodium admixtures in plastic bags after thawing by microwave radiation.
Tomecko GW, Kleinberg ML, Latiolais CL, Proior RB, Pesko LJ, Jones BC.
1980
671 Journal
J Parenter Sci Technol 1993 ; 47: 135-137.
Stability of cefazolin sodium and metronidazole at 8°C for use as an IV admixture.
Rivers TE, McBride HA, Trang JM.
1993
2707 Journal
J Clin Pharm Ther 1998 ; 23, 1: 41-47.
Stability of cefazolin sodium eye drops
How TH, Loo WY, Yow KL, Lim LY, Chan EW, Ho PC, Chan SY.
1998
1805 Journal
Am J Health-Syst Pharm 2002 ; 59: 2362-2364.
Stability of cefazolin sodium in icodextrin-containing peritoneal dialysis solution.
Lin YF, Wu CC, Lin SH, Wang DP, Wang CN.
2002
2372 Journal
Am J Hosp Pharm 1991 ; 48: 291 - 292.
Stability of cefazolin sodium in peritoneal dialysis solutions
Nahata MC, Ahalt PA.
1991
3230 Journal
Can J Hosp Pharm 2011 ; 64, 4: 241-245.
Stability of Cefazolin Sodium in Polypropylene Syringes and Polyvinylchloride Minibags
Donnelly RF.
2011
2505 Journal
Am J Hosp Pharm 1987 ; 44: 2287-2290
Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles
Ahmed I, Day P.
1987
440 Journal
Am J Hosp Pharm 1989 ; 46: 1408-1412.
Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs.
Stiles ML, Tu YH, Allen LV.
1989
1452 Journal
Eur Hosp Pharm 2000 ; 6: 17-23.
Stability of cefazolin, cefotiam, cefuroxime, cefotaxime, ceftriaxone and ceftazidime in normal saline solutions, stored in a new IV container made of Biofine*.
Muller HJ, Howe K, Frank C, Haker I.
2000
1626 Journal
Int J Pharm Compound 2001 ; 5: 151-152.
Stability of cefepime hydrochloride after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V.
2001
873 Journal
Int J Pharm Compound 1997 ; 1: 435-436.
Stability of cefepime hydrochloride dextrose in 5% dextrose injection and 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J, Bailey RE.
1997
1834 Journal
Ann Pharmacotherapy 2003 ; 37, 6: 804-807.
Stability of cefepime hydrochloride in autodose infusion system bags.
Trissel LA, Xu QA.
2003
1068 Journal
Am J Health-Syst Pharm 1999 ; 56: 457-459.
Stability of cefepime hydrochloride in polypropylene syringes at -20°C, 4°C and 22-24°C.
Stewart JT, Warren FW, Maddox FC.
1999
1046 Journal
Am J Health-Syst Pharm 1999 ; 56: 1134.
Stability of cefepime hydrochloride in polypropylene syringes.
Stewart JT, Maddox FC, Warren FW.
1999
1605 Journal
Hosp Pharm 2000 ; 35: 1057-1064.
Stability of cefepime hydrochloride injection and metronidazole in polyvinyl chloride bags at 4°C and 22-24°C.
Stewart JT, Maddox FC, Warren FW.
2000
3182 Journal
Pharmazie 2011 ; 66, 1: 17-23.
Stability of cefepime in eye drops.
Kodym A, PawLowska M, Ruminski JK, Bartosinska A, Kieliba A.
2011
1945 Journal
Ann Pharmacotherapy 2004 ; 38: 2041-2044.
Stability of cefepime in icodextrin peritoneal dialysis solution.
Elwell RJ, Volino LR, Frye RF.
2004
1290 Journal
Ann Pharmacotherapy 1999 ; 33: 906-909.
Stability of cefepime in peritoneal dialysis solution.
Williamson JC, Volles DF, Lynch PLM, Rogers PD, Haverstick DM.
1999
237 Journal
Am J Health-Syst Pharm 1996 ; 53: 432.
Stability of cefmetazole and famotidine.
Lee DKT, Wong CY, Wang DP, Chang LC, Wu KH.
1996
652 Journal
Int J Pharm Compound 1997 ; 1: 208-209.
Stability of cefmetazole sodium in 5% dextrose injection and 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J, Bailey R.E, County H.
1997
1664 Journal
J Clin Pharm Ther 1994 ; 19: 317-325.
Stability of cefmetazole-doxycycline mixtures in sodium chloride and dextrose injections.
King AD, Stewart JT, Warren FW.
1994
420 Journal
Am J Hosp Pharm 1985 ; 42: 1980-1983.
Stability of cefonicid sodium in infusion fluids.
Wong WW, Maderich AB, Polli GP, Ravin LJ.
1985
2374 Journal
Am J Hosp Pharm 1990 ; 47: 147 - 150.
Stability of cefotaxime in two peritoneal dialysis solutions
CM Paap CM, Nahata MC.
1990
1711 Journal
Int J Pharm Compound 2002 ; 6: 234-236.
Stability of cefotaxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Das Gupta V.
2002
281 Journal
Am J Health-Syst Pharm 1995 ; 52: 1561-1563.
Stability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bags.
Belliveau PP, Nightingale CH, Quintiliani R.
1995
593 Journal
J Pharm Sci 1984 ; 73: 565-567.
Stability of cefotaxime sodium as determined by High-Performance Liquid Chromatography.
Das Gupta V.
1984
3840 Journal
Acta Pol Pharm 2016 ; 73, 1: 23-27.
Stability of cefpirome sulfate in aqueous solutions.
Zalewski P, Jelinska A, Paczkowska M, Garbacki P, Talaczynska A, Step-niak P, Cielecka- Piontek J.
2016
280 Journal
Am J Health-Syst Pharm 1995 ; 52: 2427-2433.
Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
Allen LV, Stiles ML, Prince SJ, Sylvestri MF.
1995
443 Journal
Am J Hosp Pharm 1992 ; 49: 2761-2764.
Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs.
Stiles ML, Allen LV, Fox JL.
1992
287 Journal
Am J Health-Syst Pharm 1995 ; 52: 1912-1914.
Stability of ceftazidime (with arginine) in an elastomeric infusion device.
Bednar DA, Klutman NE, Henry DW, Fox JL, Strayer AH.
1995
477 Journal
Am J Hosp Pharm 1992 ; 49: 2954-2956.
Stability of ceftazidime (with arginine) stored in plastic syringes at three temperatures.
Nahata MC, Morosco RS, Fox JL.
1992
4056 Journal
Perit Dial Int 2017
Stability of ceftazidime and heparine in four different types of peritoneal dialysis solutions.
Kandel S, Zaidi S, Wanandy T, Ming L, Castelino R, Sud K, Patel R.
2017
2369 Journal
Am J Hosp Pharm 1992 ; 49: 1139 - 1142.
Stability of ceftazidime and tobramycin sulfate in peritoneal dialysis solution
Mason NA, Johnson CE, O'Brien MA.
1992
3289 Journal
Acta Pol Pharm 2011 ; 68, 1: 99-107.
Stability of ceftazidime in 1% and 5% buffered eye drops determined by HPLC method.
Kodym A, Hapka-Zmich D, Golab M, Gwizdala M.
2011
2708 Journal
J Clin Pharm Ther 1999 ; 24: 299-302
Stability of ceftazidime in a viscous eye drop formulation
Barnes AR, Nash R.
1999
445 Journal
Am J Hosp Pharm 1992 ; 49: 2765-2768.
Stability of ceftazidime in plastic syringes and glass vials under various storage conditions.
Stewart JT, Warren FW, Johnson SM, Fox JL, Mullaney J.
1992
2450 Journal
Am J Health-Syst Pharm 1996 ; 53: 2731 - 2734.
Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution
Manduru M, Fariello A, White RL, Fox JL, Bosso JA.
1996
591 Journal
Can J Hosp Pharm 1993 ; 46: 13-16.
Stability of ceftizoxime in 5 percent dextrose and 0.9 percent sodium chloride.
Knoppert DC, Freeman D, Webb D.
1993
282 Journal
Am J Health-Syst Pharm 1995 ; 52: 2568-2570.
Stability of ceftizoxime sodium, ceftriaxone sodium, and ceftazidime with metronidazole in ready-to-use metronidazole bags.
Rivers TE, Webster AA.
1995
4378 Journal
Perit Dial Int 2020
Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.
Harmanjeet H, Jani H, Zaidi S.T.R, Wanandy T, Castelino R.L, Sud K, Peterson G.M, Patel R.P.
2020
276 Journal
Am J Hosp Pharm 1994 ; 51: 92-94.
Stability of ceftriaxone sodium and aminophylline or theophylline in intravenous admixtures.
Parrish MA, Bailey LC, Medwick T.
1994
11 Journal
Am J Health-Syst Pharm 1997 ; 54: 424-427.
Stability of ceftriaxone sodium and metronidazole hydrochloride.
Bailey LC, Orosz ST.
1997
259 Journal
Am J Hosp Pharm 1993 ; 50: 2092-2094.
Stability of ceftriaxone sodium in infusion-pump syringes.
Bailey LC, Tang KT, Medwick T.
1993
279 Journal
Am J Hosp Pharm 1994 ; 51: 2159-2161.
Stability of ceftriaxone sodium in injectable solutions stored frozen in syringes.
Bailey LC, Cappel KM, Orosz ST.
1994
586 Journal
Am J Hosp Pharm 1983 ; 40: 2193-2194.
Stability of ceftriaxone sodium in intravenous solutions.
Nahata MC.
1983
100 Journal
Am J Health-Syst Pharm 1996 ; 43: 2320-2323.
Stability of ceftriaxone sodium in polypropylene syringes at -20, 4, and 20°C.
Plumridge RJ, Rieck AM, Annus TP, Langton SR.
1996
649 Journal
Int J Pharm Compound 1997 ; 1: 280-281.
Stability of ceftriaxone sodium when mixed with metronidazole injection.
Das Gupta V.
1997
2491 Journal
Am J Hosp Pharm 1989 ; 46: 256.
Stability of cefuroxime axetil in beverages
St Claire RL, Caudill WL.
1989
2699 Journal
J Clin Pharm Ther 1991 ; 16, 5: 341-345.
Stability of cefuroxime axetil in suspensions.
Pramar Y, Das Gupta V, Bethea C, Zerai T.
1991
3290 Journal
Acta Pol Pharm 2011 ; 68, 4: 555-564.
Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A, Wisniewski A, Kniola D, Olejniczak M.
2011
2095 Journal
EJHP Science 2006 ; 12, 2: 32-34.
Stability of cefuroxime infusion: the brand-name drug versus a generic product.
Rodenbach, MP, Hecq JD, Vanbeckbergen D, jamart J, Galanti L.
2006
96 Journal
Am J Hosp Pharm 1994 ; 51: 809-811.
Stability of cefuroxime sodium and aminophylline or theophylline.
Stewart JT, Warren FW, Johnson SM.
1994
636 Journal
J Clin Hosp Pharm 1986 ; 11: 47-54.
Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures.
Das Gupta V, Stewart KR.
1986
1268 Journal
J Clin Hosp Pharm 1986 ; 11: 47-54.
Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures.
Das Gupta V, Stewart KR.
1986
3078 Journal
Can J Hosp Pharm 2009 ; 62, 6: 464-468.
Stability of celecoxib oral suspensions.
Donnelly RF, Pascuet E, Ma C, Vaillancourt R.
2009
3135 Journal
Am J Health-Syst Pharm 2010 ; 67, 3: 223-226.
Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags.
Ikesue H, Vermeulen LC, Hoke R, Kolesar JM.
2010
2206 Journal
Am J Health-Syst Pharm 2015 ; 72:1292-1297
Stability of chlorothiazide sodium in polypropylene syringes
McCluskey S.V, Gardner B, . Graner K.K, Nicole Vu N.
2015
1 Journal
Am J Health-Syst Pharm 1996 ; 53: 1939-1943.
Stability of cidofovir in 0.9% sodium chloride and in 5% dextrose injection.
Yuan LC, Samuels GJ, Visor GC.
1996
71 Journal
Am J Health-Syst Pharm 1997 ; 54: 2204-2206.
Stability of cidofovir in 0.9% sodium chloride injection for five days.
Ennis RD, Dahl TC.
1997
1989 Journal
Am J Health-Syst Pharm 2005 ; 62: 506-509.
Stability of cidofovir in extemporaneously prepared syringes.
Hennere G, Havard L, Bonan B, Prognon P.
2005
3722 Journal
Acta Pol Pharm 2014 ; 71, 4: 661-666.
Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms.
Beata J. Stanisz, Sylwia K. Paszun, Anna Zalewska.
2014
80 Journal
Am J Hosp Pharm 1993 ; 50: 2559-2561.
Stability of cimetidine hydrochloride and of clindamycin phosphate in water for injection stored in glass vials at two temperatures.
Nahata MC, Morosco RS, Hipple TF.
1993
1503 Journal
Am J Hosp Pharm 1983 ; 40: 1002-1006.
Stability of cimetidine hydrochloride in admixtures after microwave thawing
Elliott GT, McKenzie MW, Curry SH, Pieper JA, Quinn SL.
1983
1614 Journal
Hosp Pharm 2001 ; 36: 1170-1173.
Stability of ciprofloxacin and vancomycin hydrochloride in autodose infusion system bags.
Trissel LA, Xu QA, Zhang Y, Saenz CA, Ingram DS.
2001
666 Journal
J Clin Pharm Ther 1994 ; 19: 261-262.
Stability of ciprofloxacin in 5% dextrose and normal saline injections.
Mathew M, Das Gupta V, Zerai T.
1994
1740 Journal
Int J Pharm Compound 1998 ; 2, 4: 314-317.
Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson CE, Wong D, Hoppe HL, Bhatt-Mehta V.
1998
2676 Journal
Int J Pharm Compound 1998 ; 2: 314-317.
Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson C.E, Wong D.V, Hoppe H.L, Bhatt-Mehta V.
1998
2368 Journal
Am J Hosp Pharm 1992 ; 49: 2956 - 2959.
Stability of ciprofloxacin in peritoneal dialysis solution
Mawhinney WM, Adair CG, Gorman SP, McClurg B.
1992
3231 Journal
Can J Hosp Pharm 2011 ; 64, 4 : 252-256.
Stability of Ciprofloxacin in Polyvinylchloride Minibags.
Donnelly RF.
2011
4263 Journal
Am J Hosp Pharm 1994 ;51:373-377
Stability of ciprofloxacin injection in peritoneal dialysis solutions.
Kane MP, Bailie GR, Moon DG, Siu I.
1994
533 Journal
Am J Health-Syst Pharm 1998 ; 55: 1037-1041.
Stability of cisatracurium besylate in vials, syringes and infusion admixtures.
Xu QA, Zhang YP, Trissel LA, Gilbert DL, Martinez JF, Fox JL.
1998
1080 Journal
Am J Hosp Pharm 1985 ; 42: 2652.
Stability of cisplatin admixtures in polyvinyl chloride bags.
La Folette JM, Arbus MH, Lauper RD.
1985
417 Journal
Am J Hosp Pharm 1989 ; 46: 1400-1404.
Stability of cisplatin and etoposide in intravenous admixtures.
Stewart CF, Hampton EM.
1989
53 Journal
Am J Health-Syst Pharm 1995 ; 52: 2570-2573.
Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion.
Henry DW, Marshall JL, Nazzar OD, Fox JL, Leff RD.
1995
1729 Journal
Pharmazie 1998 ; 53: 490-492.
Stability of cisplatin containing infusion.
Mittner A, Vincze Z, Jemnitz K.
1998
742 Journal
Am J Hosp Pharm 1979 ; 36: 38-43.
Stability of cisplatin in aqueous solution.
Greene RF, Chatterji DC, Hiranaka PK, Gallelli JF.
1979
149 Journal
J Clin Pharm Ther 1992 ; 17: 315-318.
Stability of cisplatin in ethylene vinylacetate portable infusion-pump reservoirs.
Rochard E, Barthes D, Courtois P.
1992
147 Journal
Pharm World Sci 1993 ; 15: 34-36.
Stability of cisplatin in sodium chloride 0.9% intravenous solution related to the container’s material.
Pujol Cubells M, Prat Aixela J, Girona Brumos V, Duran Pou S, Villaronga Flaque MV.
1993
409 Journal
Am J Hosp Pharm 1987 ; 44: 124-130.
Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
Cheung YW, Cradock JC, Vishnuvajjala BR, Flora KP.
1987
1604 Journal
Eur Hosp Pharm 2001 ; 7: 11-14.
Stability of citalopram hydrochloride in polyvinyl chloride bag for I.V. solutions and compatibility in the presence of dipotassium clorazepate.
Gury C, Dolizy I, Aymard N, Sellali Y, Rochet S.
2001
318 Journal
Am J Hosp Pharm 1994 ; 51: 512-514.
Stability of citrated caffeine injectable solution in glass vials.
Donnelly RF, Tirona RG.
1994
1354 Journal
Am J Hosp Pharm 1984 ; 41: 2405-2406.
Stability of citrated caffeine solutions for injectable and enteral use.
Eisenberg MG, Kang N.
1984
1505 Journal
Eur Hosp Pharm 1997 3,4: 154-6
Stability of cladribine in either polyethylene containers or polyvinylchloride bags.
Daouphars M, Vigneron J, Perrin A, Hoffman MA, Hoffman M.
1997
3901 Journal
Int J Pharm Compound 2016 ; 20, 5 : 421-425.
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt
Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A,Mandal Tarun K
2016
567 Journal
Can J Hosp Pharm 1989 ; 42: 109-112.
Stability of clindamycin phophate in dextrose and saline solutions.
Das Gupta V, Parasrampuria J, Bethea C, Wright W.
1989
418 Journal
Am J Hosp Pharm 1985 ; 42: 2211-2214.
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
Bosso JA, Townsend RJ.
1985
1815 Journal
Int J Pharm Compound 2003 ; 7, 2: 149-151.
Stability of clindamycin phosphate in autodose infusion system bags.
Xu QA, Trissel LA.
2003
432 Journal
Am J Hosp Pharm 1986 ; 43: 1732-1736.
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
Marble DA, Bosso JA, Townsend RJ.
1986
3649 Journal
Am J Health-Syst Pharm 2014 ; 71:657-661.
Stability of clonidine suspension in oral plastic syringes.
Ma C, Decarie D, Ensom M.H.H.
2014
2592 Journal
Can J Hosp Pharm 2005 ; 58, 5: 279-284.
Stability of clozapine stored in oral suspension vehicles at room temperature.
Walker SE, Baker D, Law S.
2005
2397 Journal
Am J Health-Syst Pharm 2007 Dentinger PJ, Swenson CF
Stability of codeine phosphate in an extemporaneously compounded syrup
Dentinger PJ, Swenson CF.
2007
2783 Journal
Int J Pharm 2015 ; 486; 1-2: 367-369.
Stability of colistimethate sodium in a disposable elastomeric infusion device.
Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P.
2015
3360 Journal
Antimicrob Agents Chemother 2012 ; 56:6432-6433.
Stability of Colistimethate Sodium in Aqueous Solution.
Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J.
2012
2285 Journal
Antimicrob Agents Chemother 2008 ; 52, 9: 3047-3051.
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.
Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL.
2008
3202 Journal
Am J Health-Syst Pharm 2011 ; 68: 900-908.
Stability of compounded thioguanine oral suspensions
Montazeri Aliabadi H, Romanick M, Somayaji V, Mahdipoor P, Lavasanifar A
2011
4214 Journal
Int J Pharm Compound 2019 ;23,1:70-76
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.
Pramar Y.V, Mandal T.K, Bostanian L.A, Nguyen A.TQ, Miller V, Morris T.C, Graves R.A.
2019
4089 Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:23-30
Stability of Concentrated Solution of Vancomycin Hydrochloride in Syringes for Intensive Care Units.
Godet M, Simar J, Closset M, Hecq J.D, Braibant M, Soumoy L, Gillet P, Jamart J, Bihin B, Galanti L.
2018
2162 Journal
Perit Dial Int 1990 ; 10: 157-160.
Stability of cotrimoxazole in peritoneal dialysis fluid.
Holmes SE, Aldous S.
1990
1833 Journal
Ann Pharmacotherapy 2003 ; 37, 12: 1789-1792.
Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
Menard C, Bourguignon C, Schlatter J, Vermerie N.
2003
1728 Journal
Pharmazie 1999 ; 54: 224-225.
Stability of cyclophosphamide containing infusions.
Mittner A, Vincze Z, Jemnitz.
1999
3096 Journal
Ann Pharmacotherapy 2010 ;44:295-301.
Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
Kennedy R, Groepper D, Tagen M, Christensen R, Navid F, Gajjar A, Stewart CF.
2010
3476 Journal
Am J Health-Syst Pharm 2013 ;70:1970-1972.
Stability of cyclosporine diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in ethylene-vinyl acetate containers.
Li M, Coursol C, Leclair G.
2013
471 Journal
Am J Hosp Pharm 1989 ; 46: 2053-2055.
Stability of cyclosporine in 5% dextrose injection.
Shea BF, Ptachcinski RJ, O?Neill S, Cersosimo RJ, Sesin GP, Souney PF.
1989
2444 Journal
Am J Health-Syst Pharm 1995 ; 52: 2204-2207.
Stability of cyclosporine in an extemporaneously compounded paste
Ghnassia LT, Yau DF, Kaye KI, Duggin GG.
1995
3229 Journal
Am J Health-Syst Pharm 2011 ;68:1646-1650.
Stability of cyclosporine solutions stored in polypropylene–polyolefin bags and polypropylene syringes
Li M, Forest JM, Coursol C, Leclair G
2011
291 Journal
Am J Hosp Pharm 1993 ; 50: 470-472.
Stability of cyclosporine with magnesium sulfate in 5% dextrose injection.
Nieforth KA, Shea BF, Souney PF, Scavone JM.
1993
1028 Journal
Am J Hosp Pharm 1984 ; 41: 1802-1806.
Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures.
Cheung YW, Vishnuvajjala BR, Flora KP.
1984
859 Journal
Nor Pharm Acta 1983 ; 45: 61-67.
Stability of cytotoxic intravenous solutions subjected to freeze-thaw treatment.
Karlsen J, Thonnesen HH, Olsen IR, Sollien AH, Skobba TJ.
1983
1635 Journal
Am J Health-Syst Pharm 2002 ; 59: 1351-1356.
Stability of dacarbazine in amber glass vials and polyvinyl chloride bags.
El Aatmani M, Poujol S, Astre C, Malosse F, Pinguet F.
2002
4031 Journal
Int J Pharm Compound 2017 ;21 , 5 : 426-429
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes.
Kirkham K, Munson J, McCluskey S, Graner K.
2017
4106 Journal
Can J Hosp Pharm 2018 ;71,2/152-154
Stability of Dapsone in Extemporaneously Compounded Oral Suspensions.
Alarie H, Friciu M, Leclair G.
2018
2545 Journal
Ann Pharmacotherapy 2000 ;34:848-850.
Stability of dapsone in two oral liquid dosage forms.
Nahata MC, Morosco RC, Trowbridge JM.
2000
3665 Journal
Am J Health-Syst Pharm 2014 ; 71:956-959
Stability of daptomycin 5 mg/mL and heparin sodium 100 units/mL combined in lactated Ringer’s injection and stored in polypropylene syringes at 4 and -20°C.
Ortega R, Salmer?n-Garc?a A, Cabeza J, Capit?n-Vallvey L.F, Navas N.
2014
4074 Journal
EJHP 2018 ; 25: 107-110.
Stability of daptomycin reconstituted vials and infusion solutions.
Ferrandez J, Sanchez R, Diaz D, Diaz M, Estevan M, Garcia T.
2018
5 Journal
Am J Health-Syst Pharm 1996 ; 53: 1583-1588.
Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes.
Stiles ML, Allen LV Jr, Prince SJ.
1996
2156 Journal
Perit Dial Int 1994 ; 14: 396-398.
Stability of deferoxamine peritoneal dialysate solutions.
Kane MP, Bailie GR, Moon DG, Siu I.
1994
2961 Journal
Can J Hosp Pharm 2001 ; 54: 96-101.
Stability of dexamethasone in extemporaneously prepared oral suspensions.
Wen-Lin Chow J, Decarie D, Dumont RJ.
2001
24 Journal
Am J Hosp Pharm 1994 ; 51: 514-517.
Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs.
Stiles ML, Allen LV Jr, Prince SJ, Holland JS.
1994
3299 Journal
Am J Health-Syst Pharm 2012 ; 69:595-597.
Stability of dexmedetomidine 4 µg/mL in polypropylene syringes.
Anderson C.R, Mackay M.W, Holley M, Kay B.A
2012
4029 Journal
Int J Pharm Compound 2017 ; 21, 5: 436-439
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags.
Marquis K, Hohlfelder B, Szumita Paul.
2017
3433 Journal
Am J Health-Syst Pharm 2013 ; 70:1336-1341
Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injection.
Preslaski C.R, Mueller S.W, Wempe M.F, Robert MacLaren R.
2013
779 Journal
J Pharm Pharmacol 1986 ; 38: 51P.
Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration.
Collins AJ, Abethell JA, Holmes SG, Rain R.
1986
1199 Journal
Am J Hosp Pharm 1982 ; 1687-1690.
Stability of diazepam injection repackaged in glass unit-dose syringes.
Smith FM, Nuessle NO.
1982
4313 Journal
PlosOne 2017
Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions.
Friciu M, Zaraa S, Roullin G, Leclair G.
2017
2840 Journal
Can J Hosp Pharm 2010 ; 63, 1 : 25-30.
Stability of Diclofenac Sodium Oral suspensions Packaged in Amber Polyvinyl Chloride Bottles.
Donnell RF, Pascuet E, Ma C, Vaillancourt R.
2010
618 Journal
Am J Hosp Pharm 1982 ; 39: 844-846.
Stability of digoxin in common large-volume injections.
Shank WA, Coupal JJ.
1982
3426 Journal
Journal of Addiction Medicine 2013 ; 7,2:113-115.
Stability of Dilute Oral Morphine Solution for Neonatal Abstinence Syndrome.
Sauberan, Jason; Rossi, Steven; Kim, Jae H.
2013
3422 Journal
Hosp Pharm 2013 ; 48, 6: 484-488.
Stability of Diluted Adenosine Solutions in Polyolefin Infusion Bags.
Almagambetova E, Hutchinson D, Blais D.M, Zhao F.
2013
3223 Journal
Am J Health-Syst Pharm 2011 ;68:1533-1536.
Stability of diluted adenosine solutions in polyvinyl chloride infusion bags
Kaltenbach M, Hutchinson DJ, Bollinger JE, Zhao F.
2011
546 Journal
Ann Pharmacotherapy 1994 ; 28: 1018-1019.
Stability of diluted dexamethasone sodium phosphate injection at two temperatures.
Lugo RA, Nahata MC.
1994
3309 Journal
EJHP 2012 ;19:378-380
Stability of diluted epinephrine in prefilled syringes for use in neonatology.
Zenoni D, Priori G, Bellan C, Invernizzi R.W.
2012
1183 Journal
Am J Hosp Pharm 1981 ; 38: 1001-1004.
Stability of diluted heparin sodium stored in plastic syringes.
Tunbridge LJ, Lloyd JV, Penhall RK, Wise AL, Maloney T.
1981
3443 Journal
J Pharm Pract and Res 2013 ; 43: 112-116.
Stability of Diluted Iron Polymaltose in PVC Infusion Bags.
Patel R.P, Wanandy T, Loring S, Johns C, Hutchinson J, Shastri M.
2013
3435 Journal
Can J Hosp Pharm 2013 ; 66, 3 : 198.
Stability of Diluted Ketamine Packaged in Glass Vials.
Donnelly R.F.
2013
3243 Poster
ECCO Congress Stockholm 2011
Stability of diluted L-asparaginase in normal saline solution.
Nicolson O, d'Hayer B, Vieillard V, Dollet S, Astier A, Paul M.
2011
212 Journal
Am J Hosp Pharm 1994 ; 51: 2157-2159.
Stability of diluted methylprednisolone sodium succinate injection at two temperatures.
Nahata MC, Morosco RS, Hipple TF.
1994
2310 Journal
EJHP Science 2008 ; 14, 6: 36-38.
Stability of diluted nadroparin for the treatment of paediatric thrombosis.
Hunfeld N, Ypma P, Westerman E, Leebeck F, Touw D.
2008
2132 Journal
Int J Pharm Compound 2015 ; 19, 4 : 344-347.
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes.
Anderson Collin R, Halford Zachery, MacKay Mark.
2015
2471 Journal
Am J Hosp Pharm 1982 ; 39: 309-310.
Stability of disopyramide phosphate in cherry syrup
Mathur LK, Lai PK, Shively CD.
1982
2765 Journal
Pharm World Sci 1999 ; 21: 275-277.
Stability of dithranol in creams.
Wuis EW, Burger DM, Beelen M.
1999
3293 Journal
EJHP 2012 ; 19: 52-56.
Stability of dobutamine 500 mg in 50 ml syringes prepared using a Central Intravenous Additive Service
Patel N, Taki M, Tunstell P, Forsey P, Forbes B.
2012
1753 Journal
Int J Pharm Compound 1999 ; 3: 412-414.
Stability of dobutamine hydrochloride 4 mg/ml in 5% dextrose injection at 5 and 23°C.
Webster AA, English BA, McGuire JM, Riggs RM, Lander V, Buckle T.
1999
1045 Journal
Am J Hosp Pharm 1984 ; 41: 686-689.
Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5 % dextrose injections.
Das Gupta V, Stewart KR.
1984
2371 Journal
Am J Hosp Pharm 1991 ; 48: 1234 - 1237.
Stability of dobutamine hydrochloride in peritoneal dialysis solutions
Gora ML, Seth S, Visconti JA, Shields B, Bay W.
1991
628 Journal
Am J Hosp Pharm 1982 ; 39: 1923-1925.
Stability of dobutamine hydrochloride in selected large-volume parenterals.
Kirschenbaum HL, Aronoff W, Perentesis GP, Piltz GW, Goldberg RJ, Cutie AJ.
1982
4141 Journal
J Clin Pharm Ther 2018 : 530-535.
Stability of dobutamine in continuous ambulatory delivery devices.
Al Madfai F, Valah B, Zaidi S.T.R, Wanandy T, Ming M.C, Peterson G.M, Patel R.P.
2018
2210 Journal
Can J Hosp Pharm 2007 ; 60, 4: 231-237.
Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags.
Walker S.E, Charbonneau F, Law S.
2007
1807 Journal
Can J Hosp Pharm 2003 ; 56, 2: 87-92.
Stability of dolasetron mesylate in 0.9% sodium chloride and 5% dextrose in water.
Chan J, Walker SE, Law S.
2003
3712 Journal
Pediatr Crit Care Med 2001 ; 2, 4: 315-317.
Stability of dopamine and epinephrine solutions up to 84 hours.
Ghanayem N.S, Lee L, Nelson T, Wong S, Gordon G.B, Markdante K et al.
2001
1820 Journal
J Clin Pharm Ther 2003 ; 28: 471-474.
Stability of dopamine hydrochloride 0.5 mg/ml in polypropylene syringes.
Braenden JU, Stendal TL, Fagernaes CB.
2003
206 Journal
Am J Health-Syst Pharm 1996 ; 53: 186.
Stability of dopamine hydrochloride and of dobutamine hydrochloride in plastic syringes and administration sets.
Sautou-Miranda V, Gremeau I, Chamard I, Cassagnes J, Chopineau J.
1996
1249 Journal
Am J Hosp Pharm 1985 ; 42: 595-597.
Stability of dopamine hydrochloride exposed to blue-light phototherapy.
Dandurand KR, Stennett DJ.
1985
3145 Journal
Am J Health-Syst Pharm 2010 ; 67: 1539-1544.
Stability of doripenem in polyvinyl chloride bags and elastomeric pumps.
Crandon JL, Sutherland C, Nicolau DP.
2010
2316 Journal
Clin Ther 2008 ; 30, 11: 2075-2087.
Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas P.A, Kuzmission A, Ikeda K, Yasuo S.
2008
2256 Manufacturer
Ebewe Pharma 2007
Stability of doxorubicin "Ebewe" infusion solutions.
2007
32 Journal
Am J Health-Syst Pharm 1996 ; 53: 1171-1173.
Stability of doxorubicin and vincristine sulfate in two portable infusion-pump reservoirs.
Nyhammar EK, Johansson SG, Seiving BE.
1996
686 Journal
J Clin Pharm Ther 1990 ; 15: 279-289.
Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags.
Wood MJ, Irwin WJ, Scott DK.
1990
3207 Journal
Int J Pharm Compound 2011 ; 15, 2: 170-173.
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes.
McCluskey Susan V, Lovely Jenna K .
2011
2425 Journal
Am J Health-Syst Pharm 1998 ; 55: 1155-1157.
Stability of enalapril maleate in three extemporaneously prepared oral liquids
Nahata MC, Morosco RS, Hipple TF.
1998
1720 Journal
Int J Pharm Compound 2001 ; 5: 394-396.
Stability of ephedrine sulfate at ambient temperature and 4°C in polypropylene syringes.
Storms ML, Stewart JT, Warren FW.
2001
1292 Journal
Int J Pharm Pract 1995 ; 3: 174-177.
Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags.
Grassby PF, Roberts DE.
1995
3704 Journal
Can J Hosp Pharm 2014 ; 67, 3:179-202.
Stability of Epinephrine at Standard Concentrations
Carr R.R, Decarie D, Ensom M.H.H
2014
2437 Journal
Am J Health-Syst Pharm 1996 ; 53: 659-662.
Stability of epinephrine hydrochloride in an extemporaneously compounded topical anesthetic solution of lidocaine, racepinephrine, and tetracaine
Larson TA, Uden DL, Schilling CG.
1996
2077 Journal
Ann Emerg Med 1990 ; 19: 1242-1244.
Stability of epinephrine in alkalinized solutions.
Bonhomme L, Benhamou D, Comoy E, Preaux N.
1990
2257 Manufacturer
Ebewe Pharma 2007
Stability of epirubicin "Ebewe" infusion solutions.
2007
3891 Journal
Can J Hosp Pharm 2015 ; 68, 2: 121-126.
Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C
Walker S.E, Law S, Perks W, Iazzetta J.
2015
3717 Journal
Am J Health-Syst Pharm 2014 ; 71:1480-1484
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C.
Jain J.G, Sutherland C, Nicolau D.P, Kuti J.L.
2014
3208 Journal
Int J Pharm Compound 2011 ; 15, 3: 252-254.
Stability of Ertapenem in an Elastomeric Infusion Device.
Phipps Stephen D, Peacock Gina F, Smith Douglas L .
2011
2178 Journal
J Pharm Biomed Anal 2007 ; 43: 445-449.
Stability of ertapenem in aqueous solutions.
Zajac M, Cielecka-Piontek J, Jelinska A.
2007
20 Journal
Am J Hosp Pharm 1986 ; 43: 2732,2738.
Stability of erythromycin in intravenous admixtures.
Pluta PL, Morgan PK.
1986
2159 Journal
Perit Dial Int 1994 ; 14: 79-81.
Stability of erythromycin lactobionate in peritoneal dialysate solutions.
Kane MP, Bailie GR, Moon DG, Siu I, Eisele G.
1994
363 Journal
Am J Hosp Pharm 1989 ; 46: 101-104.
Stability of esmolol hydrochloride and sodium nitroprussiate in intravenous admixtures.
Karnatz NN, Wong J, Baaske DM, Johnson JH, Speicher ER, Herbranson DE.
1989
137 Journal
Am J Health-Syst Pharm 1995 ; 52: 716-718.
Stability of esmolol hydrochloride in 5% dextrose injection.
Wiest DB, Garner SS, Childress LM.
1995
204 Journal
Am J Hosp Pharm 1994 ; 51: 2693-2696.
Stability of esmolol hydrochloride in intravenous solutions.
Baaske DM, Dyskstra SD, Wagenknecht DM, Karnatz NN.
1994
1716 Journal
Int J Pharm Compound 2001 ; 5: 73-75.
Stability of ethacrynate sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V.
2001
2482 Journal
Am J Hosp Pharm 1992 ; 49: 2784-2785.
Stability of etoposide solution for oral use
McLeod HL, Relling MV.
1992
4304 Journal
Drugs R D 2014 ; 14:13?23.
Stability of Etoposide Solutions in Disposable Infusion Devices for Day Hospital Cancer Practices.
Klasen K, Kessari R, Mercier L, Valade C, Grill J, Desmaris R, Paci A.
2014
2852 Journal
Int J Pharm Compound 2004 ; 8, 6: 486-488.
Stability of Extemporaneous Oral Ribavirin Liquid Preparation
Chan JP, Tong HHY, Chow AHL.
2004
3893 Journal
Can J Hosp Pharm 2016 ; 69, 4: 327-329.
Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions
Friciu M, Zaraa S, Leclair G.
2016
3714 Journal
Can J Hosp Pharm 2014 ; 67, 4: 274-280.
Stability of Extemporaneously Compounded Clonidine in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D.
2014
3713 Journal
Can J Hosp Pharm 2014 ; 67, 4 : 274-278
Stability of Extemporaneously Compounded Dexamethasone in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D.
2014
3409 Journal
Am J Health-Syst Pharm 2013 ; 70:894-899.
Stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags
Kaushal G, Sayre B.E, Prettyman T.
2013
4142 Journal
Can J Hosp Pharm 2018 ;71,3:165-172
Stability of Extemporaneously Compounded Domperidone 5 mg/mL Suspension in Oral Mix in Plastinc and Glass Bottles and Plastic Syringes.
Lingertat-Walsh K, Law S, Walker S.E.
2018
677 Journal
Can J Hosp Pharm 2015 ; 68, 4 : 346-348.
Stability of Extemporaneously Compounded Levetiracetam in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D.
2015
3826 Journal
Can J Hosp Pharm 2015 ; 68, 6: 489-491.
Stability of Extemporaneously Compounded Naproxen 25 mg/mL Suspension in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D, Lingertat-Walsh K.
2015
3763 Journal
Can J Hosp Pharm 2014 ; 67, 5:
Stability of Extemporaneously Compounded Pyridoxine in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D.
2014
2489 Journal
Am J Hosp Pharm 1989 ; 46: 2040-2042.
Stability of extemporaneously compounded spironolactone suspensions
Mathur LK, Wickman A
1989
3946 Journal
Can J Hosp Pharm 2017 ; 70,1 :51-53.
Stability of Extemporaneously Compounded Tacrolimus in Glass Bottles and Plastic Syringes
Friciu M, Zaraa S, Leclair G.
2017
4397 Journal
J Oncol Pharm Practice 2020
Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF in glass and plastic syringes.
Lingertat-Walsh K, Weilnau J, Cober M P, Ostrenga A, Poon B, Pacita S, Law S, Dupuis LL, Walker SE.
2020
3854 Journal
Can J Hosp Pharm 2016 ; 69, 2: 171-173.
Stability of extemporaneously compounded trimethioprim in glass and plastic bottles and plastic syringes.
Ensom M.H.H, Decarie D.
2016
3308 Journal
Antimicrob Agents Chemother 2012 ; 56: 3435-3437;
Stability of Extemporaneously Prepared 0.5-Percent Caspofungin Eye Drops: a Potential Cost-Savings Exercise.
Neoh C.F, Jacob J, Leung L, Li J, Stathopoulos A, Stewart K, Kong D.C.M.
2012
3165 Journal
Am J Health-Syst Pharm 2011 ; 68: 69-72.
Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus
Fohl AL, Johnson CE, Cober P.
2011
3275 Journal
Am J Health-Syst Pharm 2012 ; 69: 232-240.
Stability of extemporaneously prepared cytarabine, methotrexate sodium, and methylprednisolone sodium succinate
D?Hondt M, Vangheluwe E, Van Dorpe S, Boonen J, Bauters T, Pelfrene B, Vandenbroucke J, Robays H, De Spiegeleer B
2012
3921 Journal
Can J Hosp Pharm 2016 ; 69, 6: 505-507.
Stability of extemporaneously prepared enalapril maleate suspensions in glass bottles and plastic syringes.
Friciu M, Zaraa S, Leclair G.
2016
2547 Journal
Ann Pharmacotherapy 2001 ;35:1293-1294.
Stability of extemporaneously prepared gentamicin ophthalmic solutions.
Ho PC, Soh H, Lim SM, Yow KL.
2001
3203 Journal
Am J Health-Syst Pharm 2011 ; 68:843-845.
Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Cober MP, Johnson CE, Sudekum D, Penprase K
2011
3963 Journal
Int J Pharm Compound 2017 ; 21, 2: 160-163.
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
Kabiche D,Balde I.B,Majoul E,Kabiche S,Bourguignon E,Fontan J-E,Cisternino S,Schlatter J.
2017
3993 Journal
Int J Pharm Compound 2017 ; 3: 251-254
Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
McHenry A.R,Wempe M.F., Rice P.J.
2017
4307 Journal
J Pediatr Pharmacol Ther 2013 ;18(2):122-127.
Stability of Extemporaneously Prepared Lansoprazole Suspension at Two Temperatures.
Morrison J.T, Lugo R.A, Thigpen J.C, Brown S.D.
2013
2556 Journal
Aust J Hosp Pharm 1989 ; 19,: 344-346.
Stability of extemporaneously prepared mixtures of metoprolol and spironolactone.
Peterson GM, Meaney MF, Reid CA.
1989
2394 Journal
Am J Health-Syst Pharm 2009 ; 66: 665-667.
Stability of extemporaneously prepared moxifloxacin oral suspensions
Hutchinson DJ, Johnson CE, Klein KC.
2009
4111 Journal
Am J Health-Syst Pharm 2018 ;75,9:231-235
Stability of extemporaneously prepared ophtalmic solutions for mydriasis.
Camp N, Nadra J, Hughes S, Gilbert J, Zhao F.
2018
3185 Journal
Am J Health-Syst Pharm 2011 ; 68:519-521.
Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE, Cober MP, hawkins KA, Julian JD.
2011
4054 Journal
Am J Health-Syst Pharm 2018 , 75, 1: 28-35
Stability of extemporaneously prepared preservative-free prochlorperazine nasal spray.
Yellepeddi V.
2018
3095 Journal
Am J Health-Syst Pharm 2010 ; 67: 287-289.
Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP, Johnson CE, Lee J, Currie K.
2010
4022 Journal
Am J Health-Syst Pharm 2017 ; 74,19: 1579-1583
Stability of extemporaneously prepared rosuvastatin oral suspension.
Zaid A.N, Shtayah R, Qadumi A, Ghanem M, Qedan R, Daibes M, Abu Awwad S, Jaradat N, Kittana N.
2017
2381 Journal
Ann Pharmacotherapy 2010 ;44:462-465.
Stability of Extemporaneously Prepared Rufinamide Oral Suspensions .
Hutchinson DJ, Liou Y, Best R, Zhao F.
2010
2824 Journal
J Clin Pharm Ther 2003 ; 28: 457-463.
Stability of extemporaneously prepared saquinavir formulations
Tan LK, Thenmozhiyal JC, Ho PC.
2003
4139 Journal
Int J Pharm Compound 2018 ;22,4:326-328
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspensions.
Atkins J.R, Lull M.E, Decker A.S, Hutchinson D.J.
2018
2399 Journal
Am J Health-Syst Pharm 2007 ; 64: 1513-1515.
Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions
Caruthers RL, Johnson CE.
2007
3083 Journal
Am J Health-Syst Pharm 2009 ; 66: 1478-1483.
Stability of extemporaneously prepared voriconazole ophthalmic solution
Al-Badriyeh D, Li J, Stewart K, Kong DCM, Leung L, Davies GE, Robert Fullinfaw R.
2009
77 Journal
Am J Hosp Pharm 1990 ; 47: 2073-2074.
Stability of famotidine frozen in polypropylene syringes.
Shea BF, Souney PF.
1990
2392 Journal
Am J Health-Syst Pharm 2000 ; 57: 1340-1342.
Stability of famotidine in an extemporaneously compounded oral liquid
Dentinger PJ, Swenson CF, Anaizi NH.
2000
2516 Journal
Am J Hosp Pharm 1993 ; 50: 691-693.
Stability of famotidine in an extemporaneously prepared oral liquid.
Quercia RA, Jay GT, Fan C.
1993
553 Journal
Ann Pharmacotherapy 1989 ; 23: 132-135.
Stability of famotidine in minibags refrigerated and/or frozen.
Bullock LS, Fitzgerald JF, Glick MR.
1989
215 Journal
Ann Pharmacotherapy 1993 ; 27: 422-426.
Stability of famotidine in polyvinyl chloride minibags and polypropylene syringes and compatibility of famotidine with selected drugs.
Keyi X, Gagnon N, Bisson C, Desmarais M, LeBel M.
1993
1618 Journal
Am J Health-Syst Pharm 2002 ; 59: 846-848.
Stability of fenoldopam in two infusion solutions.
Trissel LA, Zhang Y, Baker MB.
2002
2334 Journal
Am J Health-Syst Pharm 2009 ; 66, 9: 860-863.
Stability of fentanyl 5 µg/mL diluted with 0.9% sodium chloride injection and stored in polypropylene syringes
McCluskey S.V, Graner K.K, Kemp J, Aloumanis V, Ben M, Kupiec T, Nicole Vu N.
2009
60 Journal
Am J Hosp Pharm 1990 ; 47: 2037-2040.
Stability of fentanyl citrate and bupivacaine hydrochloride in portable pump reservoirs.
Tu YH, Stiles ML, Allen LV Jr.
1990
225 Journal
Am J Health-Syst Pharm 1995 ; 52: 511-513.
Stability of fentanyl citrate and midazolam hydrochloride during simulated intravenous coadministration.
Bhatt-Mehta V, Johnson CE, Leininger N, Agarwal M.
1995
222 Journal
Am J Hosp Pharm 1990 ; 47: 1572-1574.
Stability of fentanyl citrate in 0.9% sodium chloride solution in portable infusion pumps.
Allen LV, Stiles ML, Tu YH.
1990
223 Journal
Am J Hosp Pharm 1990 ; 47: 1584-1587.
Stability of fentanyl citrate in glass and plastic containers and in a patient-controlled delivery system.
Kowalski SR, Gourlay GK.
1990
3916 Journal
Int J Pharm Compound 2016 ; 20, 6 : 514-516.
Stability of Fentanyl Citrate in Polyolefin Bags.
Donnelly R F.
2016
4303 Journal
Pharmacy 2015 3, 379-385.
Stability of Fentanyl Citrate, Hydromorphone Hydrochloride, Ketamine Hydrochloride, Midazolam, Morphine Sulfate, and Pentobarbital Sodium in Polypropylene Syringes.
Anderson C, MacKay M.
2015
507 Journal
Br J Anaesth 1992 ; 68: 414-417.
Stability of fentanyl, bupivacaine and adrenaline solutions for extradural infusion.
Dawson PJ, Bjorksten AR, Duncan IP, Barnes RK, Beemer GH.
1992
1832 Journal
Pharmazie 2003 ; 6
Stability of fentanyl/ropivacain preparations for epidural application.
Hartmann M, Knoth H, K?ler W, Meissner W.
2003
3694 Journal
Am J Hosp Pharm 1989 ; 46: 985-989.
Stability of floxuridine and leucovorin calcium admixtures for intraperitoneal administration.
Smith J.A, Morris A, Duafala M.E, Bertino J.R, Markman M, Kleinberg M.
1989
286 Journal
Am J Hosp Pharm 1992 ; 49: 1459-1462.
Stability of fluconazole and amino acids in parenteral nutrient solutions.
Couch P, Jacobson P, Johnson CE.
1992
2527 Journal
Am J Hosp Pharm 1993 ; 50: 2366-2367.
Stability of fluconazole in an extemporaneously prepared oral liquid
Yamreudeewong W, Lopez-Anaya A, Rappaport H.
1993
256 Journal
Am J Hosp Pharm 1993 ; 50: 1206-1208.
Stability of fluconazole in commonly used intravenous antibiotic solutions.
Inagaki K, Takagi J, Lor E, Lee KJ, Nii L, Gill MA.
1993
257 Journal
Am J Hosp Pharm 1993 ; 50: 1186-1187.
Stability of fluconazole in injectable solutions.
Hunt-Fugate AK, Hennessey CK, Kazarian CM.
1993
2405 Journal
Am J Health-Syst Pharm 2002 ; 59: 1853-1855.
Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations
VandenBussche HL, Johnson CE, Yun J, Patel SA.
2002
2455 Journal
Am J Health-Syst Pharm 2002 ; 59: 1853-1855.
Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations
VandenBussche HL, Johnson CE, Yun J, Patel SA.
2002
2440 Journal
Am J Health-Syst Pharm 1996 ; 53: 407-409.
Stability of flucytosine in an extemporaneously compounded oral liquid
Wintermeyer SM, Nahata MC.
1996
2621 Journal
Eur J Pharm Biopharm 2003 ; 55: 209-213.
Stability of fludrocortisone acetate solutions prepared from tablets and powder.
Cisternino S, Schlatter J, Saulnier JL.
2003
187 Journal
Am J Hosp Pharm 1993 ; 50: 1907-1912.
Stability of flumazenil with selected drugs in 5% dextrose injection.
Olsen KM, Gurley BJ, Davis GA, Christensen R, Monaghan MS.
1993
415 Journal
Am J Hosp Pharm 1989 ; 46: 2036-2040.
Stability of fluorouracil administered through four portable infusion pumps.
Stiles ML, Allen LV, Tu YH.
1989
844 Journal
J Pharm Clin 1989 ; 9: 31-35.
Stability of fluorouracil and cytarabine in ethylvinylacetate containers.
Rochard E, Chapelle G, Bouquet S, Barthes D, Courtois PH.
1989
1040 Journal
Am J Hosp Pharm 1984 ; 41: 1153-1156.
Stability of fluorouracil in plastic containers used for continuous infusion at home.
Quebbeman EJ, Hamid AAR, Hoffman NE, Ausman RK.
1984
33 Journal
Am J Health-Syst Pharm 1996 ; 53: 1457-1458.
Stability of fluorouracil in polypropylene syringes and ethylene vinyl acetate infusion-pump reservoirs.
Baud-Camus F, Crauste-Manciet S, Klein E, Richard L, Brossard D.
1996
142 Journal
Am J Hosp Pharm 1992 ; 49: 619-623.
Stability of fluorouracil, cytarabine, or doxorubicin hydrochloride in ethylene vinylacetate portable infusion-pump reservoirs.
Rochard EB, Barthes DMC, Courtois PY.
1992
3155 Journal
J Ocular Pharm Ther 2010 ; 26, 5: 485-490.
Stability of Fortified Cefazolin Ophthalmic Solutions Prepared in Artificial Tears Containing Surfactant-Based Versus Oxidant-Based Preservatives.
Rojanarata T, Tankul J, Woranaipinich C, Potawanich P, Plianwong S, Sakulma S, Saehuan C.
2010
2 Journal
Am J Hosp Pharm 1994 ; 51: 88-90.
Stability of foscarnet in 0.9% sodium chloride injection.
Woods K, Steinmann W, Bruns L, Neels JT.
1994
75 Journal
J Clin Pharm Ther 1994 ; 19: 35-36.
Stability of foscarnet sodium in 5% dextrose and 0.9% sodium chloride injections.
Mathew M, Das Gupta V, Bethea C.
1994
800 Journal
Ann Pharmacotherapy 1997 ; 31: 553-559.
Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes.
Fischer JH, Cwik MJ, Luer MS, Sibley CB, Deyo KL.
1997
3974 Journal
Eur J Pharm Sci 2020
Stability of frozen 1% voriconazole eye drops in glass and in innovative containers.
Roche M, Lannoy D, Bourdon F, Dhorne C, Berneron C, Danel C, G.Fernandez, M.J,Simon N, Odou P.
2020
3561 Journal
Am J Health-Syst Pharm 2015 ; 72:479-482
Stability of frozen 1% voriconazole ophthalmic solution.
Amor?s-Reboredo P, Bastida-Fernandez C, Guerrero-Molina L, Soy-Muner D, L?pez-Cabezas C.
2015
4032 Poster
EAHP Congress - Paris 2013
Stability of frozen ceftazidime in polypropylene syringes for intravitreal injection.
Daul A, Vigneron J, Zenier H, May I, Demor? B.
2013
583 Journal
Am J Hosp Pharm 1980 ; 37: 98-101.
Stability of frozen solutions of cefamandole nafate.
Bornstein M, Klink PR, Farrell BT, Winely CL, Boylan JC.
1980
581 Journal
Am J Hosp Pharm 1976 ; 33: 639-641.
Stability of frozen solutions of cefazolin sodium.
Carone SM, Bornstein M, Coleman DL, Thomas PN, Boylan JC.
1976
563 Journal
Am J Hosp Pharm 1978 ; 35: 1386-1387.
Stability of frozen solutions of doxycycline hyclate for injection.
Petrick RJ, Wolleben JE, Vargas TA.
1978
580 Journal
Am J Hosp Pharm 1972 ; 29: 687-689.
Stability of frozen solutions of sodium cephalothin and cephaloridine.
Boylan JC, Simmons JL, Winely CL.
1972
2382 Journal
Am J Health-Syst Pharm 1999 ; 56: 547-550.
Stability of fumagillin in an extemporaneously prepared ophthalmic solution
Abdel-Rahman SM, Nahata MC.
1999
4341 Journal
Int J Pharm Compound 2019 ;23,5:414-417
Stability of Furosemide 5 mg/mL in Polypropylene Syringes.
Van der Schaar JAJ, Grouls R, Franssen EJF, Crul M.
2019
3821 Journal
Am J Health-Syst Pharm 2015 ; 72:2182-2188
Stability of furosemide and chlorothiazide stored in syringes.
Cies J.J, Moore W.S, Chopra A, Lu G, Mason R.W.
2015
3490 Journal
Ann Pharmacotherapy 2002 ; 36: 423-426.
Stability of furosemide in human albumin solution.
Elwell R.J, Spencer A.P, Barnes J.F, Wynn J.E, Jones C.E.
2002
4308 Journal
PlosOne 2017
Stability of gabapentin in extemporaneously compounded oral suspensions.
Friciu M, Roullin G, Leclair G.
2017
3322 Journal
Int J Pharm Compound 2012 ; 16, 4 : 347-349.
Stability of Gabapentin in SyrSpend SF.
Sorenson B, Voudrie M, Gehrig D.
2012
141 Journal
Hosp Pharm 1989 ; 24: 929-934.
Stability of gallium nitrate and mitoguazone dihydrochloride in commonly used intravenous fluids.
Kleinberg ML, Oberdier J, Muller RJ, Duafala M, Boylan JC.
1989
245 Journal
J Pharm Belg 1992 ; 47: 494-498.
Stability of ganciclovir sodium (Cymevan*) after dilution in PVC infusions and polypropylene syringes.
Phaypradith S, Vigneron J, Perrin A, Durney-Archeray MJ, Hoffman MA, Hoffman M.
1992
69 Journal
Am J Hosp Pharm 1986 ; 43: 2810-2812.
Stability of ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride injections.
Visor GC, Lin LH, Jackson SE, Winterle JS, Lee G, Kenley RA.
1986
76 Journal
Am J Hosp Pharm 1992 ; 49: 116-118.
Stability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 days.
Parasrampuria J, Li LC, Stelmach AH, Sykes TR, Gordon GA.
1992
74 Journal
Am J Hosp Pharm 1994 ; 51: 1348-1349.
Stability of ganciclovir sodium in an infusion-pump syringe.
Mulye NV, Turco SJ, Speaker TJ.
1994
4147 Journal
Minerva Anestesiologica 2014 ;81,3:283-287
Stability of generic brands of meropenem reconstituted in isotonic saline.
Carlier M, Stove V, Verstraete A.G, De Waele J.J.
2014
4182 Poster
Professional Practice Conference - Canadian Societ 2018
Stability of Generic Formulations of Bortezomib 1.0 and 2.5 mg/mL in Vials and Syringes Stored 4°C and Room Temperature (23°C)
Law S, Charbonneau L, Iazetta J, Perks W, Walker S.E.
2018
1486 Journal
Hosp Pharm 1987 ; 22: 1131-1132.
Stability of gentamicin diluted in 0.9% sodium chloride injection in glass syringes.
Nahata MC, Hipple TF, Strausbaugh SD.
1987
1704 Journal
Int J Pharm Compound 2002 ; 6: 152-154.
Stability of gentamicin sulfate and tobramycin sulfate in autodose infusion system bags.
Xu QA, Trissel LA, Saenz A.
2002
2487 Journal
Am J Hosp Pharm 1991 ; 48: 507-509.
Stability of gentamicin sulfate and tobramycin sulfate in extemporaneously prepared ophthalmic solutions at 8 degrees C
McBride HA, Martinez DR, Trang JM, Lander RD, Helms HA.
1991
1008 Journal
Pharm Int 1985 ; 6: 7.
Stability of glyceryl trinitrate in plastic and glass containers.
D?Arcy PF.
1985
1756 Journal
Int J Pharm Compound 2003 ; 7: 65-67.
Stability of glycopyrrolate injection at ambient temperature and 4°C in polypropylene syringes.
Storms ML, Stewart JT, Flynn WW.
2003
51 Journal
Am J Health-Syst Pharm 1995 ; 52: 1541-1543.
Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
Chung KC, Chin A, Gill MA.
1995
2427 Journal
Am J Health-Syst Pharm 1997 ; 54: 1404-1406.
Stability of granisetron hydrochloride in an extemporaneously prepared oral liquid
Quercia RA, Zhang J, Fan C, Chow MS.
1997
2429 Journal
Am J Health-Syst Pharm 1997 ; 54: 1404-1406.
Stability of granisetron hydrochloride in an extemporaneously prepared oral liquid
Quercia RA, Zhang J, Fan C, Chow MS.
1997
48 Journal
Am J Health-Syst Pharm 1996 ; 53: 2744-2746.
Stability of granisetron hydrochloride in polypropylene syringes.
Quercia RA, Zhang J, Fau C, Chow MSS.
1996
2423 Journal
Am J Health-Syst Pharm 1998 ; 55: 2511-2513.
Stability of granisetron hydrochloride in two oral suspensions
Nahata MC, Morosco RS, Hipple TF.
1998
27 Journal
Am J Health-Syst Pharm 1996 ; 53: 1174-1176.
Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days.
Chin A, Moon YSK, Chung KC, Gill MA.
1996
605 Journal
Am J Hosp Pharm 1982 ; 39: 292-294.
Stability of haloperidol in 5% dextrose injection.
Das Gupta V, Stewart KR.
1982
791 Journal
JPEN 1996 ; 20: 219-220.
Stability of heparin anticoagulant activity over time in parenteral nutrition solutions.
Hensrud DD, Buritt MF, Hall LG.
1996
4166 Journal
J Clin Pharm Ther 1978 3:211-214
Stability of heparin in sodium chloride solution.
Bowie H.M, Haylor V.
1978
339 Journal
Am J Hosp Pharm 1990 ; 47: 377-381.
Stability of heroin hydrochloride in infusion devices and containers for intravenous administration.
Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D.
1990
192 Journal
Am J Health-Syst Pharm 1997 ; 54: 1417-1419.
Stability of high-concentration dopamine hydrochloride, norepinephrine bitartrate, epinephrine hydrochloride, and nitroglycerin in 5% dextrose injection.
Peddicord TE, Olsen KM, ZumBrunnen TL, Warner DJ, Webb L.
1997
1416 Journal
Am J Health-Syst Pharm 1999 ; 56: 246-248.
Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions.
Stamatakis MK, Leader G, Tracy TS.
1999
3256 Journal
EJHP 2011 ; 17, 5: 49-56.
Stability of Hospira filgrastim following changes to thermal and photic storage conditions.
Burnett B, Radic I.
2011
2836 Journal
Int J Pharm Compound 2003 ; 7, 4: 313-319.
Stability of Hydralazine Hydrochloride in Both Flavored and Nonflavored Extemporaneous Preparations
Okoka CC, Modwick T, Naira G, Khuspo S, Grady LT.
2003
3168 Journal
Am J Hosp Pharm 1993 ; 50: 683-686.
Stability of hydralazine hydrochloride syrup compounded from tablets.
Alexander KS, Pudipeddi M, Parker GA.
1993
909 Journal
J Informed Pharmacother 2003 ; 13: 100-110.
Stability of hydrocortisone in extemporaneously compounded suspensions.
Chong G, Decarie D, Ensom M.H.H.
2003
2538 Journal
Ann Pharmacotherapy 1995 ;29:987-990.
Stability of hydrocortisone oral suspensions prepared from tablets and powder.
Fawcett JP, Boulton DW, Jiang R, Woods DJ.
1995
4416 Journal
J Pediatr Pharmacol Ther 2015 ; 20, 3: 197-202.
Stability of Hydrocortisone Preservative-Free Oral Solutions.
Chappe J, Osman N, Cisternino S, Fontan J-E, Schlatter J.
2015
2354 Journal
Int J Pharm Compound 2000 ; 4, 5: 396-397.
Stability of hydrocortisone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Das Gupta V, Ling J.
2000
3892 Journal
Can J Hosp Pharm 2016 ; 69, 4 : 329-333.
Stability of Hydrocortisone, Nifedipine, and Nitroglycerine Compounded Preparations for the Treatment of Anorectal Conditions
Friciu M, Chefson A, Leclair G.
2016
2336 Journal
Can J Hosp Pharm 2009 ; 62, 2: 112-118.
Stability of Hydromorphone–Ketamine Solutions in Glass Bottles, Plastic Syringes, and IV Bags for Pediatric Use
Ensom M.H.H, Decarie D, Leung K, MontgomeryC
2009
3779 Journal
Am J Health-Syst Pharm 2014 ; 71:2061-2065
Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection
Kintzel P.E, Zhao T, Wen B, Sun D.
2014
1981 Journal
Am J Health-Syst Pharm 2002 ; 59: 2434-2439.
Stability of i.v. mycophenolate mofetil in 5% dextrose injection in polyvinyl chloride infusion bags.
Certain E, Beteta F, Goudou-Sinha C, Darbord JC, Prognon P, Jacquot C.
2002
1985 Journal
Am J Health-Syst Pharm 2005 ; 62: 630-633.
Stability of ibuprofen in injection solutions.
Volont? MG, Valora PD, Congolani A, Ferrara M.
2005
489 Journal
Am J Hosp Pharm 1992 ; 49: 1137-1139.
Stability of ifosfamide in 0.9% sodium chloride solution or water for injection in a portable IV pump cassette.
Munoz M, Girona V, Pujol M, Duran S, Vicente P, Sol? LA.
1992
898 Journal
JPEN 1990 ; 14: 306-309.
Stability of imipenem and cilastatin sodium in total parenteral nutrient solution.
Zaccardelli DS, Sanders Kromarik C, Wolk R, Khalidi N.
1990
1811 Journal
Hosp Pharm 2003 ; 38: 130-134.
Stability of imipenem-cilastatin sodium in autodose infusion system bags.
Trissel LA, Xu QA.
2003
923 Journal
Int J Pharm Compound 1998 ; 2: 170-171.
Stability of indomethacin in 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J.
1998
3333 Journal
Am J Health-Syst Pharm 2012 ; 69:1509-1512.
Stability of infliximab in polyvinyl chloride bags.
Ikeda R, Vermeulen L.C, Lau E, Jiang Z, Saha S, Reichelderfer M, Kolesar J.M.
2012
4049 Journal
J Pharm Biomed Anal 2018 ; 150 : 386-395
Stability of infliximab solutions in different temperature and dilution conditions.
Tokhadze N, Chennell P, Le Basle Y, Sautou V.
2018
1288 Journal
Int J Pharm Pract 1994 ; 3: 57-59.
Stability of injections containing diamorphine and midazolam in plastic syringes.
Allwood MC, Brown PW, Lee M.
1994
2091 Journal
J Pharm Pract and Res 2004 ; 34: 11-13.
Stability of insulin aspart in normal saline infusion.
Lim SC, Roberts MJ, Paech MJ, Peng L, Jones A.
2004
803 Journal
Diabetes Care 1997 ; 20: 1061-1065.
Stability of insulin lispro in insulin infusion systems.
Lougheed WD, Weymouth AB, Zinman B, Bernstein EA, Strack TR, Korbas AM, Janis LJ, Frank BH.
1997
426 Journal
Am J Hosp Pharm 1986 ; 43: 925-927.
Stability of intravenous admixtures containing aztreonam and cefazolin.
Riley CM, James MJ.
1986
422 Journal
Am J Hosp Pharm 1985 ; 42: 1095-1100.
Stability of intravenous admixtures of aztreonam and ampicillin.
James MJ, Riley CM.
1985
19 Journal
Am J Hosp Pharm 1986 ; 43: 1444-1453.
Stability of intravenous admixtures of aztreonam and cefoxitin, gentamicin, metronidazole, or tobramycin.
Bell RG, Lipford LC, Massanari MJ, Riley CM.
1986
419 Journal
Am J Hosp Pharm 1985 ; 42: 1984-1986.
Stability of intravenous admixtures of aztreonam and clindamycin phosphate.
James MJ, Riley CM.
1985
2094 Journal
EJHP Science 2006 ; 12, 1: 10-12.
Stability of intravenous admixtures of doxorubicin and vincristine confirmed by LC-MS.
Trittler R.
2006
408 Journal
Am J Hosp Pharm 1986 ; 43: 3022-3027.
Stability of intravenous admixtures of doxorubicin and vincristine.
Beijnen JH, Neef C, Meuwissen OJAT, Rutten JJMH, Rosing H, Underberg WJM.
1986
690 Journal
Ann Pharmacotherapy 1989 ; 23: 588-590.
Stability of intravenous famotidine stored in polyvinyl chloride syringes.
Bullock LS, Fitzgerald JF, Mazur HI.
1989
3189 Journal
J Pharm Pract and Res 2010 ; 40, 2: 101-105.
Stability of intravenous flucloxacillin solutions used for hospital-in-the-home.
Tho T-P, Ching MS, Elis AG, Williams L, Garrett MK.
2010
694 Journal
Can J Hosp Pharm 1988 ; 41: 233-238, 242.
Stability of intravenous vancomycin.
Walker SE, Birkhans B.
1988
1823 Journal
J Clin Pharm Ther 2003 ; 28: 349-353.
Stability of intravesical epirubicin infusion: a sequential temperature study.
Sewell GJ, Rigby-Jones AE, Priston MJ.
2003
3850 Journal
Eur J Cancer 2016 ; 58: 8-16.
Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues.
Bardo-Brouard P, Vieillard V, Shekarian T, Marabelle A, Astier A, Paul M.
2016
2685 Journal
Int J Pharm Pract 1995 ; 3: 169-173.
Stability of ipratropium bromide and salbutamol nebuliser admixtures.
Jacobson GA, Peterson GM.
1995
1617 Journal
Am J Health-Syst Pharm 2002 ; 59: 539-544.
Stability of irinotecan hydrochloride in aqueous solutions.
Li WY, Koda RT.
2002
2671 Journal
J Oncol Pharm Practice 2010 ; 16: 53-61.
Stability of irinotecan-loaded eluting beads (DC Bead) used for transarterial chemoembolization.
Kaiser J, Thiesen J, Krämer I.
2010
2818 Journal
J Pharm Biomed Anal 1998 ; 17: 885-890.
Stability of isoniazid in isoniazid syrup: formation of hydrazine
Carlin A, Gregory N, Simmons J.
1998
4113 Journal
Am J Health-Syst Pharm 2018 ; 75, 10: 622-626.
Stability of isoniazid injection in i.v. solutions.
Lee J, Moriyama B, Henning S, Danner R, Walsh T, Penzak S, Grimes G, Gopal K.
2018
2523 Journal
Am J Hosp Pharm 1994 ; 51: 2409-2411.
Stability of isradipine in an extemporaneously compounded oral liquid
MacDonald JL, Johnson CE, Jacobson P.
1994
2442 Journal
Am J Health-Syst Pharm 1995 ; 52: 189-191.
Stability of itraconazole in an extemporaneously compounded oral liquid
Jacobson PA, Johnson CE, Walters, JR.
1995
2982 Journal
J Ped Pharm Pract 1998 ; 3: 115-118.
Stability of itraconazole in an extemporaneously suspension.
Abdel-Rahman SM, Nahata MC.
1998
1714 Journal
Int J Pharm Compound 2002 ; 6: 316-317.
Stability of ketamine hydrochloride injection after reconstitution in water for injection and storage in 1-ml tuberculin polypropylene syringes for pediatric use.
Gupta VD.
2002
2329 Journal
Can J Hosp Pharm 2008 ; 61, 6: 426-430.
Stability of Ketamine-Propofol mixtures for procedural sedation and analgesia in the emergency department.
Donnely R.F, Willman E, Andolfatto G.
2008
2441 Journal
Am J Health-Syst Pharm 1996 ; 53: 2073-2078.
Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA,
1996
451 Journal
Int J Pharm Compound 1997 ; 1: 206-207.
Stability of ketorolac tromethamine in 5% dextrose injection and 0.9% sodium chloride injections.
Das Gupta V, Maswoswe J, Bailey RE.
1997
1634 Journal
Can J Hosp Pharm 2000 ; 53: 263-269.
Stability of ketorolac tromethamine in IV solutions and waste reduction.
Shi A, Walker SE, Law S.
2000
1858 Journal
Pharm Acta Helv 1999 ; 74: 1-9.
Stability of L-asparaginase: an enzyme used in leukemia treatment.
Stecher AL, Morgantetti de Deus P, Polikarpov I, Abrahao-Neto J.
1999
3793 Journal
Drug Intell Clin Pharm 1991 ; 25: 465-469.
Stability of labetalol hydrochloride in distilled water, simple syrup, and three fruit juices.
Nahata M.C.
1991
199 Journal
Am J Hosp Pharm 1994 ; 51: 2143-2145.
Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
Hassan E, Leslie J, Martir-Herrero ML.
1994
2435 Journal
Am J Health-Syst Pharm 1996 ; 53: 2304-2309.
Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA,
1996
2416 Journal
Am J Health-Syst Pharm 1999 ; 56: 240-242.
Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C
Nahata MC, Morosco RS, Hipple TF.
1999
2594 Journal
Can J Hosp Pharm 2007 ; 60, 3: 184-191.
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration.
Ensom MHH, Decarie D, Sheppard I.
2007
2635 Journal
Hosp Pharm 2008 ; 43, 4: 303-306.
Stability of levalbuterol in a mixture of levalbuterol and ipratropium nebulizer solution.
Yamreudeewoh W, Teixeira G, Mayer GE.
2008
2970 Journal
J Pharm Pharm Sci 2005 ; 8: 322-325.
Stability of levamisole oral solutions prepared from tablets and powder.
Chiadmi F, Lyer A, Cisternino S et al.
2005
3221 Journal
Can J Hosp Pharm 2011 ; 64, 3: 207-211.
Stability of Levetiracetam in Extemporaneously Compounded Suspensions.
Ensom MHH, Decarie D, Rudolph S.
2011
3568 Journal
Am J Health-Syst Pharm 2014 ;71:219-222
Stability of levetiracetam oral solution repackaged in oral plastic syringes.
Prohotsky D.L, Hughes S.E, Zhao F.
2014
3926 Journal
Hosp Pharm 2016 ; 51 ; 11 : 915-921.
Stability of Levodopa/Carbidopa Rectal Suspensions.
Donnelly R.F.
2016
2409 Journal
Am J Health-Syst Pharm 1999 ; 56: 2316-2318.
Stability of levofloxacin in an extemporaneously compounded oral liquid
VandenBussche HL, Johnson CE, Fontana EM, Meram JM.
1999
108 Journal
Am J Health-Syst Pharm 1996 ; 53: 2309-2313.
Stability of levofloxacin in intravenous solutions in polyvinyl chloride bags.
Williams NA, Bornstein M, Johnson K.
1996
3166 Journal
Can J Hosp Pharm 2011 ; 63, 6: 437-443.
Stability of Levothyroxine in Sodium Chloride for IV Administration.
Strong DK, Decarie D, Ensom MHH.
2011
3228 Journal
Am J Health-Syst Pharm 2011 ;68:1723-1728.
Stability of levothyroxine injection in glass, polyvinyl chloride, and polyolefin containers
Frenette AJ, MacLean RD, Williamson D, Marsolais P, . Donnelly RF
2011
2358 Journal
Int J Pharm Compound 2000 ; 4, 6: 482-483.
Stability of levothyroxine sodium injection in polypropylene syringes.
Das Gupta V.
2000
3811 Journal
Int J Pharm Compound 2015 ; 19, 5 : 428-431.
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures.
Nahata Milap C.
2015
1202 Journal
Am J Hosp Pharm 1981 ; 38: 1745-1747.
Stability of lidocaine hydrochloride in 5% dextrose injection in plastic bags.
Smith FM, Nuessle NO.
1981
1715 Journal
Int J Pharm Compound 2002 ; 6: 388-390.
Stability of lidocaine hydrochloride injection at ambient temperature and 4°C in polypropylene syringes.
Storms ML, Stewart JT, Warren FW.
2002
2549 Journal
Ann Pharmacotherapy 2004 ;38:396-399.
Stability of Lisinopril in Two Liquid Dosage Forms
Nahata MC, Morosco RS.
2004
2680 Journal
Int J Pharm Compound 2000 : 398-399.
Stability of lisinopril syrup (2 mg/ml) extemporaneously compounded from tablets.
Rose DJ, Webster AA, English BA.
2000
2647 Journal
Int J Pharm 1998 ; 51, 2: 157-160.
Stability of loperamide hydrochloride in aqueous solutions as determined by high performance liquid chromatography
Tu YH, Allen LV, Wang DP.
1998
765 Journal
Am J Health-Syst Pharm 1998 ; 55: 2013-2015.
Stability of lorazepam 1 and 2 mg/ml in glass bottles and polypropylene syringes.
Share MJ, Harrison RD, Folstad J, Fleming RA.
1998
1935 Journal
Am J Health-Syst Pharm 2004 ; 61: 1039-1041.
Stability of lorazepam in 0.9% sodium chloride stored in polyolefin bags.
Norenberg JP, Achusim LE, Steel TH, Anderson TL.
2004
935 Journal
Int J Pharm Compound 1998 ; 2: 322-324.
Stability of lorazepam in 5% dextrose injection.
Das Gupta V, Pramar Y.
1998
1234 Journal
Br J Pharm Pract 1989 ; 11: 34-36.
Stability of low-dosage heparin in pre-filled syringes.
Parkinson R, Wilson JV, Ross M, Denyer SP.
1989
1414 Journal
J Pharm Technol 1999 ; 15: 13-17.
Stability of low-dose vancomycin hydrochloride in heparin sodium 100 UI / ml.
Mayer JLR, Pascale VJ, Clyne LP, Malkus H, Santos FS, van Hoff J.
1999
2294 Journal
Can J Hosp Pharm 2008 ; 61, 5: 356-357.
Stability of magnesium sulfate 20% in Viaflex bags.
Newby B.D, Benes C, Palmer L, Cleve R.
2008
2356 Journal
Int J Pharm Compound 1998 ; 2, 5: 385-388.
Stability of magnesium sulfate in 0.9% sodium chloride and lactated Ringers solutions.
Sarver J.G, Pryka R, Alexander K.S, Weinstein L, Erhardt P.W.
1998
2668 Journal
Int J Pharm Compound 1998 ; 2: 89-91.
Stability of mechlorethamine hydrochloride 0.01% ointment in Aquafor Base.
Zhang Y, Trissel LA, Johansen JF, Kimball CL.
1998
2872 Journal
Int J Pharm Compound 2009 ; 13, 2: 170-174.
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule
Haywood A, Burrell A, van Breda K, Testa C, Norris R.
2009
3977 Journal
Drugs R D 2015 ;15:253-259.
Stability of Melphalan in 0,9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection.
Desmaris R.P, Mercier L, Paci A.
2015
3786 Journal
JAMA Ophtalmology 2014 ; 132, 11: 1372-1373.
Stability of Melphalan Solution for Intravitreal Injection for Retinoblastoma
Buitrago E, Lagomarsino E; Mato G; Schaiquevich P.
2014
2842 Journal
Int J Pharm Compound 2006 ; 10, 4: 316-317.
Stability of Memantine in an Extemporaneously Prepared Oral Liquid
Yamreudeewong W, Teixeira MJ, Mayer GE.
2006
343 Journal
Am J Hosp Pharm 1985 ; 42: 112-115.
Stability of meperidine hydrochloride, promethazine hydrochloride, and atropine sulfate in plastic syringes.
Rhodes RS, Rhodes PJ, McCurdy HH.
1985
1735 Journal
J Pharm Biomed Anal 1999 ; 21: 577-583.
Stability of mepiridine in an implantable infusion pump using capillary gas chromatography-mass spectrometry and a deuterated internal standard.
Harvey SC, Toussaint CP, Coe SE, Watson EE, O?Neil MG, Patrick KS.
1999
4122 Journal
Hosp Pharm 2018 ;54,3:190?196
Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion.
Fawaz S, Barton S, Whitney L, Swinden J, Nabhani-Gebara S.
2018
3112 Journal
J Antimicrob Chemother 2010 ; 65: 1073-1075
Stability of meropenem and doripenem solutions for administration by continuous infusion
Berthoin K, Le Duff, CS , Marchand-Brynaert J, Carryn S, Tulkens PM
2010
4180 Journal
Perit Dial Int 2018 ;38,6:430-440
Stability of meropenem and piperacillin/tazobactam with heparin in various peritoneal dialysis solutions.
Mendes K, Harmanjeet H, Sedeeq M, Modi A, Wanandy T, Zaidi S, Ming L, Castelino R, Sud K, Peterson G, Patel R.
2018
1454 Journal
Am J Health-Syst Pharm 2000 ; 57: 992-995.
Stability of meropenem in a portable infusion device in a cold pouch.
Grant EM, Zhong MK, Ambrose PG, Nicolau DP, Nightingale CH, Quiniliani R.
2000
1639 Journal
Eur Hosp Pharm 1997 ; 3: 168-171.
Stability of meropenem in elastomeric portable infusion devices.
Krämer I.
1997
10 Journal
Am J Health-Syst Pharm 1997 ; 54: 412-421.
Stability of meropenem in intravenous solutions.
Patel PR, Cook SE.
1997
3837 Journal
South Asian J Trop Med Pub Health 2003 ; 34: 627-629.
Stability of meropenem in normal saline solution after storage at room temperature.
Jaruratanasirikul S, Sriwiriyajan S.
2003
1942 Journal
Am J Health-Syst Pharm 2004 ; 61: 1682-1685.
Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device.
Smith DL, Bauer SM, Nicolau DP.
2004
1275 Journal
Can J Hosp Pharm 1998 ; 51: 156-168.
Stability of meropenem in saline and dextrose solutions and compatibility with potassium chloride.
Walker SE, Varrin S, Yannicelli D, Law S.
1998
2524 Journal
Am J Hosp Pharm 1994 ; 51: 2955-2957.
Stability of mesalamine in rectal suspension diluted with distilled water
Henderson LM, Johnson CE, Berardi RR.
1994
3080 Journal
Ann Pharmacotherapy 2010 ; 44: 224-225.
Stability of mesna in ReadyMed devices.
Almoazen H, Bhattacharjee H, Samsa AC, Pate S.
2010
3033 Journal
Eur Respir J 1998 ; 11: 946-948.
Stability of metacholine chloride solutions under different storage conditions over a 9 months period.
Haynes RD, Beach JR, Rutherford DM et al.
1998
646 Journal
J Clin Pharm Ther 1999 ; 24: 365-368.
Stability of methacholine chloride in isotonic sodium chloride using a capillary electrophoresis assay.
Henn S, Monfort P, Vigneron JH, Hoffman MA, Hoffman M.
1999
4406 Journal
Can J Hosp Pharm 2020 2020;73(2):141-4
Stability of Methadone Hydrochloride for Injection in Saline Solution
Friciu M, Alarie H, Beauchemin M, Forest JM, Leclair G.
2020
224 Journal
Am J Hosp Pharm 1991 ; 48: 515-517.
Stability of methadone hydrochloride in 0.9% sodium chloride injection in single-dose plastic containers.
Denson DD, Crews JC, Grummich KW, Stirm EJ, Sue CA.
1991
1158 Journal
Int J Pharm 1988 ; 47: 239-247.
Stability of methotrexate and vinblastine in burette administration sets.
McElnay JC, Elliott DS, Cartwright-Shamoon J, D?Arcy PF.
1988
1155 Journal
Int J Pharm 1988 ; 45: 237-244.
Stability of methotrexate injection in prefilled plastic disposable syringes.
Wright MP, Newton JM.
1988
1922 Journal
J Am Pharm Assoc 2002 ; 42: 868-870.
Stability of methylprednisolone sodium succinate in autodose infusion system bags.
Trissel LA, Zhang Y.
2002
180 Journal
Am J Health-Syst Pharm 1996 ; 53: 1300-1302.
Stability of metoclopramide hydrochloride in plastic syringes.
Zhang Y, Trissel LA, Martinez JF, Gilbert DL.
1996
2634 Journal
Hosp Pharm 1997 ; 32: 691-693.
Stability of metolazone in a liquid dosage form.
Nahata MC, Morosco RS, Hipple TF.
1997
238 Journal
Am J Hosp Pharm 1993 ; 50: 950-952.
Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection.
Belliveau PP, Shea BF, Scavone JM.
1993
2267 Journal
Am J Health-Syst Pharm 2008 ; 65, 7: 636-638.
Stability of metoprolol tartrate injection 1 mg/ml undiluted and 0.5 mg/ml in 0.9% sodium chloride injection and 5% dextrose injection.
Kraft MD, Johnson CE, Chung C, Julian F.
2008
267 Journal
Am J Health-Syst Pharm 1996 ; 53: 1046-1048.
Stability of metronidazole and ceftizoxime sodium in ready-to-use metronidazole bags stored at 4 and 25°C.
Nahata MC, Edmonds JJ, Morosco RS.
1996
630 Journal
J Clin Hosp Pharm 1985 ; 10: 67-72.
Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions.
Das Gupta V, Stewart KR.
1985
2702 Journal
J Clin Pharm Ther 1994 ; 19, 1: 31-34.
Stability of metronidazole benzoate in suspensions
Mathew M, Gupta VD, Bethea C.
1994
2250 Journal
Int J Pharm Compound 2008 ; 12, 6: 558-564.
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System.
Vu N.T, Aloumanis V, Ben MJ, Kupiec T.C, Patterson E K, Radke J, Erickson M A III, Schneider G.
2008
4375 Journal
Int J Pharm Compound 2020 ;24,1:77-82
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets.
Jarouche M, Ibrahim M, Pearson J, Venkataya B, Low M, Rowe J.
2020
2695 Journal
Int J Pharm Compound 2015 ; 19, 3: 248-251.
Stability of Metronidazole Suspensions.
Donnelly Ronald F, Ying James.
2015
2690 Journal
J Am Pharm Assoc 2000 ; 40: 257-259.
Stability of mexiletine in two extemporaneously liquid formulatioons stored under refrigeratrion and et room temperature.
Nahata MC, Morosco RS, Hipple TF.
2000
1889 Journal
Int J Pharm 2015 ; 492 : 137?140.
Stability of micafungin sodium solutions at different concentrations in glass bottles and syringes.
Briota Th, Vrignaud S, Lagarce F.
2015
929 Journal
J Pain Symptom Manage 1998 ; 16: 52-58.
Stability of midazolam and fentanyl in infusion solutions.
Wilson KM, Schneider JJ, Ravenscroft PJ.
1998
3989 Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ; 2,1: 35
Stability of midazolam and noradrenaline stored in cyclic olefin copolymer AT-Closed Vials® and polypropylene syringes during 365 days.
Feutry F, Genay S, Velghe C, Barth?l?my C, D?caudin B, Odou, P.
2017
86 Journal
Am J Hosp Pharm 1994 ; 51: 2812-2815.
Stability of midazolam hydrochloride and morphine sulfate during simulated intravenous coadministration.
Johnson CE, Bhatt-Mehta V, Mancari SC, McKown JA.
1994
231 Journal
Am J Hosp Pharm 1993 ; 50: 2379-2381.
Stability of midazolam hydrochloride in 5% dextrose injection or 0.9% sodium chloride injection over 30 days.
Hagan RL, Jacobs III LF, Pimsler M, Merritt GJ.
1993
2499 Journal
Am J Hosp Pharm 1992 ; 49: 615-618.
Stability of midazolam hydrochloride in a flavored, dye-free oral solution
Steedman SL, Koonce, JR, Wynn JE, Brahen NH.
1992
185 Journal
Am J Health-Syst Pharm 1995 ; 52: 2018-2020.
Stability of midazolam hydrochloride in polyvinyl chloride bags under fluorescent light.
McMullin ST, Burns Schaiff RA, Dietzen DJ.
1995
41 Journal
Am J Health-Syst Pharm 1997 ; 54: 913-915.
Stability of midazolam hydrochloride in syringes and IV fluids.
Pramar YV, Loucas VA, El-Rachidi A.
1997
3222 Journal
Am J Health-Syst Pharm 2011 ;68:1537-1540.
Stability of midazolam hydrochloride injection 1-mg/mL solutions in polyvinyl chloride and polyolefin bags
Karlage K, Earhart Z, Green-Boesen K, . Myrdal PB
2011
399 Journal
Aust J Hosp Pharm 1993 ; 23: 260-262.
Stability of midazolam in sodium chloride infusion packs.
Bleasel MD, Peterson GM, Jestrimski KW.
1993
3437 Journal
Int J Pharm Compound 2013 ; 17, 4: 344-346.
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry.
Geiger C.M, Sorenson B, Whaley P.A.
2013
2772 Journal
South Med J 1993 ; 86: 771-772.
Stability of midazolam prepared for oral administration
Gragory DF, Koestner JA, Tobias JD.
1993
191 Journal
Am J Hosp Pharm 1988 ; 45: 2079-2091.
Stability of milrinone and digoxin, furosemide, procainamide hydrochloride, propranolol hydrochloride, quinidine gluconate, or verapamil hydrochloride in 5% dextrose injection.
Riley CM.
1988
366 Journal
Am J Hosp Pharm 1986 ; 43: 2218-2220.
Stability of milrinone in 0.45% sodium chloride, 0.9% sodium chloride, or 5% dextrose injections.
Wilson TD, Forde MD, Crain AVR, Dombrowski LJ, Joyce MA.
1986
4109 Journal
Am J Health-Syst Pharm 2018 ;75,9:241-245
Stability of milrinone in continuous ambulatory delivery devices.
Madfai F, Zaidi S, Ming L, Wanandy T, Patel R.
2018
922 Journal
Int J Pharm Compound 1998 ; 2: 168-169.
Stability of milrinone lactate 200 microg /mL in 5% dextrose injection and 0.9% sodium chloride injection.
Wong F, Gill MA.
1998
928 Journal
Int J Pharm Compound 1998 ; 2: 246-248.
Stability of milrinone lactate in 5% dextrose injection and 0.9% sodium chloride injection at concentrations of 400, 600 and 800 microg/mL.
Nguyen D, Gill MA, Wong F.
1998
813 Journal
Am J Health-Syst Pharm 1999 ; 56: 63-68.
Stability of milrinone lactate in the presence of 29 critical care drugs and 4 IV solutions.
Akkermann SR, Zhang H, Mullins RE, Yaughn K.
1999
3403 Journal
Int J Pharm Compound 2013 ; 17 ; 2 : 165-167.
Stability of Minoxidil in Espumil Foam Base
Geiger C.M, Sorenson B, Whaley P.A.
2013
2785 Journal
Am J Health-Syst Pharm 2005 ; 62, 11: 1192-1194.
Stability of misoprostol in suppositories.
Hafirassou H, Chaidmi F, Schlatter J, Ratiney R, Fontan JE.
2005
407 Journal
Am J Hosp Pharm 1985 ; 42: 1750-1754.
Stability of mitomycin admixtures.
Quebberman EJ, Hoffman NE, Ausman RK, Hamid AAR.
1985
648 Journal
Int J Pharm Compound 1997 ; 1: 282-283.
Stability of mitomycin aqueous solution when stored in tuberculin syringes.
Das Gupta V.
1997
485 Journal
J Oncol Pharm Practice 1995 ; 1: 19-24.
Stability of mitomycin C in different infusion fluids: compatibility with heparin and glucocorticosteroids.
Dorr RT, Liddil JD.
1995
828 Journal
J Pharm Clin 1990 ; 9: 159-165.
Stability of mitoxantrone (Novantrone*) after dilution in PVC infusions.
Lecompte D, Bousselet M, Magnam J.
1990
3052 Journal
J Pharm Pract and Res 2007 ; 37: 95-97.
Stability of mixtures formulated from warfarin tablets or powder.
Sharley NA, Yu AMC, Williams DB.
2007
1968 Journal
Hosp Pharm Pract 1992 ; 2, 9: 597-600.
Stability of morphine and droperidol separately and combined, for use as an infusion.
Williams OA, Middleton M, Henderson P, Reilly CS.
1992
679 Journal
Pharm Weekbl [Sci] 1992 ; 14: 23-26.
Stability of morphine hydrochloride in a portable pump reservoir.
Roos PJ, Glerum JH, Meilink JW.
1992
515 Journal
J Pharm Clin 1998 ; 17: 35-39.
Stability of morphine hydrochloride solutions in portable single-use PCA systems. Additives leaching into the morphine solutions.
Le Hoang MD, Sarbach C, Prognon P, Delvordre P, Mignot A, Pradeau D.
1998
4395 Poster
Sunnybrook Health Sciences Centre 2020
Stability of Morphine Solutions of 20, 40, 100 , 200 and 1,000 µg/mL in Syringes Following Dilution with 0.9% Sodium Chloride or D5W at Room Temperature (25°C).
Hook R, Riss V, Neault A, Ma N, Law S, Walker S.E.
2020
340